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Exercise-based cardiac rehabilitation is a cornerstone of secondary prevention in 
patients after myocardial infarction or coronary procedure, as it reduces cardiovascular 
morbidity and mortality. 
So far, the exercise type usually studied has been land-based exercise, aerobic and 
resistive by nature. In cardac patients, dynamic–aerobic exercise training in the form of 
walking or cycling is recommended as a mens of improving cardiovascular health. Water-
based physical activities, however, have traditionally been cautioned against because of 
the purportedly higher risk of adverse cardiovascular events. 
Increased interest in the water exerce, on the one hand, and the lack of sufficient 
information of the efficacy of short-term water-based exercise on the other, have indicated 
a need for the scientific evaluation of this type of exercise from the aspect of safety and 
efficiency in coronary patients. 
We hypothesized that water-based exercise training is as safe and effective as land-
based training in improving:  i) physical performance, ii) vascular function, iii) autonomic 
cardiac function, iv) biological markers of cardiovascular disease, and v) quality of life. 
Therefore, we conducted a randomized clinical trial comparing the safety and effects of 
14-day water- and land-based exercise training to the usual exercise routines (with no 




Patients after recent myocardial infarction or coronary revascularization were 
randomly allocated to two intervention groups and control group (30 patients each).The 
intervention groups performed supervised aerobic endurance and calisthenics exercise 
training sessions in thermoneutral water or on land, at a moderate intensity (60–80% peak 
heart rate achieved at symptom limited exercise testing), for 30 minutes twice a day for 2 
weeks. The control group, continued with their usual treatment, but did not participate in 
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any controlled physical exercise program, advised instead to perform low- to moderate-
intensity physical activities at home during the course of the study. 
Before, and after the intervention, the following examinations were made in all 
study participants: i) estimation of aerobic exercise capacity (peak oxygen uptake, V̇O2 
peak, obtained  during cardiopulmonary exercise testing), ii)  ultrasound assessment of 
flow-mediated dilation of the brachial artery during reactive hyperemia, iii) analysis of 
cardiac autonomic function with a 20-minute high-resolution ECG, iv) determination of the 
serum concentrations of markers of neurohumoral activity (NT-proBNP), inflammation 
(hsCRP, IL-6, IL-8, IL-10), endothelial activation (ICAM, P-selectin), and hemostasis 




Eighty-nine participants (mean age 59.9  8.2 years; 77.5% males, baseline V̇O peak 
14.8   3.5 ml kg-1 min-1) completed the study. One patient was excluded from the study 
due to upper respiratory tract infection. No adverse events were observed in either of the 
intervention groups during the course of the study. 
Exercise capacity, determined as V̇O2 peak, increased significantly in both training 
groups in comparison to control. When controlling for baseline V̇O2 peak and patients’ age, 
mean estimate end-of-study V̇O2 peak improved in the land-based exercise group by up to 
15.3% (16.7 [95%CI 16.0 – 17.4]; ml  kg -1 min-1; p< .001 for change from baseline) and up 
to 27.4% (18.6 [95%CI 17.9 – 19.3] ml kg-1 min-1; p< .001 for change from baseline) in the 
water-based exercise group, while the increase was not observed in controls (– 0.6%, 14.9 
[95%CI 14.2 – 15.6] ml kg-1 min-1; p= .775 for change from baseline). The land-based 
exercise group had an, on average, 1.8 (95%CI 0.8 – 2.8) ml kg-1 min-1 and the water-based 
exercise group 3.7 (95%CI 2.7 – 4.7) ml kg-1 min-1 higher end-of-study V̇O peak in 
comparison to control. 
Flow-mediated dilation improved in both training groups, with greater 
improvements after water-based exercise: in the land-based exercise group from 5.5% 
(interquartile range, IQR: 3.1 – 8.6) to 8.8% (IQR: 5.3 – 11.4), p< .001 and in the water-
based exercise group from 7.2% (IQR: 4.0 – 8.7) to 9.2% (IQR: 7.4 – 12.9), p< .001. There 
was no significant improvement in the control group (p=0.629). Non-flow-mediated 
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vasodilation improved significantly in both intervention groups, i.e. in land-based exercise, 
from baseline values of 10.6% (IQR:7.0 – 13.3) to end-of-study values of 11.1% (IQR: 9.0 – 
14.3), p< .001, and in water-based exercise from the baseline 10.5% (IQR: 8.5 – 14.0) to 
end-of-study 11.4% (IQR: 7.6 – 13.4), p= .042. 
D-dimer values significantly decreased in the water-based exercise group, from 400 
μg L
-1 (IQR: 270 – 810) to 370 μg L
-1 (IQR: 260 – 590), p< .001, while in the land-based 
exercise group we recorded lower but insignificant values in relation to basal. Significant 
reduction in NT-proBNP values was noticed only in patients in the water-based exercise 
group, from 396 ngL-1 (IQR: 296 – 541) to 308 ngL-1 (IQR: 187 – 394), (- 22%, p = .001), while 
in the land-based exercise group no significant changes were noted. There were no 
significant changes in the values of inflammatory (hsCRP, IL6, IL8, IL 10) and endothelial 
activation (ICAM, selectin) parameters, or in fibrinogen values. 
By analyzing the heart rate variability parameters before and after rehabilitation, 
we observed no significant changes in the selected time-domain parameters in patients 
undergoing water- or land-based exercise, or in the control group. Regarding the 
frequency-domain parameters, we observed a statistically significant change in the high 
frequency and low frequency parameters ratio (LF/HF) in the group of patients who 
underwent water-based exercise (p = .036). Furthermore, a significant change of indicator 
of vagal modulation - nonlinear parameter 1 (p = .043), and a marginally statistically 
significant change of another nonlinear parameter SE (p = .096), were observed in the same 
group of patients.  
Both types of exercise training were associated with improvements in the mental 




The results of our study indicate that relatively short supervised water-based 
exercise training is as safe and effective as land-based exercise training in improving 
exercise capacity and endothelial function (estimated by flow-mediated dilation) in 
patients with coronary artery disease, thus providing evidence on an additional modality 
to propose to patients in cardiac rehabilitation, according to their preference. In addition, 
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we confirmed that water-based exercise is efficient in decreasing serum D-dimer and NT-
proBNP concentrations as well as certain indicators of vagal modulation. In improving 
health-dependent quality of life, both types of exercise were equally effective. 
Besides contributing to the growing body of evidence on the effectiveness of 
exercise training in coronary artery disease patients, our findings confirms that water-
based exercise may be a safe and effective exercise option both for patients after a recent 
coronary event referred to short-term cardiac rehabilitation and as a life-long exercise 
modality. 
  






Kardiološka rehabilitacija, ki temelji na telesni vadbi, je ključna prvina sekundarne 
preventive bolnikov po srčnem infarktu ali koronarnem posegu, saj zmanjšuje srčno-žilno 
zbolevnost in umrljivost. V okviru kardiološke rehabilitacije je najbolj raziskana kombinacija 
aerobne in uporovne telesne vadbe na kopnem; večina priporočil poudarja hojo in 
kolesarjenje kot dinamično-aerobni vrsti vadbe, ki izboljšata kazalnike srčno-žilnega zdravja 
pri srčnih bolnikih. Telesne vadbe, ki se izvajajo v vodi, so srčnim bolnikom tradicionalno 
odsvetovali, ker naj bi bile povezane z zvečanim tveganjem za neželene srčno-žilne 
dogodke. Povečano zanimanje za izvajanje telesne vadbe v vodi na eni strain ter skope 
informacije o učinkovitosti kratkoročne telesne vadbe v vodi na drugi strain narekujeta 
potrebo, da se tovrstna vadba znanstveno ovrednoti z vidika varnosti in učinkovitosti pri 
koronarnih bolnikih. 
Domnevali smo, da telesna vadba v vodi enako varno in učinkovito kot vadba na 
kopnem izboljša i) telesno zmogljivost, ii) žilno funkcijo, iii) avtonomno funkcijo srca, iv) 
biološke označevalce srčno-žilne bolezni in v) kakovost življenja. Zato smo izvedli 
randomizirano klinično raziskavo, s katero smo pri koronarnih bolnikih primerjali varnost 





Bolnike po nedavnem srčnem infarktu ali revaskularizaciji srčne mišice smo 
naključno razvrstili v dve interventni skupini in eno kontrolno skupino (po 30 bolnikov v 
vsaki skupini). Interventni skupini sta bodisi v termo-nevtralni vodi bodisi na kopnem 
izvajali nadzorovani trening aerobnih in kalisteničnih vaj z zmerno intenzivnostjo (60–80 % 
najvišjega srčnega utripa, doseženega med obremenitvenim testiranjem), in sicer po 30 
minut dvakrat na dan 2 tedna. Kontrolna skupina je nadaljevala običajno zdravljenje; 
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bolniki v času raziskave niso bili vključeni v nadzorovan program telesne vadbe, smo jim pa 
svetovali telesno dejavnost nizke do zmerne intenzivnosti v domačem okolju.  
Pred obdobjem telesne vadbe in po njem smo pri vseh preiskovancih: i) ocenili 
aerobno telesno zmogljivost (največjo porabo kisika, V̇O2 peak, med kardiopulmonalnim 
obremenitvenim testiranjem), ii) ultrazvočno izmerili od pretoka odvisno dilatacijo 
brahialne arterije med reaktivno hiperemijo, iii) določili kazalnike avtonomne srčne fukcije 
z 20-minutnim visokoločljivim EKG, iv) izmerili označevalce nevrohumoralne aktivnosti (NT-
proBNP), vnetja (hsCRP, IL-6, IL-8, IL-10), endotelijske aktivacije (ICAM, P-selectin) in 
hemostaze (fibrinogen, D-dimer) v krvi ter v) ocenili z zdravjem povezano kakovost življenja 




Raziskavo je zaključilo 89 bolnikov (povprečna starost 59.9 ± 8.2 leta, 77.5% moških 
izhodiščni V̇O2 peak 14.8   3.5 ml kg-1 min-1). En udeleženec pa je nil izključen iz študije 
zaradi okužbe zgornjih dihal. V opazovanem obdobju v skupinah ni bilo zabeleženih 
nobenih neželenih dogodkov. 
Telesna zmogljivost se je v obeh interventnih skupinah v primerjavi s kontrolno 
skupino znatno izboljšala. Povprečna vrednost V̇O2 peak (ob statističnem upoštevanju 
izhodiščnega V̇O2 peak in starosti bolnika) se je po telesni vadbi na kopnem izboljšala za 
15.3% (16.7 [95%CI 16.0–17.4] ml kg -1 min-1; p< .001 za spremembo od izhodiščne 
vrednosti) oziroma po telesni vadbi v vodi za 27.4% (18.6 [95%CI 17.9– 19.3] ml kg-1 min-1; 
p < .001 za spremembo od izhodiščne vrednosti), ne pa v kontrolni skupini (–0.6 %, 14.9 
[95%CI 14.2–15.6] ml kg -1 min-1, p= .775 za spremembo od izhodiščne vrednosti). Skupina, 
ki je telovadila na kopnem, je imela v povprečju 1.8 (95%CI 0.8–2.8) ml kg -1 min-1 višji 
V̇O2peak na koncu raziskave v primerjavi s kontrolno skupino, skupina, ki je telovadila v 
vodi, pa 3.7 (95%CI 2.7–4.7) ml kg-1 min-1. 
Od pretoka odvisna dilatacija brahialne arterije se je izboljšala v obeh vadbenih 
skupinah. V skupini, ki je telovadila na kopnem, se je povečala s 5.5 % (medkvartilni razpon, 
IQR: 3.1–8.6) na 8.8 % (IQR: 5.3–11.4), p< .001), v skupini, ki je telovadila v vodi, pa s 7.2 % 
(IQR: 4.0–8.7) na 9.2 % (IQR: 7.4–12.9), p< .001. V kontrolni skupini se ni spremenila 
značilno (p=0.629). V obeh intervencijskih skupinah se je značilno izboljšala tudi od pretoka 
Danijela Vasić   Doctoral dissertation 
7 
neodvisna dilatacija brahialne arterije: v skupini, ki je telovadila na kopnem, se je povečala 
z 10.6 % (IQR: 7.0 –13.3) na 11.1 % (IQR: 9.0–14.3), p< .001, v skupini, ki je telovadila v vodi, 
pa z 10.5 % (IQR: 8.5–14.9) na 11.4 % (IQR: 7.6– 13.4), p= .042. 
Vrednosti D-dimera so se v skupini, ki je telovadila v vodi, značilno zmanjšale, in 
sicer s 400 µg L-1 (IQR: 270–810) na 370 µg  L-1 (IQR: 260–590) (p= .001), medtem ko v 
skupini, ki je telovadila na kopnem, statistično značilni razlik ni bilo. Tudi vrednosti NT-
proBNP so se značilno zmanjšale le v skupini, ki je telovadila v vodi, in sicer s 396 ngL-1 (IQR: 
296–541) na 308 ng L-1 (IQR: 187–394) (–22 %, p= .001), medtem ko v skupini, ki je 
telovadila na kopnem, statistično značilnih razlik ni bilo. Pri obeh skupinah ni bilo 
pomembnih sprememb v vrednosti označevalcev vnetja (hsCRP, IL6, IL8, IL10), endotelijske 
aktivacije (ICAM, selektin) oziroma fibrinogena. 
Med kazalniki variabilosti srčne frekvence nismo zaznali razlik med skupinami v 
izbranih linearnih kazalnikih časovne domene; smo pa pri linearnih kazalnikih frekvenčne 
domene zaznali pomembno spremembo v razmerju med visoko- in nizkofrekvenčnimi 
kazalniki (LF/HF) v skupini, ki je telovadila v vodi (p= .036). Prav tako se je pri tej skupini 
statistično značilno spremenil kazalnik vagalne modulacije α1 (p= .043), mejno pa tudi 
kazalnik SE (p= .096). 
Obe vrsti telesne vadbe sta značilno izboljšali duševne in telesne domene z 




Izsledki naše raziskave kažejo, da je pri koronarnih bolnikih razmeroma kratkotrajna 
(tj. 2-tedenska) nadzorovana telesna vadba v vodi varna in enako učinkovita pri izboljšanju 
telesne zmogljivosti in endotelijske funkcije (ocenjene s pretokom odvisne dilatacije) kot 
vadba na kopnem. S tem smo dokazali, da lahko vadbo v vodi vključimo v program 
rehabilitacije koronarnih bolnikov, če je to njihova želja. Dodatno smo pokazali, da utegne 
vadba v vodi izraziteje znižati koncentracijo D-dimera in NT-proBNP ter posamezne 
kazalnike vagalne modulacije. Nasprotno, obe vrsti vadbe primerljivo izboljšata z zdravjem 
povezano kakovost življenja. 
Z raziskavo smo prispevali k vse večjemu naboru dokazov o učinkovitosti in varnosti 
telesne vadbe pri bolnikih s koronarno boleznijo, hkrati pa potrdili, da je telesna vadba v 
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vodi lahko varna in učinkovita možnost za koronarne bolnike, ki opravljajo kratkotrajni 
program srčno-žilne rehabilitacije. 
  
Danijela Vasić   Doctoral dissertation 
9 
1. INTRODUCTION  
 




Coronary artery disease (CAD) belongs to the group of cardiovascular diseases 
(CVD) that have been confirmed as a leading cause of death globally. Available data show 
that in 2016, about 17.9 million people died of CVDs, which represented 31% of all deaths 
across the world. Of these deaths, 85% were due to heart attack or stroke (Virani et al., 
2020; World Health Organization WHO (2017) Global status report on noncommunicable 
diseases 2017 / https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-
diseases-(cvds)/). 
Despite the decline in CVD mortality seen in recent decades, in the European Union, 
of the 5.1 million deaths in 2016, over 1.8 million people (36%) died of CVDs; 609,000 
deaths were due to CAD (44% of all CVD deaths for males and 38% for females) (Timmis et 
al., 2019; https://ec.europa.eu/eurostat/en/web/products-eurostat-news/-/DDN-
20190716-1).  
CVD also represents the most common cause of disability and premature death 
worldwide as it is responsible for 30.4% deaths in men and 25.3% deaths in women before 




Coronary artery disease (CAD) is a pathological process characterized by varying 
degrees of obstruction of the epicardial coronary arteries, caused by the accumulation of 
atherosclerotic plaques in the arterial wall in the process of developing atherosclerosis, 
leading to restricted blood flow and myocardial ischemia (Knuuti et al., 2020). The chronic 
and progressive course of CAD leads to different degrees of coronary artery obstruction, 
which determines the clinical presentation of CAD – either in the form of an acute coronary 
event (ACS) or chronic coronary syndrome.  
Acute coronary events occur due to a sudden reduction of the blood flow in the 
coronary artery, usually triggered by psychological stress or physical exertion, resulting in 
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myocardial ischemia or myocardial infarction. Myocardial infarction, as the most common 
form of acute coronary event, is caused by complete occlusion of the epicardial coronary 
artery as the consequence (in most cases) of an obstructive atherothrombotic event in the 
artery: rupture or erosion of the atherosclerotic plaque and subsequent thrombotic 




Atherosclerosis is a chronic inflammatory disease with a secondary autoimmune 
component, characterized by progressive thickening and hardening of the vascular wall as 
a result of atheromatous deposits in the subendothelial intimal layer of large- and medium-
sized arteries (Ross, 1999; Kobiyama and Ley, 2018). It is an underlying pathology of 
coronary artery disease (Wolf and Ley, 2019). 
The main pathomorphological characteristic of atherosclerosis is atherosclerotic 
plaque, which is created during atherogenesis, a process that begins early in life in the 
period of postnatal growth and maturation, has a long asymptomatic initial phase, and 
progresses at a rate that depends on the presence of various cardiovascular risk factors 
(genetic, behavioral, associated diseases), leading to a series of changes in the arterial wall: 
endothelial dysfunction, intimal hyperplasia, smooth muscle cell and fibrous matrix 
proliferation, and the formation of lipid deposits in the vascular wall (Wong et al., 2012; 
Zhu et al., 2018). 
Endothelial cell dysfunction represents the initial step in the development of 
atherosclerosis. It is characterized by decreased nitric oxide (NO) bioavailability and 
consequent functional alterations that lead to a loss of the basic endothelial functions in 
vascular tone regulation, and the regulation of hemostasis and thrombosis and its anti-
inflammatory properties.   
Hemodynamic stress-induced endothelial breaches at sites of flow perturbation 
increase endothelial permeability (Franck et al., 2019). This accelerates the entry of 
lipoproteins into the subendothelial space, and their oxidative and enzymatic 
modifications to oxygenated LDL (oxLDL) (Wolf and Lay, 2019; Gistera and Hansson GK, 
2017). Activated endothelial cells express adhesion molecules (vascular adhesion 
molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1)), interleukin 8 (IL-8), 
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selectins (P-selectin, E-selectin), and other inflammatory factors that activate the adhesion 
of monocytes and T-cells to the endothelial cell and their entry into the arterial wall 
(intima), which actually represents the beginning of chronic inflammation. The presence of 
T-cells indicates the involvement of autoimmune response to autoantigenic LDL 
components. CD4+ T-cells have the ability to differentiate into T-helper (TH) subtypes (with 
the predominance of proatherosclerotic Th1 cells in human atherosclerotic plaque), or T-
regulatory cells (Treg) that can reduce the immune response or activate other T-cells in the 
direction of attenuating or promoting atherosclerosis through their anti- or 
proinflammatory effects, thus directing the further development of plaque (Gistera and 
Hansson, 2017). 
Upon entering the intima, activated monocytes are transformed into macrophages 
that phagocytose lipoproteins, becoming lipid-laden and transforming into foam cells, the 
hallmark of early fatty streak lesions in the initial stages of atherosclerosis. Activated 
endothelium and macrophages synthesize the proinflammatory cytokine IL-6  that initiates 
the release of C-reactive protein (CRP), cytokine IL-1, TNF-, growth factors (PDGF, FGF), 
and proteases, which leads to the migration and proliferation of smooth muscle cells into 
the intima, as well as the synthesis of extracellular matrix components. Activated CD4+ T-
cells in plaque express proinflammatory (TH 1)-associated cytokines: IL-2, IL-3, interferon-
gamma, tumor necrosis factor (TNF), and lymphotoxin, which further modulate 
inflammation in the sense of aggravation and plaque development. Conversely, by 
secreting the antiinflammatory cytokine IL-10 and suppressing the proliferation of 
proinflammatory T-cells, Tregs express their atheroprotective properties. 
The growth of atherosclerotic plaque is followed by the formation of new blood 
vessels in the arterial wall (neovascularization), whose fragility can lead to local bleeding 
and thrombosis, which renders the atherosclerotic plaque more prone to rupture, 
converting it to vulnerable plaque. At the same time, calcium salts precipitate in the 
atherosclerotic plaque, making the arterial wall hard and inelastic. 
Atherosclerosis, due to the progression of atherosclerotic plaques, leads to the 
narrowing of the lumen of the blood vessel, which results in decreased flow and ischemia 
of irrigated organs and the development of chronic syndromes. In the case of associated 
plaque disruption or endothelial erosion, consequent exposure of thrombogenic substrate 
initiates platelet adhesion and activation of the coagulation cascade, leading to local 
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thrombosis or thromboembolism and the development of acute syndromes (heart attack 
or stroke) that require urgent care.  
The clinical course of atherosclerosis can be different and depends on the 
localization of the part of the circulation that is most affected by the process of 
atherosclerosis. One of the most common forms of clinical manifestations of 
atherosclerosis is coronary artery disease.  
 
1.1.4. Risk factors for the development of atherosclerosis 
 
Risk factors may stimulate the initiation and accelerate the process of angiogenesis, 
thus contributing to the development of atherosclerosis. Major risk factors (independently 
associated with CVD) include: i) genetically determined factors: family history of premature 
CVD, advancing age (e.g. cell senescence, advanced glycation end products), sex hormonal 
imbalance (e.g. estrogen deficiency, menopause); ii) metabolic risk factors: 
hypercholesterolemia (e.g. oxidatively modified lipoproteins), hypertension (e.g. 
angiotensin II, reactive oxygen species), diabetes mellitus (e.g. advanced glycation 
endproducts, reactive oxygen species (ROS)), obesity (e.g. adipokines), and iii) factors 
influenced by lifestyle (tobacco use, physical inactivity, unhealthy diet, stress, heavy alcohol 
intake) (Dave et al., 2013; Gimbrone and Garcia-Cardena, 2017). 
 




Vascular endothelium, as a continuous cellular lining covering the luminal surface 
of blood vessels, represents a functional and structural barrier between the blood and the 
vascular wall.  It has an important role in the process of atherosclerosis from its initial to 
the advanced stages (Gimbrone and Garcia-Cardena, 2017; Thijssen et al., 2019). 
A healthy endothelium is a complex endocrine organ which, owing to its 
vasodilatory, antiinflammatory, antithrombogenic, antiproliferative, and antioxidant 
properties, maintains the vascular homeostasis (Deanfield et al., 2007).  The endothelium 
regulates the blood flow and modulates the vascular tone by balancing the production of 
vasodilators and vasoconstrictors in response to physiological demands. Producing a wide 
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range of substances, it maintains a nonadhesive luminal surface, and mediates hemostasis, 
smooth muscle cell migration and proliferation, as well as inflammatory and immune 
mechanisms in the vascular wall (Rubanyi, 1993).  
The main mediator of normal endothelial function, primarily in terms of vascular 
tone and reactivity maintenance, is nitric oxide (NO), a key endothelium-derived relaxing 
factor.  It is generated by endothelial nitric oxide synthase (eNOS) in the intact endothelial 
cell, in response to ischemia, endogenous (bradykinin, acetylcholine, catecholamines), or 
mechanical (shear stress) stimuli (Marti et al., 2012). The latter, endothelial shear stress 
caused by arterial blood flow is the main physiological stimulus to the endothelium for the 
production and release of NO (Kasprzak et al., 2006). 
The structural and functional integrity of the endothelium is of great importance 
for maintaining vascular homeostasis and preventing atherosclerosis. Endothelial integrity 
depends on the endogenous repair capacity, i.e. local endothelial cell replication (altered 
by the presence of CVD risk factors) and endothelial progenitor cells reparation (altered 
with a decrease in NO bioavailability). 
 
1.1.5.2. Endothelial activation/dysfunction 
 
Endothelial dysfunction. Activation of endothelial cells can occur due to 
physiological circumstances and in pathophysiological conditions. Physiological aging is 
accompanied by cell loss due to apoptosis (Dimmeler et al., 2000) and diffuse alteration of 
vascular function and structure, in the sense of reduced activity of endothelial nitric oxide 
synthase and impaired reactivity to nitric oxide leading to decreased endothelium-
dependent vasodilation (Lakatta and Levy, 2003).  
Under the influence of pathophysiological stimuli (oxidatively modified 
lipoproteins, proinflammatory cytokines, reactive oxygen species), in the lesion-prone 
areas of the arterial vasculature, endothelial cell activation initiates a complex cascade of 
morphological and functional alterations that consequently lead to cell dysfunction 
(Gimbrone and Garcia-Cardena, 2016; Rubanyi, 1993).  
Endothelial activation is a proinflammatory and procoagulant state of endothelial 
cells whose manifestations include increased vascular permeability, increased endothelial 
adhesiveness, and increased interaction with inflammatory cells and platelets, leading to 
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the loss of protective endothelial attributes resulting in endothelial dysfunction (Gutierrez 
et al., 2013). Endothelial activation is characterized by an increased expression of cell 
adhesion molecules (CAMs): VCAM-1, ICAM-1, E-selectin, and P-selectin. Membrane-
bound CAMs, by proteolytic cleavage, release soluble forms of adhesion molecules into the 
circulation where they can be measured. Increased plasma levels of soluble adhesion 
molecules indicate the degree of endothelial activation, representing the circulating 
markers of endothelial activation (Ribeiro et al., 2009; Drenjancevic et al., 2017; Drexler et 
al., 1995).  
Adhesion molecules are crucial to the recruitment of inflammatory cells to the 
vessel wall (Ribeiro et al., 2009). They also mediate inflammation and the immune 
response and participate in thrombosis (Zhu et al., 2018). High VCAM-1 and ICAM-1 
expressions increase plaque instability, promoting macrophage proliferation (and its 
accumulation in the plaque) and neovascularization (Mantovani et al., 2009). Elevated 
levels of cellular adhesion molecules may predict the development of cardiovascular 
disease in patients with cardiovascular risk factors (Petridou et al., 2007). Elevated serum 
ICAM concentrations are linked to the incidence of coronary artery disease among healthy 
people.  It has been reported that ICAM serum levels are increased years before an acute 
coronary event (Ridker et al., 2000).  
Selectins. Endothelium selectin (E-selectin), platelet selectin (P-selectin), and 
leukocyte selectin (L- selectin), expressed on activated endothelial cells, mediate the rolling 
adhesion of leukocytes. P-selectin has been reported to have an important role in 
atherogenesis, specifically, in the adhesion of leukocytes and platelets to the endothelium 
and their activation (Afshar-Kharghan et al., 2006). The level of its expression positively 
correlates with the degree of atherosclerotic lesions (Pasquali et al., 2010; Derosa and 
Mafioli, 2016). It may be involved in the pathogenesis of acute cerebral infarction (Pasquali 
et al., 2010). Increased plasma levels of P-selectin have been reported in CAD, predicting 
major cardiovascular events (Blann et al., 2006). 
The term endothelial dysfunction refers to any form of abnormal endothelial 
activity. In practice, however, it is most often used to indicate the basic characteristic of 
endothelial dysfunction i.e. impaired endothelium-derived relaxing factor – NO-
bioavailability due to decreased production by NO synthase (eNOS), increased NO 
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inactivation by reactive oxygen species (ROS), or both (Kasprzak et al., 2006; Thijssen et al., 
2019). 
 
1.1.5.3. Estimation of endothelial function 
 
Endothelial dysfunction might represent a useful prognostic indicator since it is an 
early marker of vascular pathology (Schächinger et al., 2000; Schindler et al., 2003; Suwaidi 
et al., 2000). In patients with cardiovascular diseases or those with CVD risk factors, it has 
been shown to independently predict future cardiovascular events (Lerman and Zeiher, 
2005).  
When endothelial function is altered, any of its activities may be impaired. But, as 
endothelial function is in practice synonymous with endothelium-dependent vascular 
reactivity, the measuring of the vasomotor response to physiological and pharmacological 
stimuli has been widely used as a clinical marker of endothelial function (Gutierrez et al., 
2013; Kasprzak et al., 2006). All methods employed for the assessment of endothelial 
function are based on the endothelial ability to respond (with vasodilation or 
vasoconstriction) to endothelial-dependent stimuli, mainly reactive hyperemia (shear 
stress), or vasoactive substances (Gutierrez et al., 2013).  
Endothelial function may be noninvasively assessed using the brachial artery flow-
mediated dilation (BAFMD) technique. Flow-mediated dilation represents endothelial-
dependent dilation of the blood vessel which occurs in response to occlusion-induced 
hyperemia and shear stress-induced NO release (Celermajer et al., 1992; Harris et al., 
2010). In response to longitudinal shear stress, calcium-activated potassium channels 
located in the endothelial cell membrane open and hyperpolarize the endothelial cell, 
increasing the driving force for calcium entry. Calcium activates eNOS, provoking NO 
release and subsequent vasodilatation that can be imaged and quantitated as an index of 
vasomotor function (Corretti et al, 2002). FMD has been shown to be attenuated in 
coronary patients compared to healthy individuals (Neunteufl et al., 1997; Lieberman et 
al., 1996; Zhang et al., 2000; Takase et al., 2008).  
As a generalized process, endothelial dysfunction is not limited to the vascular parts 
affected by clinically overt atherosclerosis. FMD relates to coronary artery endothelial 
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function and independently predicts CVD outcomes (Thijssen et al., 2019; Iantorno et al., 
2016). 
Endothelium-independent vasodilatation, estimated by nitroglycerine-induced 
vasodilation, has been used to confirm that an impaired vasodilatory response is a 
consequence of endothelial dysfunction, and not of reduced vascular smooth muscle cell 
reactivity to NO, or alterations in vascular structure. Impaired nitroglycerine-induced 
vasodilation is decreased in relation to cardiovascular risk factors in healthy subjects and 
CVD patients (Maruhashi et al., 2013) and may be used as a prognostic marker of 
cardiovascular events (Maruhashi et al., 2018). Nitroglycerin-induced dilation has been 
shown to be attenuated (Maruhashi et al., 2013; Zhang et al., 2000; Neunteufl et al., 1997) 
or maintained (Takase et al., 2008; Lieberman et al., 1996) in coronary patients. Kajikawa 
et al. (2016) reported that combination of BAFMD and nitroglycerine-induced vasodilation 
measurements may allow more accurate prediction of CVD events. 
 
1.1.5.4. Endothelial function in coronary patients 
 
As the initial step of atherosclerosis, endothelial dysfunction is implicated in the 
pathogenesis and clinical course of CAD (Schachinger et al., 2000). Endothelial function is 
impaired in the coronary and peripheral vasculature of coronary patients (Niebauer and 
Cooke, 1996) and has an important role in the progression to adverse events of coronary 
artery disease, affecting clinical outcomes (Heitzer et al., 2001). In coronary patients, 
impaired NO synthesis due to increased oxidative stress also leads to the apoptosis of 
endothelial cells and thus adversely affects the integrity of the vasculature (Hollriegel et 
al., 2013). The repair of endothelial damage by progenitor cells appears to be attenuated 
in coronary patients (Hill et al., 2003; Asahara et al., 1999).  
Post-stenting endothelial function. Coronary artery endothelial dysfunction after 
coronary artery stenting is characterized by acute endothelial injury in the presence of 
prosthetic metal material in the lumen of the artery (bare metal stent) or an artificial 
polymer and drug (drug-eluting stent). Studies have shown that the recovery of endothelial 
function after the implantation of drug-eluting stents occurs after 6 months (Togni et al., 
2005; Fuke et al., 2007) and in the case of bioabsorbable everolimus-eluting stents after 12 
to 24 months (Serruys et al., 2009; Gutierrez et al., 2013). Peripheral endothelial 
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dysfunction in patients following coronary artery stenting is a predictor of restenosis 
(Yamamoto et al., 2014). Endothelial damage has been recognized as the major cause of 
postangioplasty restenosis (Toutouzas et al., 2004). 
Post-CABG endothelial function. Surgical revascularization is also associated with 
endothelial dysfunction (Gomes et al., 2014). The systemic inflammatory response seen 
after coronary artery bypass surgery (CABG) has an impact on vascular endothelial function 
(Balčiunas et al., 2009). Patients undergoing surgical revascularization showed elevation of 
the endothelium-derived soluble forms of VCAM-1 and ICAM-1 and P-selectin 1 to 5 hours 
after cardiac surgery (Boldt et al., 1998). Endothelial function is affected not only by the 
surgical intervention (ischemia-reperfusion injury, systemic inflammatory response 
syndrome) but also by blood temperature during the artificial circulation. Higher ICAM-1 
levels were reported in patients undergoing a hypothermic coronary artery bypass 
procedure (Grünenfelder et al., 2000; He et al., 2004). CABG with no extracorporeal 
circulation is associated with lower endothelial activation as compared to on-pump 
procedures, as estimated by the levels of soluble ICAM-1 and P-selectin (Balčiunas et al., 
2009; Suzuki et al., 2001). Hilbert et al. (2016) reported significantly elevated IL-6 levels 24 
h after CABG. Endothelial damage caused by surgical trauma is considered to be a major 
cause of graft failure. 
 
1.1.6. Chronic low-grade inflammation 
 
Chronic low-grade vascular wall inflammation is a crucial process underlying the 
pathophysiology of coronary artery disease (CAD) (Hansson, 2005). Inflammation mediates 
all the phases of atherogenesis, from atherosclerotic plaque initiation and progression to 
its potential vulnerability and rupture, increasing the risk of acute clinical events (Thijssen 
et al., 2019).   
Inflammation begins with the entry of leukocytes into the intima of the vessel wall, 
which occurs under the influence of chemokines produced in the activated endothelial 
cells. Cytokine production by leukocytes, endothelial cells, and vascular smooth muscle 
cells contributes to the further progression of chronic inflammation (Wong BW, 2012). In 
the late stage of atherosclerosis, mast cells infiltrated in the vessel wall contribute to a 
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proinflammatory condition. When activated, they affect the atherosclerotic lesion by 
releasing a host of mediators, resulting in plaque rupture and thrombosis (Zhy et al., 2018).  
The inflammatory process in atherosclerotic arteries involves several cytokines 
from the interleukin group (IL-1, IL-4, IL-6, IL-8, IL-10), and macrophage-associated 
cytokines (TNF-, INF-) and acute-phase reactants (Ribeiro et al., 2009). The existence of 
a state of low-grade chronic inflammation is indicated by an elevated level of inflammatory 
parameters, which include those related to acute phase response – CRP, P-selectin, sICAM-
1, and cytokines: IL-6, IL-2, IL-7, IL-8, IL-10, IL-18, IL-1ra, TNF- (Tedgui and Mallat, 2006). 
Chronic low-grade inflammation has been defined as 2- to 4-fold elevation in the circulating 
levels of proinflammatory and antiinflammatory cytokines, naturally occurring cytokine 
antagonists, and the acute phase reactant above those seen in healthy individuals (Mathur 
and Pedersen, 2008; Bruunsgaard, 2005).  
CRP is a marker of subclinical vascular inflammation and a strong predictor of 
cardiovascular events (Ribiero et al., 2010). It is an acute-phase protein produced by the 
liver in response to elevated proinflammatory cytokines IL-6 and TNF-. Its levels are 
increased in case of vascular disease. CRP actively participates in the formation of 
atherosclerotic lesions, plaque rupture, and the development of coronary thrombosis 
through interactions with the endothelium (Vlachopoulos et al., 2015). Ample evidence 
indicates that moderately increased plasma levels of CRP (a threshold of 2 mg/L has been 
proposed for CV risk assessment) (Goff et al., 2013) were associated with increased CAD 
risk in a healthy population (Danesh et al., 2004). At concentrations at which it predicts the 
risk of CAD, CRP increases LDL oxidation and uptake by macrophages, upregulates the 
expression of adhesion molecules, inhibits NO production, facilitates infiltration of 
monocytes into the vessel wall, induces complement activation, inhibits fibrinolysis by 
increasing PAI-1 expression, facilitates endothelial cell apoptosis, attenuates angiogenesis, 
and alters endothelial progenitor cell survival and differentiation (Verma et al., 2003). 
Atherosclerosis-associated cytokines can be classified into two groups: 
proinflammatory (proatherogenic) cytokines (IL-1, IL-6, IL-8, TNF-α, and INF-) that regulate 
the acute phase reaction, induce other proinflammatory cytokines and chemokines, induce 
the expression of CAMs on endothelial cells, stimulate cell proliferation and differentiation, 
induce the release of matrix degradation enzymes, or antiinflammatory (atheroprotective) 
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(IL-10) cytokines that inhibit proinflammatory cytokines and inflammatory responses 
(Ribeiro et al., 2009). 
IL-6 regulates the acute-phase response and chronic inflammation, contributing to 
the development of coronary artery disease (Zhy et al., 2018). IL-6 levels rise with age and 
are strongly linked to fatal coronary artery disease in older adults (Parsons et al., 2017). IL-
6 release has been reported to be facilitated by adrenergic stimulation, but inhibited by 
vagal stimulation (Borikova et al., 2000; Mohamed et al., 2001). IL-6 serum concentrations 
are significantly increased in cases of plaque rupture, which makes it a potential predictive 
marker for atherosclerotic plaque vulnerability (Held et al., 2017). Elevated IL-6 levels in 
healthy men are associated with an increased risk of future MI (Ridker et al., 2000). 
In patients with unstable angina or myocardial infarction, increased levels of IL-6 
and CRP may indicate a worse prognosis (Momiyama et al., 2014; Tousoilis et al., 2016).  
CRP and IL-6 levels were positively correlated with all-cause mortality and coronary heart 
disease mortality (Harris et al., 1999), and cardiovascular risk factors (Woodward et al., 
1999; Mendal et al., 1996). Significantly elevated levels of IL-6 and CRP were reported in 
individuals presenting with chest pain (O'Malley et al., 2000). CRP levels strongly correlate 
with the occurrence of myocardial infarction (Ridker et al., 1997), and coronary events 
(Haverkate et al., 1997). Elevated preoperative CRP serum levels predict ischemia after 
CABG (Milazzo et al., 1999). High pre-procedural CRP serum concentrations indicate 
adverse events after PCI with or without stenting (Buffon et al., 1999).   
IL-8 is a cytokine that participates in all stages of atherosclerosis development, from 
vascular inflammation to cardiac remodeling after myocardial infarction (Velasquez et al., 
2014). It is produced by atherosclerotic macrophages and is involved in the preservation 
of the inflammatory micro-environment of the injured vascular wall by recruiting 
inflammatory cells into atherosclerotic plaque (Apostolopoulos et al., 1996; Apostolakis et 
al., 2009). Increased levels of IL-8 were reported in coronary patients (Herder et al., 2006). 
IL-8 is the only independent marker of cardiovascular events (Apostolakis et al., 2009). 
Elevated IL-8 levels were detected in patients with ventricular fibrillation complicating 
myocardial infarction (Elmas et al., 2007), as well as in patients with unstable angina or 
AMI (Kanda et al., 1996; Zhou et al., 2001). Elevated IL-8 levels after PCI are thought to be 
likely to predict the development of heart failure in patients with acute myocardial 
infarction (Dominguez-Rodriguez et al., 2005). In patients after CABG, IL-8 levels increase 
Danijela Vasić   Doctoral dissertation 
20 
significantly after the procedure and remain elevated for 180 min after declamping of the 
aorta (Kawamura et al., 1993). Higher IL-8 serum concentrations were reported in CABG 
patients with postoperative atrial fibrillation (Wu et al., 2008).  
IL-10 is an atheroprotective antiinflammatory cytokine that limits the production 
and release of proinflammatory cytokines and chemokines by macrophages. It is produced 
by Treg cells as part of their immunomodulatory activity (Wolf and Ley, 2019; Toisoilis et al., 
2016). By inhibiting metalloprotease activity, they perform their protective role against 
plaque rupture in coronary atherosclerosis (Taleb, 2016). IL-10 levels are decreased in 
patients with vulnerable coronary plaques, and myocardial infarction (George et al., 2012; 
Wolf and Ley, 2019). Increased plasma concentrations are associated with a more 
favorable prognosis after an acute coronary event (Taleb, 2016). 
 
1.1.7. Activated hemostasis 
 
The activated hemostatic system plays a significant role in the pathogenesis and 
progression of atherosclerotic diseases. A number of hemostatic indices are involved in the 
development of coronary artery disease, in the sense that they participate in the initiation 
and progression of atherosclerosis, and recurrent atherosclerotic events. These include 
markers of procoagulatory tendency: elevated plasma fibrinogen levels, increased plasma 
D-dimer levels, elevated factor VII, factor VIII, von-Willebrand factor, platelet 
hyperaggregation, and decreased fibrinolytic capacity: increased levels of plasminogen 
activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (t-PA) 
concentrations (Kannel, 2005; Koenig, 1998). 
In healthy individuals, a hemostatic balance between coagulation and fibrinolysis is 
a normal condition, meaning that the potentiated hypercoagulability is promptly 
compensated by an increase in fibrinolytic activity. In patients with atherosclerotic disease 
or subjects with risk factors for cardiovascular disease, this balance may be impaired 
(Willich et al., 1993). 
Hypercoagulability induces thrombus formation in the blood circulation, as well as 
on the exposed prothrombotic surface of the disrupted plaque, representing the 
pathophysiological basis of ischemic coronary syndromes (Lip and Blann, 2000; Ross, 1999; 
Davis, 2000; Fuster, 1998).  
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Fibrinogen seems to be the most important hemostatic risk factor for 
cardiovascular disease (Danesh et al., 1998; Ernst and Resch, 1995; Kannel et al., 1987). 
Plasma fibrinogen levels in excess of around 3.0 g/l have been established as an 
independent risk factor for coronary artery disease and a predictor of coronary events 
(Chou et al., 2004; Meade et al., 1986; Wilhemsen et al., 1984; Borissoff et al., 2011).  The 
plasma concentration of fibrinogen directly correlates with the extent of coronary artery 
disease (Thomson et al., 1995; Handa et al., 1989; Kruskal et al., 1987). The involvement of 
increased fibrinogen plasma levels in the process of restenosis has been confirmed (Ernst 
and Koenig, 1997). As an acute-phase reactant protein, fibrinogen has a direct effect on 
the vessel wall as the main determinant of smooth muscle cell migration and proliferation 
(Cantazaro and Suen, 1996; Kannel, 2005; El-Sayed, 1996). Clinical studies have indicated 
that fibrinogen participates in the process of thrombosis affecting platelet aggregation, 
plasma viscosity, and thrombin formation (Kannel, 2005). It is associated with other 
cardiovascular risk factors (age, hyperlipidemia, diabetes mellitus smoking, BMI) mediating 
its thrombogenic effects (Stec et al., 2000).  
Elevated levels of plasma fibrinogen and fibrin D-dimer are known predictors  of 
subsequent cardiovascular events in patients with coronary artery disease (Koenig et al., 
2000; Meade et al., 1986; Lowe et al., 2001; Lowe et al., 1997; Thompson et al., 1995; Smith 
et al., 1997; Moss et al., 1999; Oldgren et al., 2001), in those with cardiovascular risk factors 
(Junker et al., 1998), and healthy individuals (Lowe et al., 2001; Smith et al., 1997; Meade 
et al., 1986). 
Plasma fibrin D-dimer showed an independent association with incident ischemic 
heart disease (Lowe, 2001). Elevated plasma D-dimer levels are a consequence of the 
increased metabolism of cross-linked fibrin in atherosclerotic plaques. As a marker of 
ongoing fibrin formation and degradation, it is the most commonly used clinical assay for 
the detection of activated hemostasis (Wannamethee et al., 2014; Smith et al., 2011). D-
dimer is an acute phase reactant, and its elevated levels in plasma are associated with 
enhanced inflammation and an increased incidence of cardiovascular disease (Xiao et al., 
1998; Lowe et al., 2005). 
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1.1.8. Neurohumoral activity  
 
Neurohumoral activation is one of the most important mechanisms underlying the 
compensatory response to the development of heart failure (ischemic or of any other 
etiology) (Zucker et al., 2012). It implies a series of physiological processes that lead to 
changes in the heart, kidneys, and peripheral vasculature, with the aim of preserving 
cardiovascular hemostasis. The central part belongs to the sympathetic (adrenergic) 
nervous system and the renin–angiotensin–aldosterone system (RAAS) that increases salt 
and water retention, causes peripheral artery vasoconstriction, and increases contractility, 
thus maintaining cardiac output. Neurohumoral activity is useful initially and, as such, 
represents an adaptive response. However, in the case of chronic activation, this response 
may lead to an unwholesome effect on the heart in the sense of ventricular remodeling 
and heart failure progression (Ferrara et al., 2002). 
The activated natriuretic peptide system contributes to physiological homeostasis, 
with its opposing effects: anti-remodeling actions, vasodilatory, R-A-A antagonist, 
sympatho-inhibitory, antihypertrophic, and antiproliferative effects (Wong, 2017; Volpe et 
al., 2014; Lainchbury et al., 2000; Huntley et al., 2006; Stevens et al., 1995; Wan et al., 
2016; Hautala, 2001). The biologically active brain-type natriuretic peptide (BNP) and the 
more stable, biologically inactive amino-terminal fragment of its prohormone (NT-proBNP) 
are synthetized and released in equal amounts by the ventricle myocardium, and their 
production is minimal in normal healthy individuals (Yasue et al., 1994).  Increased 
production and release by cardiac myocytes are stimulated by myocardial wall stress 
(volume or pressure overload) and neurohumoral activation, usually in response to heart 
failure or myocardial ischemia (Goetze et al., 2003), indicating a physiological attempt to 
compensate for pathophysiological disorders and re-establish circulatory homeostasis 
(Levin et al., 1998). Occurring as a consequence of the ischemia-induced left ventricular 
dysfunction, natriuretic peptides represent markers of both clinically overt and subclinical 
myocardial ischemia (Norman et al., 2010). 
Elevated plasma levels of NT-proBNP may indicate vascular dysfunction, in which 
case natriuretic peptides lead to changes in the endothelium and vascular smooth muscle 
cell proliferation and contractility (by augmentation of nitric oxide synthesis or via the 
cyclic GMP signaling cascade) (D'Souza et al., 2004; Bruneau and de Bold, 1994). Interfering 
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with the proliferation, inflammation, angiogenesis, and apoptosis (as the underlying 
mechanisms of atherosclerosis) in endothelial and vascular smooth muscle cells, 
natriuretic peptides maintain vascular health in the sense of vascular remodeling, 
indicating their possible role in the pathogenesis of atherosclerotic disease (Rubattu et al., 
2008).  
All of the above confirms the clinical usefulness of natriuretic peptides both in 
stable and unstable atherosclerotic diseases, especially in terms of their prognostic value. 
Assessment of the circulating levels of BNP and NT-proBNP is applied in the stratification 
of cardiovascular risk in coronary patients. In clinical practice, they are used as biomarkers 
in the diagnosis and prognosis of heart failure.  
Given the association of BNP and NT-proBNP with adverse cardiovascular events, 
including myocardial infarction, hospitalization due to heart failure, cerebrovascular attack 
or transitory ischemic attack, and cardiovascular death (Mishra et al., 2014), both have 
become established diagnostic and prognostic biomarkers in cardiovascular medicine 
(Ponikowski et al., 2016) primarily as powerful predictors of disease severity and mortality 
in coronary patients following an acute coronary event and those with heart failure (Doust 
J, 2006).   
Current guidelines recommend that NT-proBNP levels above 125 pg/mL should be 
considered abnormal (Ponikowski et al., 2016). Since NT-proBNP values are affected by age 
or presence of other comorbidities (Partanen et al., 2011; Maries and Manitiu, 2013), 
rather than a single cut-point, specific age-related thresholds have been proposed: values 
above 450 pg/mL for patients younger than 50 and values above 900 pg/ml for patients 
aged 50 or older (Francis et al., 2016). 
 
1.1.9. Cardiac autonomic function 
 
Heart rate is determined by the coordinated action of the sinoatrial node intrinsic 
activity and a harmonized balance of sympathetic stimulation and parasympathetic 
inhibition. The autonomic nervous system, through sympathetic and parasympathetic 
fibers innervating the heart, has an important function in the modulation of heart rhythm, 
as one of a series of activities coordinating hemodynamic and neurohormonal mechanisms 
to adjust cardiac output in different circumstances. Sympathetic and parasympathetic 
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activities directed to the sinoatrial node are normally well-balanced in each cardiac cycle, 
and appropriate reciprocal changes in their activity allow adequate adjustment of heart 
rate according to physiological requirements (Task Force ESC on Electrophysiology., 1996; 
Klabunde, 2012). Different causative conditions (hemodynamic, humoral, and 
environmental) can alter the cardiac autonomic balance and thus lead to variability in the 
duration of intervals between cardiac cycles (Connes et al., 2010). 
Heart rate variability (HRV) is considered an indicator of cardiac autonomic activity 
(Camm et al., 1996) in the sense that abnormal heart rate variability represents an 
important manifestation of autonomic pathophysiology. The autonomic regulation of the 
heart, its state and balance, can be assessed by analyzing well established linear HRV 
parameters using time-and frequency-domain methods or novel non-linear HRV 
parameters, such as extremely promising detrended fluctuation analysis (Koenig et al., 
2014; Connes et al., 2010).  
Analyzing heart rate variability implies the analysis of changes in interval length 
between successive R–R intervals on continuous recording of the heart rate over a certain 
period of time. These changes can provide insight into certain physiological and 
pathological conditions, which gives them clinical relevance.  
Extensive studies of heart rate variability in patients after acute myocardial 
infarction have shown that HRV is decreased after an acute coronary event, mainly due to 
myocardial ischemia but also due to neural ventricular receptors destruction which causes 
changes in the electrical property of the myocardium (Wenneblom et al., 2000). Recovery 
of HRV begins within a few weeks after MI, with the greatest possible, but not full recovery 
by 6 to 12 months (Lombardi et al., 1992; Bigger et al., 1995; Carney et al., 2001; Cripps et 
al., 1991). Such patients, with reduced HRV indicating sympathetic prevalence and 
electrically unstable myocardium (Melanson, 2000; Camm et al., 1996; Bigger et al., 1988), 
are at an increased risk of all-cause mortality, cardiac mortality, of developing arrhythmic 
complications, and sudden cardiac death (Bigger et al., 1993; Kleiger et al., 1987; Algra et 
al., 1993; Myers et al., 1986; Martin et al., 1987; Huikuri and Stein, 2013; Odemuyiwa et 
al., 1991). Indicators of sympathetic activation or vagal depression can also identify 
restenosis in patients after PCI (Goering et al., 2006).  
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1.1.10. Functional health status and quality of life in coronary patients 
 
Health-related quality of life (HRQoL) is an important outcome measure of health 
care in patients with coronary disease (Mc Gee et al., 2005; Rumsfeld et al., 2013). It shows 
a subjective and multidimensional aspect that includes the patient’s physical, emotional, 
mental, and social health (Coelho et al., 2005). 
Primarily by negatively affecting the functional capacity of the patients, i.e. their 
ability to perform daily activities, coronary artery disease has a negative impact on the 
quality of life (Jette and Downing, 1994). After an acute coronary event, HRQoL is 
significantly decreased in the domains of physical health, mental health, and general 
health, compared to the general population (Mollon et al., 2017; Simpson and Pilote, 
2003). The main impairments occur in the domain of physical activity, daily activities, and 
mental health in the sense of depression or anxiety onset (Schweikert et al., 2009). Poor 
HRQoL is associated with adverse disease outcomes (Mommersteeg et al., 2009). 
Sophisticated technology and a modern approach to the treatment of coronary 
diseases have contributed to the longevity of CAD patients. For this reason, health-related 
quality of life has become one of the tools for evaluating the success of the treatment 
modality applied. 
It was found that the consequences of an acute coronary event include changes in 
physical, social, and mental functioning, and general health perceptions, which are most 
intense in the first weeks after the coronary event, gradually improving with time (Mollon 
et al., 2017; Szygula Jurkiewicz et al., 2004). Previous studies have indicated significant 
improvements in health-related QL in coronary patients over the first 6 months after a 
coronary event (Hofer et al., 2005) and a complete recovery of daily activities and social 
life after one year (Szygula Jurkiewicz et al., 2004). Yazdani et al. compared HRQoL in 
patients after PCI and CABG, and showed that patients following PCI had significantly 
higher HRQoL in the 6 months after revascularization; however, after 24 months of follow-
up, there were no differences between the two groups of patients (Yazdani-Bakhsh et al., 
2016).  
The impaired exercise capacity of coronary patients, together with the fear of 
possible CAD complications or an additional cardiovascular event, leads to a sedentary 
lifestyle, thereby decreasing daily physical activities and quality of life (Boini et al., 2006; 
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Hofer et al., 2005). Also, coronary artery disease has frequently been associated with 
depression and anxiety, which commonly occur immediately after an acute coronary event 
in as many as 65% of patients, greatly affecting the patient's QL (Guck et al., 2001). The 
fact that depression doubles the risk of death in these patients (Melle et al., 2004) further 
accentuates the importance of assessment of all the domains of QL in coronary patients 
for the purpose of adequate treatment (Dickens et al., 2006). Social functioning especially 
decreases among older adults (Mendes de Leon et al., 1998). 
There is a controversial gender difference in the evolution of quality of life in 
coronary patients after an acute coronary event. Namely, the baseline SF-36 score is lower 
in women, and women in physical and psychosocial terms do not achieve as good results 
as men (Duenas et al., 2011). 
The factors that are considered to have the greatest impact on the quality of life of 
coronary patients are personal history of chronic cardiac disease, age, gender, marital 
status, and presence of mental disorder (Soto et al., 2005). 
 
1.1.11. Treatment of CAD 
 
The treatment of CAD includes pharmacological therapy and/or revascularization 
procedures – percutaneous coronary artery intervention (PCI) or coronary artery bypass 
surgery (CABG).  The aims of optimal CAD treatment are prevention of atherosclerosis 
progression, that is, prevention of premature death and complications from CAD, 
alleviation of anginal symptoms, and improvement of daily living activities and quality of 
life. Current guidelines recommend β-blockers, renin–angiotensin–aldosterone system 
(RAAS) inhibitors, statins, antiplatelet agents, calcium channel blockers (CCB), and nitrates 
as the basic pharmacological approach for the treatment of CAD (Knuuti et al., 2019). In 
case of revascularization, the choice of the appropriate procedure, percutaneous arterial 
intervention or surgical approach is conditioned by a series of anatomical and clinical 
prognostic variables.  
Any of the mentioned treatment procedures is not sufficient in itself, in terms of 
efficacy and long-term effects, if not accompanied by lifestyle modifications implying a 
healthy diet, weight control, smoking cessation, stress management, and regular physical 
activity (Bruning & Sturek, 2015). Systemic benefits of regular physical activity may be 
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1.2.1. General overview 
 
Insufficient physical activity is identified as one of the four leading risk factors for 
global mortality (6–10% of all deaths from major noncommunicable diseases globally) 
(Hallal et al., 2012; Kohl et al., 2012), a leading risk factor for premature death from 
noncommunicable diseases (WHO Report, 2018), and a major risk factor in the 
development of cardiovascular disease (CVD) which is the primary cause of death in 
developed countries despite improvements in medical and interventional therapies (WHO 
Report, 2018). 
The functional and health benefits of exercise are manifested through the 
beneficial effects of exercise on functional capacity (increased maximal oxygen 
consumption, increased ventilatory threshold, decreased heart rate and blood pressure, 
improved ability to tolerate physical stress), reduced risk of diseases (of developing high 
blood pressure, coronary disease, diabetes mellitus, obesity, colon cancer), 
musculoskeletal condition (increased muscular strength and endurance, improved ability 
to locomotion, increased flexibility), psychological state (promotes psychological 
wellbeing, improves stress management) (Durstine et al., 2000). Regular physical activity 
has been shown to delay all-cause mortality and extend longevity in the general population 
(Paffenbarger Jr et al., 1994).  
While physical activity is described as any movement of the body produced by 
skeletal muscles that results in energy expenditure greater than basal (Thomspon et al., 
2003), exercise training, as defined by the World Health Organization, is a planned and 
structured subcategory of physical activity, which is repetitive for the purpose of improving 
or maintaining physical performance and overall health (WHO, 2010). Planned, structured 
training is based on the individual's physiological and exercise capacity, which further 
determines the basic components of training:  type of exercise (aerobic, strength, 
flexibility, balance), duration (length of time in which exercise is performed), frequency 
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(the number of times the exercise is performed), and intensity (rate at which the activity is 
being performed or the magnitude of effort required to perform the exercise) (WHO, 
2010). 
Intensity, defined as absolute intensity, reflects the rate of energy expenditure 
during exercise and is expressed in metabolic equivalents or METs (1 MET equals the 
resting metabolic rate of 3.5 ml 02 kg-1min-1). Relative intensity refers to the percent of 
aerobic power utilized during exercise and is expressed as the percent of maximum heart 
rate or percent of VO2 max (https://doi.org/10.1053/euhj.2000.2440).  
According to the latest guidelines for CVD prevention (Piepoli et al., 2016),  the 
physical activity recommendation for healthy adults is at least 150 minutes a week of 
moderate-intensity (3–5.9 METs; 64–76% HRmax, RPE 12–13), or 75 minutes a week of 
vigorous-intensity (≥ 6 METs; 77–93% HRmax, RPE 14–16) aerobic exercise, or an 
equivalent combination thereof. For additional benefits, in healthy adults, a gradual 
increase in aerobic exercise is recommended to 300 minutes a week of moderate-intensity, 
or 150 minutes a week of vigorous-intensity aerobic exercise, or an equivalent combination 
thereof (Class I, Level A).  
The Global Recommendations on Physical Activity for Health are relevant for the 
following health outcomes: cardiorespiratory health (coronary artery disease, CVD, stroke, 
hypertension), metabolic health (type 2 diabetes (T2D), obesity), musculoskeletal health, 
cancer, functional health, and depression (WHO Report 2017). 
 
1.2.2. Physiological effects of exercise in coronary patients 
 
Regular physical activity has been shown to decrease risk for cardiovascular 
morbidity and mortality in the general population (Lee et al., 2011; Lee et al., 2012), 
mitigate symptoms, slow the progression of disease, and reduce mortality in patients with 
established CVD (Ekelund et al., 1988). Physical capacity, indicating the patient’s exercise 
habits, is an independent predictor of cardiovascular death (Vincent et al., 2010).  
The beneficial effects of physical activity in the treatment of coronary heart disease 
were first reported in the late eighteenth century and, in a way, represent the first 
concepts of cardiac rehabilitation (Heberden W, 1772). They remained less recognized in 
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the years that followed, however, until the 1950s, when physical activity was given a 
significant place in the treatment of coronary patients.  
At the end of the 1980s, the first two systematic reviews and meta-analyses of 
exercise-based cardiac rehabilitation (O’Connor et al., 1989; Oldrige et al., 1988) indicated 
a positive effect of involvement in physical activity after a myocardial infarction, showing 
a 20–25% reduction in all-cause and cardiovascular mortality. In the period that followed, 
exercise training as a part of cardiac rehabilitation became an established and integrated 
part of treatment regimes in patients after myocardial infarction or coronary 
revascularization procedure, with the role of maintaining and improving cardiovascular 
health (Piepoli et al., 2016; Anderson et al., 2016). 
It has been reported that aerobic exercise training, lasting three or more weeks, 
results in various health-related benefits in coronary patients – it improves cardiovascular 
outcomes and the quality of life, and reduces the risk of cardiovascular mortality (Heran et 
al., 2011; Piepoli et al., 2010; Ades and Coelo, 2000; Dibben et al., 2018). Regarding the 
impact of exercise-based CR on overall mortality, it should be mentioned that, in contrast 
to a previous meta-analysis (Jolliffe, 2001) that reported a total mortality decrease of 27% 
with exercise-based CR, in the most recent meta-analysis (Anderson et al., 2016), 
statistically significant reduction in all-cause mortality with exercise-based CR was not 
observed (which was explained by the diversity of the populations of coronary patients 
included in the studies). 
The beneficial effects of exercise training are manifested primarily on the clinical 
symptoms, the physiology of the cardiovascular system, and on the risk factors for the 
development of coronary heart disease (Fiuza–Luces et al., 2013). Improvement in clinical 
symptoms, that is, angina alleviation is achieved by exercise-induced enhancement in 
myocardial oxygen supply, and improvements in exercise capacity and muscle strength 
(Mourot, 2010; Casillas, 2007). To explain the beneficial effects of training on the 
physiology of the cardiovascular system, different underlying mechanisms have been 
proposed: improvement of generalized endothelial function (Höllriegel et al., 2013; 
Habrecht et al., 2000);  increase in myocardial perfusion due to regression of 
atherosclerosis (Ornish et al., 1998; Gremeaux et al., 2012); enhancement of the 
vasoreactivity of coronary resistance arteries (Brunig and Sturek, 2015; Laughlin et al; 
2011); coronary collateral formation (Scheel et al., 1981; Ornish et al., 1998); 
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improvements in cardiac output (van Tol et al., 2006); maintenance of the hemostatic 
profile (increased circulatory fibrinolytic activity, decreased blood coagulability) (Clausen, 
1977), enhancement of autonomic tone and neurohormonal abnormalities (Sato et al., 
2005; Harries et al., 1994); diminishment of an augmented inflammatory state (Beavers et 
al., 2010); improvement in the function and number of circulating endothelial progenitor 
cells (EPC) (Steine et al., 2005; Cesari et al., 2012), and prevention of cellular senescence 
(Werner et al., 2009).  
Considering the influence of exercise training on CAD risk factors, it has been shown 
that exercise training improves the lipid profile (increases serum high-density lipoprotein 
cholesterol levels (≈ +6%), reduces serum triglyceride (-15%), and slightly decreases low-
density lipoprotein cholesterol levels (-3.4%) (Tran and Brammell, 1989; Lavie et al., 2015), 
blood pressure control (reduces systolic blood pressure by 4.7 mmHg and diastolic blood 
pressure by 3.1 mmHg) (Halbert et al., 1997; Martin et al., 1990), glucose control (by 
increasing insulin sensitivity) (Snowling and Hopkins, 2006), healthy weight control (Lavie 
and Milani, 1997; Wood et al., 1991), and reduces psychological stress (alleviates 
depression and anxiety) (Thompson et al., 2003). 
 
1.2.3. Exercise performance in coronary patients 
 
An acute coronary event, such as recent myocardial infarction and/or coronary 
revascularization procedure (PCI or CABG) procedure, may impair the patient’s ability to 
perform exercise due to cardiac dysfunction, potential risks connected with the acute 
effects of exercise, post-procedure recovery, or immediate post-event psychological 
concerns (Anderson et al., 2016). Hence, cardiac rehabilitation protocols – whether 
implemented in outpatient clinics or as intensive short-term residential programs – allows 
proper monitoring and guidance, providing much-needed support to patients immediately 
after a recent CAD event and enabling them to engage with confidence in long-term regular 
exercise and adopt a healthy lifestyle (Mampuya, 2012; Menezes et al., 2014).  
Coronary patients generally demonstrate reduced maximal oxygen consumption 
and exercise tolerance when compared with healthy subjects. They have an altered 
response to exercise in the sense of significantly reduced oxygen consumption and reduced 
stroke volume at all levels of exertion (Gleeson and Protas, 1989). The reduced physical 
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capacity of coronary patients is a consequence of left ventricular dysfunction (due to 
myocardial ischemia) and amendments of the peripheral tissues (due to impaired systemic 
perfusion) (Mc Dermott et al., 2004; Passino et al., 2006).    
Exercise performance in coronary patients is largely dependent on the extent and 
severity of coronary heart disease, left ventricular dysfunction, the patient's age, and 
comorbidities. Though rarely coronary patients can exhibit normal exercise performance, 
they usually demonstrate exercise intolerance and/or the inability to perform daily 
activities due to the appearance of symptoms in the form of increased fatigue and 
shortness of breath during physical activity. Exercise capacity also declines with age, which 
is contributed by lower stroke volume, heart rate, and arterio-venous oxygen difference at 
maximal exercise (Ogawa et al., 1992), decreased blood flow to active skeletal muscles, a 
relative reduction in skeletal muscle mass, and decreased skeletal muscle oxidative 
capacity and capillary density (Balady et al., 1996; Casillas et al., 2007). Gender differences 
in exercise capacity (up to 25% lower in females) may be explained by heart size, baseline 
activity status, and the relative amount of skeletal muscle (Pollock and Wilmore, 1990). 
After a recent acute coronary event (myocardial infarction or a coronary artery 
revascularization procedure), some coronary patients may show an impaired ability to 
partake in exercise training. Peersen et al. (2019) found that 18% of coronary patients 
perform little or no physical activity. The reasons may be physiological (reduced functional 
capacity, ventricular dysfunction, post-procedural recovery, musculoskeletal disorders), or 
psychological, implying concerns about the training-associated risk of a new coronary 
event (Anderson et al., 2016). Ades et al. (2006) reported very low peak V̇O2 in 2896 
patients after myocardial infarction treated with PCI or CABG, noticing that factors 
associated with lower V̇O2 values were female gender, CABG, and hypertension (Aedes et 
al., 2006). 
 
1.2.4. Prescribing exercise training in coronary patients 
 
The focus of exercise training programming should be the patient's individual 
limitations. The difference in the stage of coronary heart disease, age, disability status, and 
comorbidities in coronary patients requires an individual approach when planning physical 
training. Exercise prescription (exercise intensity) should be based on the patient's clinical 
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status and response (heart rate, blood pressure, perceived exertion) to exercise during 
cardiopulmonary exercise testing. A ramp incremental protocol is accepted as the most 
appropriate for the assessment of patients exercise capacity at baseline and after 
completing an exercise program, as well as for detecting of training-induced myocardial 
ischemia or rhythm disturbance (Mezzani et al., 2013; Myers and Bellin, 2000). 
Personalization of the training program implies the selection of the appropriate 
mode of exercises, determining the intensity of exercise, the frequency and duration of 
training sessions, and gradual progression of exercise (Casillas et al., 2017). The modes of 
physical activity that are recommended to increase peak aerobic capacity are those that 
involve large muscle groups, such as walking, cycling, or calisthenics (Bruning and Sturek, 
2015). The most commonly implemented exercise modalities in cardiac rehabilitation 
programs are land-based aerobic exercise training (walking, cycling) as the only type of 
exercise modality, or supplemented with low-weight resistance training and/or 
calisthenics exercise (Bjarnason-Wehrens et al., 2010).  
Cycle ergometer training is the most often recommended type of aerobic exercise. 
Optimally, aerobic exercise training should be performed at a moderate intensity, i.e.  40–
85% of the maximal functional capacity (VO2 max) which correlates with 55–90% maximal 
heart rate. Although there is no consensus on the intensity of training needed to improve 
the patient's condition, submaximal intensity (between the anaerobic threshold and 
respiratory compensation point) is considered to be the most acceptable from the aspect 
of efficacy and safety for the patient (Meyer et al., 2005). Anyway, intensity of exercise 
should be below the level that triggers symptoms of exercise intolerance, myocardial 
ischemia, or rhythm disturbance (Durstine et al., 2000). 
Duration of exercise should include 20–60 minutes of exercise training (continuous 
or interval training), with 5-minute warm-up and cool-down periods with stretching 
exercise. The minimum frequency of exercise sessions is three nonconsecutive days 
weekly, optimally 5 to 7 times a week. At initial slow exercise program should be continued 
by gradually increasing the intensity and duration of exercise (Perk et al., 2012; Pescatello 
et al., 2014; Kokkinos, 2008; Pollock and Wilmore, 1990). In deconditioned individuals, 
similar benefits to those of longer exercise sessions may be produced by accumulated 
bouts of 10-minute exercise (Woodcock et al., 2011).   
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Calisthenics are most often implemented type of exercise in cardiac rehabilitation 
programs as an addition to aerobic training. This type of exercise consists of different 
simple movements (using own body weight for resistance) which are aimed at improving 
muscle strength, flexibility, movement coordination, respiratory capacity, and patients' 
ability to perform common daily activities. The type and technique of exercises, exercising 
position, performance speed, number of exercises per session and repetitions per set must 
be adjusted to the functional condition of the patient (Casady and David, 1992; Working 
group on cardiac rehabilitation report, 2001). Callisthenic training structured according to 
the patient's physical capacity may lead to both cardiovascular fitness and muscle 
endurance. Aerobic calisthenics exercises 50 min/day for 3 days/week have been shown to 
result in increased plasma nitric oxide levels (Guzel et al., 2012). 
Resistance exercises increase peripheral muscle strength (25–30%), mass, and 
endurance, in contrast to aerobic exercise which primarily increases the circulatory 
capacity for exercising. Combined with aerobic exercise, resistance training has been 
shown to improve exercise capacity more than aerobic exercise alone (Volaklis & 
Tokmakidis, 2005; Williams et al., 2007; Vona et al., 2009). Resistance exercise reduces 
cardiac demands at given workloads by reducing the rate-pressure products (systolic blood 
pressure x heart rate) (Sorace et al., 2008). Special caution is required, however, when 
planning this type of training in coronary patients following myocardial infarction or CABG, 
those with rhythm disturbance, hypertension, diabetes, low functional capacity, and 
musculoskeletal limitations (Stewart et al., 1998).  
Following an acute coronary event, PCI, or CABG, individually prescribed exercise 
programs should start as early as possible: immediately after healing of the punctured 
vessel in patients after PCI, and 6–8 weeks after thoracotomy, until thoracic stabilization 
(Vanhees et al., 2012). 
 
1.2.4.1. Effects of exercise on functional capacity in coronary patients 
 
Exercise capacity (EC) is a strong predictor of cardiovascular and all-cause mortality 
in both healthy adults and coronary patients. It is defined as “the maximal ability of the 
cardiovascular system to deliver oxygen to exercising skeletal muscles and the ability of 
exercise muscles to extract oxygen from the blood“, indicating that cardiac performance, 
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skeletal muscle metabolism, and pulmonary gas exchange represent the basic 
determinants of exercise capacity (Conraads et al., 2014). The most precise parameter of 
exercise capacity is measured peak aerobic capacity, defined in terms of the maximal 
oxygen uptake (VO2 max  - maximal person's capacity to utilize oxygen, the product of 
maximal cardiac output and the maximal arterio-venous O2 difference) (Malek et al., 
2004). An increase in exercise capacity by 1.0 metabolic equivalent (MET) i.e. 3.5 
ml/kg/min-1 leads to a 12% improvement in survival in cardiovascular disease patients 
(Conraads et al., 2015; Uddin et al., 2015).  
Exercise training causes improvements in the physical performance capacity of 
coronary patients through beneficial effects that promote the functioning of the 
cardiovascular, muscular, and neurohumoral system (Belardinelli et al., 2001). An exercise 
training program performed as dynamic exercise  (walking, bicycling, swimming) of 
sufficient intensity and duration leads to both central (improved oxygen transport capacity 
of the circulatory system) and peripheral (increased oxidative metabolic capacity of the 
skeletal muscle) adaptations in accordance with the degree of stress imposed on the heart 
and skeletal muscles. The increase in cardiac output obtained with exercise is related to 
the reduced peripheral resistance and augmentation of the maximal flow capacity (Clausen 
et al., 1977).  
Previous studies have reported beneficial effects of exercise training on exercise 
capacity in coronary patients with stable coronary artery disease and those after 
myocardial infarction treated with PCI or CABG (Belardinelli et al., 2001; Hambrecht et al., 
2004). By increasing the arteriovenous oxygen difference and stroke volume, exercise 
training increases functional capacity and peak oxygen uptake in coronary patients 
(Clausen, 1977). The contribution of these two factors to the increase in V̇O2 peak varies 
with the characteristics of exercise training (type, intensity, duration), as well as the 
individual characteristics of the patient (age, gender, diagnosis, baseline V̇O2 peak) (Uddin 
et al., 2015; Clausen, 1977; Rowel, 1986).  
It has been documented that exercise training (at a moderate intensity of 60–80% 
of peak VO2) increases exercise capacity, with variations in the increase magnitude from 
11% to 66% (average about 20%) for V̇O2 peak improvement in coronary patients following 
myocardial infarction or CABG after 3–6 months of regular exercise training (Fletcher et al., 
1995; Kirolos et al., 2019; Hartung and Rangel, 1981; Thomson, 1988; Vanhees et al., 2004; 
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Belardinelli et al., 2001). On the other hand, low V̇O2 peak (< 10 ml/kg/min-1) and lack of 
improvement in exercise capacity after an exercise training program imply poor prognosis 
(Savage et al., 2009; Francis et al., 2000). 
The beneficial effects of aerobic endurance exercise training (walking, cycling, 
jogging) have been well established. Moderate- to high-intensity aerobic endurance 
training is recommended as the baseline activity in patients with preserved or reduced left 
ventricle function (Reibis al., 2015). Combined aerobic and resistance training showed 
greater improvements in exercise capacity compared to aerobic exercise alone (Volakis and 
Tokmakidis, 2005). The results of studies comparing the results of interval and continuous 
training are still contradictory. Exercise capacity improvement during training programs is 
positively associated with the frequency and intensity of exercise training (Vanhees et al., 
2012). 
 
1.2.4.2. Effects of exercise on vascular function  
 
Endothelial dysfunction is characterized by reduced NO bioavailability, which 
occurs due to a number of prooxidant processes modified by endothelial vasoactive 
substances, caused by cardiovascular risk factors. All segments of the vascular system are 
exposed to the atherogenic effect of risk factors, but atherosclerotic lesions mostly form 
at specific sites in the vessels where turbulent flow and low endothelial shear stress occur 
(Chatzizisis et al., 2007). Endothelial shear stress (ESS) is the contact pressure created by 
the friction of the circulating blood on the surface of the vascular wall endothelium 
(Wentzel et al., 2012).  Low ESS, recognized by the mechanoreceptors on the surface of 
endothelial cells, induces a range of intracellular cascades leading to an atherogenic 
endothelial phenotype. By stimulating the production of ROS and increasing endothelin-1, 
low ESS leads to nitric oxide reduction and endothelial dysfunction (Chatzizisis et al., 2007; 
Wentzel et al., 2012). Low ESS participate not only in the initiation of plaque formation but 
also in plaque growth and its evolution into an unstable plaque prone to rupture (Wentzel 
et al., 2012). 
The beneficial effects of exercise training on endothelial function are achieved by 
the mechanical forces of shear stress, which are known as potent physiological stimuli for 
NO release (Di Francescomarino et al., 2009). The results of previous studies indicate that 
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regular physical activity may improve endothelial function by increasing NO production 
through the upregulation of eNOS gene expression and decreasing NO inactivation through 
the augmentation of antioxidant defense capacity. The complex hemodynamic effects of 
exercise result in markedly (4- to 6-fold) increased blood flow and laminar shear stress 
(Laughlin et al., 2008; Green et al., 2017) on the surface of the endothelium, leading to the 
upregulation of eNOS (vasodilatory effects) and enzymes responsible for reactive oxygen 
species (ROS) scavenging (superoxide dismutase, and glutathione peroxidase) (antioxidant 
effect) (Inoue et al., Franke et al., 1998; Niebauer et al., 1996). Exercise training can also 
improve age-related endothelial dysfunction, as pointed out by Early et al. (2017). They 
found no influence of age on change in BAFMD with exercise training, suggesting that 
endothelial function can be improved throughout life regardless of age (Early et al., 2017). 
It has been reported that exercise may inhibit apoptosis in endothelial cells (Dimmeler et 
al., 1999) and increase the number of circulating endothelial progenitor cells (EPCs) in 
coronary patients (Steiner et al., 2005; Adams et al., 2004).   
The effects of exercise training on vascular function have been well documented. 
In most studies, flow-mediated dilation of the brachial artery was used as the benchmark 
of vascular function. Exercise training is generally accepted as a non-pharmacological 
intervention for the improvement of endothelial function in coronary patients. However, 
some practical issues (optimal exercise modality, intensity, and volume) remain unclear. 
Evidence supports the assumption that regular, moderate-intensity aerobic exercise 
involving large muscle groups is the exercise modality with the greatest beneficial effect 
on BAFMD, which speaks in favor of being the most effective way to improve vascular 
function (Green et al., 2004; Maiorana et al., 2000).   
A meta-analysis (Early  et al., 2017) of 66 studies that examined the impact of 
exercise  training on BAFMD (in patients with different pathologies: coronary heart disease, 
arterial hypertension, T2D, T1DM, heart failure, thyroid dysfunction, metabolic-related 
disease, obesity, and in asymptomatic/healthy subjects)  showed that physical training at 
a moderate intensity – regardless of the disease status, exercise modality used (aerobic, 
resistance, combined aerobic/resistance), training duration (from 8 to 20 weeks), 
frequency (from 2 to 5 sessions per week), or volume (167  93 min/week) – leads to 
significant improvement in BAFMD, as compared to the control group. The initial BAFMD 
values (5.5 ± 2.4%) increased significantly upon the completion of the exercise training 
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program (up to 8.1 ± 3.9%). Also BAFMD was associated with training duration and 
intensity in a dose-response manner. Increased exercise intensity may trigger a greater 
shear stimulus which regulates nitric oxide production, although moderate exercise 
intensity has been shown to be sufficient to ameliorate endothelial function (Early et al., 
2017). 
Vona et al. revealed similar observations in their study evaluating the effects of 
different types of 4-week exercise training on endothelial function in coronary patients 
following myocardial infarction. They found that exercise training was associated with 
improved endothelial function independently of the type of training, but increase in 
BAFMD was the greatest in the group with combined aerobic and resistance training (Vona 
et al., 2009).  
The time course of exercise training-induced changes in endothelial function has 
not yet been determined. In trained animals, endothelial function may improve after as 
few as 7 days of exercise (Mc Allister et al., 1997; Wang et al., 1993). In healthy young male 
subjects, after 2 weeks of aerobic training, an increase in FMD of the brachial and popliteal 
arteries was found, from baseline 5.9 ± 0.5% to 9.1 ± 0.6% (P < 0.01) (Tinken et al., 2008). 
In pathological conditions associated with decreased NO bioactivity, such as coronary heart 
disease, a more rapid response to exercise training should be expected. According to 
recent studies, endothelial response to exercise was noted in coronary patients after 
exercise training lasting 4 weeks (Hornig et al., 1996; Hambrecht et al., 2000; Vona et al., 
2009), 8 weeks (Luk et al., 2011), and 12 weeks (Edwards et al., 2004; Cornelissen et al., 
2012; Cornelissen et al., 2014; Currie et al., 2013). The significant increase in FMD was in 
the range from 1.84% (Luk et al., 2011) to 37% (Cornelissen et al., 2014). Oliviera et al. 
reported no beneficial effect of three-week exercise training on endothelial function in 
patients following myocardial infarction (Oliviera et al., 2015.) Nitroglycerin-mediated 
dilatation was unaffected after 10 weeks (Gokce et al., 2002), or 12 weeks of exercise 
(Moriguchi et al., 2005; Higashi et al., 1999).  
In patients with coronary heart disease, the effects of exercise on the endothelium 
of peripheral vasculature most likely extend to the coronary circulation (Hambrecht et al., 
2000).  Exercise raises myocardial oxygen demand, acting as a stimulus for increasing 
coronary blood flow (CBF). Enhanced CBF modulates eNOS expression, resulting in 
functional (improvement in endothelial and coronary smooth muscle function) and 
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structural changes in the epicardial and resistance coronary vessels (Hambrecht et al., 
2000). In coronary patients, exercise may promote collateralization via inducing 
arteriogenesis (enlargement of preexisting collateral arterioles) by physical forces, and 
angiogenesis (growth and proliferation of capillaries) by promoting ischemia (Heaps et al., 
2011; McKirnan et al., 1994; Bruning and Sturek, 2015). Hambrecht et al. reported 
significant improvement in coronary endothelial dysfunction after 4 weeks of exercise 
training in patients with non-occlusive CAD (Hambrecht et al., 2000). The same results were 
reported in an animal model of subacute coronary artery occlusion (Griffin et al., 1999).  
 
1.2.4.3. Effect of exercise on endothelial activation 
 
The results of previous studies indicate that exercise training may have a positive 
impact on the circulating markers of endothelial activation. Exercise may express a positive 
effect on circulating CAMs directly, by changing the expression of the CAMs related to 
changes in transcriptional regulation of CAMs induced by shear stress, or indirectly, by 
reducing antagonists of CAM synthesis: proinflammatory cytokines, reactive oxidative 
species, and thus oxidation of LDL (Ribiero et al., 2012; Koh and Park, 2018). 
Recent studies have confirmed that low-to-moderate intensity aerobic exercise 
training for 8-12 weeks beneficially affects markers of endothelial activation, leading to a 
significant reduction in CAMs in patients following myocardial infarction (Ribiero et al., 
2012; Schumacher et al., 2005), those with stable heart failure (Adamopoulos et al., 2001; 
Rothenbacher et al., 2003), type 2 diabetes mellitus (Zoppini et al., 2006; Roberts et al., 
2006), with a certain form of cardiometabolic disease (Aksoy et al., 2015), or in individuals 
with CVD risk (Wegge et al., 2004). In contrast to aerobic exercise training, resistance 
exercises regardless of intensity did not have a significant effect on serum CAMs 
concentrations (Ribeiro et al., 2009). 
Several studies however, reported no changes in serum concentrations of CAMs 
after exercise in coronary patients following MI (Oliveira et al., 2015) or PCI (Munk et al., 
2009), in healthy men (Petridou et al., 2007; Wang et al., 2005; Jilma et al., 1997), obese 
young males (Kargarfag et al., 2016), patients with T2D (Scheede-Bergdahl et al., 2009), 
and metabolic syndrome (Gonzales et al., 2010). Bjornstad et al. observed a decrease in 
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the serum concentrations of P-selectin, but not sVCAM-1 after 20 weeks of exercise 
training in patients with mild to moderate chronic heart failure (Bjornstad et al., 2008).  
 
1.2.4.4. Effects of exercise on low-grade inflammation 
 
Exercise has been shown to be an effective way to modulate the proinflammatory 
activity associated with atherogenesis. Biomarkers of low-grade vascular inflammation 
involved in atherogenesis include CRP and cytokines from the interleukin group, the 
proinflammatory IL-6 and IL-8, and the antiinflammatory cytokine IL-10. All of them are 
strong predictors of cardiovascular events and may correlate with the severity of CAD 
(Ribiero et al., 2010; Ridker et al., 2000). 
Measurement of the circulating levels of inflammatory biomarkers has been used 
for the assessment of the antiinflammatory effects of exercise. Regular aerobic exercise 
training is associated with a chronic antiinflammatory effect. Geffken et al. investigated 
the association between physical activity and markers of inflammation in a healthy elderly 
population and reported 19% lower concentrations of C-reactive protein in physically 
active persons (Geffken DF et al., 2001). The effects of exercise training on serum CRP 
values in healthy individuals depend on the type of exercise (in swimmers, 80% lower CRP 
values were recorded than in control subjects) (Kasapis and Thompson, 2005).  
Data from randomized controlled trials suggests that the effects of aerobic exercise 
training are beneficial for reducing the levels of inflammatory biomarkers in individuals 
with a higher inflammation status (Beavers et al., 2010). Studies assessing the 
antiinflammatory effect of exercise in patients with CAD reported that exercise training 
reduced vascular wall inflammation, as indicated by the reduction in the circulating levels 
of proinflammatory cytokines and CRP (Munk et al., 2009; Roca-Rodriguez et al., 2015; 
Schumaher et al., 2006; Goldhammer et al., 2005; Balen et al., 2008; Kim et al., 2008; 
Ribeiro et al., 2012; Walther et al., 2008; Oliviera et al., 2015; Milani et al., 2004; Tisi et al., 
1997), and increase in the levels of the antiinflammatory cytokine IL-10 (Munk et al., 2009; 
Goldhammer et al., 2005; Balen et al., 2008; Kim et al., 2008). An increase in 
atheroprotective cytokines (IL-10 and IL-4), and decrease in atherogenic cytokines (IL-1, 
TNF-, INF-) and CRP were also observed in individuals with risk factors for CVD after 6 
months of exercise (Smith et al., 2000). On the other hand, some studies have failed to 
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confirm the antiinflammatory effect of exercise, reporting no changes in CRP or 
proinflammatory cytokine levels with exercise (Neissner et al., 2006; Luk et al., 2001; 
Hansen et al., 2008; Sixt et al., 2008). 
Studies investigating the effect of exercise on IL-8 concentration are rare. Balen et 
al. noticed a decrease in IL-8 concentration after a 3-week exercise program in coronary 
patients (Balen S et al., 2008). It has been reported that high-intensity interval exercise 
reduced IL-8 and increased IL-10 in lean and overweight young men (Dorneles GP et al., 
2016). 
In chronic heart failure patients, no decrease in IL-6 and IL-8 was noticed after 12 
weeks of aerobic exercise (Larsen et al., 2001) or in IL-6 after 16 weeks of combined aerobic 
and resistance training (Conraads et al., 2002). Similarly, in chronic heart failure patients, 
Milani et al. did not observe a decrease in CRP, while a significant decrease in this 
parameter was observed in coronary patients. 
The exact mechanism by which physical activity affects low-grade inflammation 
associated with coronary heart disease is still unclear. It is believed that the modulation of 
the inflammatory process, which occurs as a result of long-term regular physical training, 
can be attributed to the improvements in endothelial function (improved NO 
bioavailability, reduction of oxidative stress and LDL oxidation, and thus decreased 
monocyte activation and production of inflammatory mediators), lipid profile, arterial 
blood pressure control, and adipose tissue reduction (Ribeiro et al., 2010; Bruunsgaars, 
2005; Beavers et al., 2010). 
Pedersen et al. suggested that myokines (IL-6 and other cytokines produced and 
released by skeletal muscles) may be involved in the mechanisms by which exercise 
attenuates low-grade inflammation. Namely, the positive effects of regular long-term 
exercise are considered to be a consequence of the antiinflammatory response that occurs 
in the initial stages of training. High levels of IL-6 after exercise induce the production of 
antiinflammatory cytokines IL-10 and IL-1ra, and inhibit the production of proinflammatory 
cytokine TNF- (Petersene and Pedersen, 2005; Pedersen et al., 2003). However, some 
recent studies have found no exercise-induced cytokine response in healthy older adults 
(Windsor et al., 2018). 
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1.2.4.5. Effects of exercise on activated hemostasis 
 
It has been confirmed that exercise training improves activated hemostasis by 
reducing the values of fibrinogen and D-dimer, the indices of thrombogenesis whose raised 
levels are independent predictors of cardiovascular outcome in coronary patients (Lee et 
al., 2006). Physical activity has a significant influence on hemostatic and fibrinolytic 
systems in healthy individuals and patients with atherosclerotic disease, which is probably 
one of the ways in which it achieves the overall health benefits (Lee and Lip, 2003). 
Referring to the results of numerous published studies, the biological effects of exercise 
depend on the type of exercise, its intensity, and duration, as well as the health status of 
the person performing the exercise, including genetic factors (Montgomery et al., 1996). 
The same applies to its effects on hemostasis. Concerning the influence of physical exercise 
on hemostasis, vigorous and acute exercise is associated with a transient 
hypercoagulability state, particularly in physically inactive subjects or those with latent or 
manifested coronary disease (Lippi and Mafulli, 2009; Haskel et al., 2007; El-Sayed, 1996; 
Arai et al., 1990; Acil et al., 2007). In healthy individuals, the activation of coagulation is 
accompanied by an increase in fibrinolytic activity, which does not occur in coronary 
patients, who are unable to reach the required increase in fibrinolytic potential (Koenig 
and Ernst, 2000). Conversely, long-term regular exercise at a low-to-moderate intensity 
inhibits the procoagulatory tendency and significantly improves fibrinolytic activity, leading 
to an antithrombotic state (Wosornu et al., 1992; Lee et al., 2006; El-Sayed et al., 2000; 
Koenig and Ernst, 2000).  
The effects of exercise on fibrinogen levels have been intensively studied. Regular physical 
activity at a low-to-moderate intensity modifies plasma fibrinogen levels. Most studies 
have reported reduced fibrinogen levels after regular exercise (Lee and Lip, 2003; Eliason 
et al., 1996; Koenig et al., 1997; De Souza et al., 1998; Lakka and Salonen, 1993; Folsom et 
al., 1991; Rankinen et al., 1993; Suzuki et al., 1992; Dudaev et al., 1986; Stratton et al., 
1991; Vanninen et al., 1994; Lindahl et al., 1999; Folsom et al., 1991). The decrease in 
plasma fibrinogen brought about by regular endurance training over several months is 
around 0.4 g/l (Ernst, 1993). According to data from the Northwick Park Heart Study 
(Meade et al., 1986), 0.1 g/l difference corresponds to a coronary heart disease risk 
modification of 15%, so a decrease in plasma fibrinogen level of 0.4 g/l would mean a CHD 
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risk decrease by 60% (Conelly et al., 1992). However, as regards fibrinogen levels in 
response to regular physical exercise, some trials have failed to show changes in plasma 
fibrinogen (Ponjee et al., 1993). 
Previous studies have presented different results in terms of the effect of physical activity 
on plasma D-dimer levels. Shanjani et al. (Shanjani et al., 2014) and Lee et al. (Lee et al., 
2006) reported a significant decrease in plasma D-dimer values in coronary patients after 
a cardiac rehabilitation exercise program, while Erickson-Berg et al. (Erickson-Berg et al., 
2002), in a study conducted on female post-MI patients, demonstrated that D-dimer was 
unaffected by exercise.  
The beneficial impact of cardiac rehabilitation on the patients' thrombogenic 
profile in the sense of lowering coagulability and promoting fibrinolysis can be viewed from 
the side of the positive influence of physical exercise itself, as described, but also from the 
aspect of positive effects on other risk factors (blood lipid profile regulation, weight loss, 
cigarette smoking cessation, glucose level regulation) whose improvements are associated 
with a lower prothrombin tendency (Suzuki et al., 1992; Wosorny et al., 1992; Weiss et al., 
1998).  
 
1.2.4.6. Effects of exercise on neurohumoral activity 
 
The exercise-induced increase in plasma levels of natriuretic peptides immediately 
after exercise in healthy individuals is a consequence of transient myocardial wall stress, 
metabolic changes in cardiac myocytes, and the physiological neurohumoral response to 
the myocardial stress induced by exercise. Peak values were recorded immediately after 
exercise, with a return to baseline values within one hour after exercise (Hamasaki, 2016) 
or up to 3 hours after prolonged high-intensity exercise in marathon runners (Hermann et 
al., 2003). 
In coronary patients undergoing short-bout exercise (e.g. exercise test), the 
induced transient ischemia may cause the release of BNP and NT-proBNP, with an increase 
in value proportional to the degree of myocardial ischemia (Sabatine et al., 2004; Foote et 
al., 2004; Win et al., 2005). However, regular moderate-intensity aerobic exercise training 
leads to a decrease in the circulating levels of NT-proBNP in coronary patients (Berent et 
al., 2009; Giallauria et al., 2006; Giallauria et al., 2005; Saghiv et al., 2017).  Also, regular 
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and continuous exercise reduces NT-proBNP levels in healthy individuals and heart failure 
patients (Passino et al., 2006; Conraads et al., 2004; Bordbar et al., 2012; Maria-Sarullo et 
al., 2006).  
The drop in circulating NT-pro BNP levels after a continuous exercise program is 
considered a consequence of reduced ventricular wall tension and an expression of 
improved myocardial function. The reduced ventricular wall tension may be explained by 
the improved endothelial function and decreased peripheral vascular resistance, i.e. the 
same mechanisms that lead to improved functional capacity after regular physical activity 
(Bordbar et al., 2012). Sympathetic deactivation has also been proposed as one of the 
underlying mechanisms (Conraads et al., 2004).  
Previous studies examining the effects of land-based physical exercise on plasma 
NT-proBNP levels in coronary patients during cardiac rehabilitation have reported reduced 
levels of NT-proBNP (Berent et al., 2009; Gialluria et al., 2006; Diallauria et al., 2005; Saghiv 
et al., 2006; Svealv  et al., 2009). 
 
1.2.4.7. Effects of exercise on cardiac autonomic function 
 
Exercise training has a beneficial impact on the modulation of cardiac autonomic 
balance (the sympatho-inhibitory effect) (Arai et al., 1989; Abolahrari-Shirazi et al., 2019; 
Astolfi et al., 2018; Kirolos et al., 2019; Badrov et al., 2019), and changes in cardiac electrical 
stability (Hull et al., 1994), which are probably the underlying mechanisms by which regular 
exercise training decreases cardiovascular mortality and sudden cardiac death after 
myocardial infarction. Regular moderate-intensity aerobic exercise promotes adjustments 
in the cardiac autonomic nervous system, manifested through rest heart rate alterations 
(Rodrigues et al., 2014; Dart et al., 1992). Alterations of central afferent and efferent 
pathways as well as in effector organs are thought to be the basic mechanism by which 
training leads to changes in autonomic control, although they have not been fully 
elucidated yet (Favret et al., 2001).  
HRV modification in response to exercise training in coronary patients has been 
well documented. There is ample evidence to suggest a positive relationship between 
cardiorespiratory fitness and HRV modifications (Keney et al., 1985).  
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Findings indicating that exercise training significantly increases different indexes of 
HRV suggest that HRV analysis can be used for assessing the effects of exercise training on 
cardiac autonomic function in post-MI coronary patients (Routledge et al., 2010).  
 
1.2.4.8. Effects of exercise on health status and quality of life 
 
Quality of life is dependent on many components that include physical fitness, 
social environment, financial condition, education, employment, leisure and culture, 
ecology (www.cdc.Gov/hrqol/index.Htm). Since impaired functional capacity is the main 
characteristic of the condition of coronary patients, and since functional capacity per se is 
the main determinant of health quality, it is to be expected that exercise training, by 
improving the functional capacity of coronary patients, leads to improved health-related 
quality of life. In addition to functional capacity, an important determinant of quality of life 
is mental health, both playing important roles in HRQoL in coronary patients.  
Previous studies have demonstrated positive effects of exercise training on 
cardiorespiratory fitness and HRQoL in coronary patients following myocardial infarction, 
treated with PCI or CABG (Hirano et al., 2005; Staniute et al., 2010; Tofighi et al., 2012; 
Oldrige et al., 1991; Francis et al., 2019). Common to most studies with coronary patients 
is the fact that exercise training has led to better improvements in physical as compared 
to mental health.  
The results of studies indicate that exercise modalities do not affect quality of life 
in the same way as functional capacity. Namely, while the combination of aerobic and 
resistance exercise training increases physical capacity to a greater extent than aerobic 
training itself, in terms of the impact on quality of life, aerobic exercise has a greater 
beneficial effect (Mandic et al., 2009). Low-to-moderate aerobic exercise training as part 
of a cardiac rehabilitation program resulted in enhanced functional capacity and moderate 
improvement in QoL primarily in the pain domain (Stanuite and Brožaitiene, 2010). It has 
been shown that resistance exercise training does have a positive impact on QoL (Ostman 
et al., 2017). 
While the influence of training variables on functional capacity is known, their 
influence on the magnitude of the effect of exercise training on quality of life is not known. 
Exercise training in the total duration of 12 months, with a training frequency of 3–4 
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sessions per week and session duration of 30–45 minutes, proved to be the most effective 
exercise training for QoL improvement, noting that shorter training duration yielded better 
results (Slimani et al., 2018). Hirano et al. reported improvement in QoL after 4 weeks of 
exercise (assessed by SF-36) in patients after cardiac surgery (Hirano et al., 2005). The best 
improvements in QoL were seen after 6 months in patients following MI, PCI, or CABG 
(Stanuite and Brožaitiene, 2010). Some studies have shown that there are no significant 
differences between the exercise-induced changes in HRQoL in terms of age and gender or 
treatment (Tofighi et al., 2012; Brorsson et al., 2001; Wahrborg et al., 1999). Stanuite and 
Brožaitiene reported better improvement in QoL in the physical component summary 
domains in older patients (Stanuite and Brožaitiene, 2010).  
 
1.2.5. Aquatic exercise 
 
Aquatic exercise refers to the use of immersion pools or natural aquatic 
environments at different water temperatures and depths that facilitate the application of 
various established therapeutic interventions, including various modalities of endurance 
training (Schrepfer, 2007). Due to the physical properties of water, aquatic exercise has a 
beneficial effect on the cardiovascular, respiratory, musculoskeletal, endocrine, and 
autonomic nervous system  has a long history of being used in rehabilitation medicine 
(Becker, 2009). Aquatic rehabilitation dates back to the time of early civilizations and 
implies a medical treatment modality of using water immersion for the restoration of 
physical mobility and physiological activity (De Vierville, 2003).  
 
1.2.5.1. Physical properties of water 
 
The biophysiological effects of water immersion are determined primarily by the 
physical properties of water: hydrostatic pressure, buoyancy, density, viscosity, and 
thermodynamic. The physical properties of water may be highly beneficial in exercise 
training due to its possible use as a thermal conductor, compressor, or counterbalance to 
gravity and resistance (Torees-Ronda et al., 2014). 
Hydrostatic pressure implies pressure that water exerts on immersed objects 
immediately upon immersion and it is directly proportional to the depth of immersion (1 
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mmHg/1.36 cm of water depth) and water density. It leads to the redistribution of 
peripheral blood towards the abdominal and thoracic vascular areas, thus increasing 
central venous pressure and consequently cardiac output (Becker, 2009). In this way, 
hydrostatic pressure makes the conditions of exercising in water different in relation to the 
conditions on dry land.  
Buoyancy is the upward force that acts opposite to gravity and is equal to the 
volume of the water displaced with the immersion of the body. Displaced water, creating 
the force of buoyancy, decreases the influence of gravity thus allowing the body to unload. 
The effects of gravity on body weight decrease with the depth of immersion: at symphysis 
depth by 40%, at waist depth by 50%, at xiphoid depth by 60% or more, and further 
immersion to the shoulder level may cause a drop by up to 85% (Becker, 2009; Atkinson, 
2005).  
Density of water is related to buoyancy and it makes the water act as a 
counterbalance to the effects of gravity, allowing the immersed body to float (Torees-
Ronda et al., 2014). These two properties of water are of great therapeutic benefit for 
patients with weight-bearing restrictions. By providing the patient with weightlessness and 
joint unloading and by decreasing the force needed to move, it allows easier exercise 
(Becker, 2009; Schrepfer R, 2007).  
Viscosity signifies the friction occurring between the molecules of fluid creating 
resistance with active movement. It is proportional to the velocity of movement through 
the fluid and the surface area colliding with water during movement. Viscosity of water 
provides adequate resistance which allows strengthening of the muscles with decreased 
joint stress, facilitating the training conditions in comparison to land-based exercise.  
Thermodynamics – water has a high capacity for transferring heat energy and 
maintaining constant temperature, so that an immersed body adapts to the temperature 
of the water. The magnitude of water temperatures used for therapeutic purposes is wide, 
with the thermoneutral water temperatures (30–34°C) most commonly used. The 
transferred heat energy is thought to contribute to the peripheral vasodilation caused by 
a decrease in peripheral resistance during water immersion (Wilcock et al., 2006). 
The physical properties of water (primarily its density and hydrostatic pressure) are 
significantly different from the properties of air, which leads to a different response of the 
body to exercise in these two environments. As compared to air, thermoneutral water 
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immersion increases SV and CO (increasing cardiac filling volume); causes peripheral 
vasodilation, decreases peripheral resistance,  reduces vasomotor tone thus decreasing 
afterload;  increases cardiac efficiency (by increasing SV and CO and decreasing the effort 
required to circulate blood) (Arborelius et al., 1972; Christie et al., 1990); decreases SBP, 
DBP; attenuates  SY and increases PSY cardiac autonomic control (due to loading of 
baroreceptors caused by relative hypervolemia) (Mourot et al., 2008; Bousuges et al., 
2006; Miwa et al., 1997; Park et al., 1999); reduces lung function (Shah et al., 2019), 
facilitates movements (by reducing gravity and load imposed on the musculoskeletal 
system, it diminishes weight-bearing stress, and also hydrostatic pressure (buoyancy) 
counteracts gravitational blood pooling in the lower limbs) (Mourot et al., 2008); facilitates 
swelling reduction; leads to pain relief (due to the pressure and warmth of water) (Hinman 
et al., 2007). 
Exercise in an aquatic environment may provide health benefits both to healthy 
individuals and chronic disease patients. Since it enables the combination of aerobic and 
resistance exercises, it may be suitable for individuals who are not able to perform 
exercises safely and sufficiently with land-based training, like patients with lower 
functional capacities, frail, patients with advanced age, overweight, or those with limited 
mobility, orthopedic limitation, balance problems or concomitant conditions (neurological, 
musculoskeletal). Water, with its thermal property and low weight-bearing environment, 
reduces pain and, using the principles of hydrodynamic, allows exercise to be performed 
(Matsui et al., 2013).   
Caution is required when aquatic exercise is advised to patients with severe valvular 
insufficiency, very recent myocardial infarction, or unstable chronic heart failure (increased 
preload and cardiac enlargement may worsen the existing disease or precipitate 
ventricular dysfunction and pulmonary edema) (Meyer, 2006).  
Aquatic exercise should be discouraged in patients with unstable angina, severe 
cardiac failure, resting complex ventricular ectopy, after cardiogenic shock, with a drop in 
SBP during exercise, severe respiratory dysfunction (VC < 1 L), severe peripheral vascular 
disease, severe renal disease, danger of bleeding or hemorrhage, inability to self-monitor 
exercise, uncontrolled seizures (pts with heat-intolerant multiple sclerosis, epilepsy) 
(Becker, 2009). 
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1.2.5.2. Physiological effects of thermoneutral water immersion 
 
The aquatic environment causes immediate and delayed physiological effects, 
which may be attributed to the increase in venous return and decrease in peripheral 
vascular resistance, mainly affecting the cardiovascular, pulmonary, and renal systems.  
Immersion in thermoneutral water. During thermoneutral water immersion, 
hydrostatic pressure induces a fluid shift from the interstitial space to the intravascular 
space, increasing plasma volume. By further reducing the peripheral vascular capacitance, 
it induces the redistribution of peripheral blood into the abdominal and thoracic 
vasculature, thus increasing venous return and central venous pressure. Central venous 
pressure rises with immersion to the xiphoid and increases until the body is completely 
immersed. With the increase in central venous pressure, there is also an increase in end-
diastolic volume, stroke volume, and cardiac output (Gabrielsen et al., 1993). 
Thermoneutral water immersion increases the parasympathetic influence and, by 
stimulating baroreceptors, induces a decrease in HR, blood pressure, and systemic vascular 
resistance (Schmid et al., 2009). Physiological alterations during resting immersion and 
exercising are conditioned by immersion depth and water temperature (Becker, 1994).  
In immersion up to the iliac crest, the shift of the blood volume is not significant. 
Immersion to the diaphragm leads to an increase in heart volume by approximately 130 
ml. During neck-deep water immersion, water exerts a pressure on the body surface of 
approximately 75 mm Hg, which compresses superficial veins, particularly those of the 
lower extremities and abdomen, resulting in a blood shift to the thorax and heart, 
consequently increasing central venous pressure (pressure in the right atria increases by 
up to 15–20 mm Hg) (Rich et al., 1978; Arborelius, 1972). Blood redistribution from the 
periphery to the intrathoracic vasculature leads to an increase in central blood volume of 
700 ml (it represents 60% of the increase in central volume), of which around one–third 
(180–240 ml) is distributed to the heart, causing enlargement of all four chambers and an 
increase in heart size of around 30% within six seconds (Rich et al., 1978; Lehmann et al., 
1990). As a consequence, the left ventricular end-diastolic volume rises by 40–70 ml. Due 
to the Starling mechanism, along with the preload enhancement, stroke volume increases 
by 35–45% (normal resting stroke volume is about 70 mL/beat, the additional 25 mL 
resulting from immersion equals about 100 mL), and the heart rate usually drops 
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approximately by 12%–15% (Risch et al., 1978). During clavicle depth immersion, cardiac 
output increases by about 1.5 L/min, of which 50% is directed to increased muscle blood 
flow (Weston et al., 1987). This leads to decreased end-diastolic pressure. Heart chamber 
enlargement and increased transmural pressure in the chamber walls induce the release 
of natriuretic peptides (Mourot et al., 2004), increasing diuresis and decreasing peripheral 
vascular resistance, thus contributing to blood pressure regulation (Weston et al., 1987; 
Epstein, 1992). Blood pressure is usually unchanged or slightly decreased during rest 
immersion (12 mmHg/10 min of immersion (Arborelius et al., 1981), or approximately 20% 
lower than on land.  
Cardiac autonomic system. Increased central blood volume causes the loading of 
arterial and cardiopulmonary baroreceptors (Gabrielsen et al., 1996) which is followed by 
modulation of endocrine and cardiac autonomic system responses, in terms of suppressing 
the RAA axis and attenuating the SY tone (Epstein, 1992; Miwa et al., 1996). Attenuated 
sympathetic vasoconstriction decreases systemic vascular resistance by 30% (Arborelius et 
al., 1972). PSY predominance leads to a decrease in HR (Gabrielsen et al., 2003).  
Pulmonary system. The pulmonary system response to thermoneutral water 
immersion is a consequence of the simultaneous effect of hydrostatic thorax compression 
and increased intrathoracic blood volume (Becker, 2009). By compressing the abdomen, 
hydrostatic pressure raises the diaphragm to a position that interferes with full respiration, 
leading to a decrease in the expiratory reserve volume, which reduces the partial pressure 
of oxygen contributing to a 60% increase in the work of breathing (Agostoni et al., 1966). 
Vital capacity may be reduced by 3–9% during immersion to the xiphoid process. During 
maximum-effort immersion, the breathing frequency may increase, causing lower tidal 
volumes (Pendergast et al., 2015).  
Water immersion improves oxygen flow to tissues, increasing circulation to the 
deep muscle structures (Balldin and Lundgren, 1972). Neck-level water immersion may 
improve brain function (memory, cognition), thus enhancing cerebral circulation (by 
reducing peripheral vascular resistance and increasing CO) (Bonde-Petersen et al., 1992).  
Immersion in cold water. Compared to thermoneutral immersion, the increase in 
SV is lower in cold water (about 15° C). At the same time, heart rate, systolic blood 
pressure, and diastolic blood pressure slightly increase (Barbosa, 2009). During cold-water 
immersion, body temperature-induced peripheral vasoconstriction leads to an additional 
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increase in cardiac preload and consequently further increase in SV (Park et al., 1999). The 
rise in TPR leads to increased afterload, hence, CO does not increase in cold water 
immersion (Matsui and Onodera, 2013). Cool water decreases sympathovagal balance, 
which is an effect opposite to the one observed in warm water. The increase in sympathetic 
tone, mediated by rapid fall-induced activation of thermoreceptors, reduces the 
ventricular fibrillation threshold (Armour et al., 1972). Consequent vasoconstriction 
increases afterload and, together with the simultaneously increased preload due to 
hydrostatic pressure, creates the conditions of increased risk for arrhythmias. The increase 
in catecholamines is enhanced inversely to water temperature (two-fold higher than in 
thermoneutral water immersion) (Schmid et al., 2009).   
Immersion in warm water. The increase in cardiac output is greater at higher 
temperatures (at 39°C by 121%) than in thermoneutral water (at 33°C by 30%) (Weston et 
al., 1987). During immersion in warm water (40°C), the heat load induces a significant 
increase in heart rate (by an average of 21.6 bpm) (Matsui and Onodera, 2013), SV, a 
decrease in systolic and diastolic blood pressures, increases PSY activation (Nashimura et 
al., 2008), decreases the plasma concentrations of antidiuretic hormones thus increasing 
diuresis, decreases systemic and pulmonary vascular resistance, and hence potentially 
improves left and right ventricular function (Tei et al., 1995). Concerns over increased 
cardiac work the possibility that the acute strain of the right heart may elicit dysrhythmias 
are the major reasons why warm water has been considered inappropriate after a recent 
coronary event or in CHF patients (Tei et al., 1995). Based on previous research, water 
temperatures between 31° and 38°C appear to be a safe and potentially therapeutic 
environment.  
Studies examining the effect of water immersion in coronary and CHF patients are 
presented in Table 1. 
Exercise in thermoneutral water. Exercise in water leads to increased central blood 
volume in the same way as the resting water immersion. During exercise, SV is maintained 
at a level that is higher compared to the level during land-based exercise. Since there are 
no further increases in SV during water exercise, it is considered that the increase in CO 
depends on the increase in heart rate. The decrease in total peripheral resistance is larger 
than in land-based exercise. There is no change in DBP during exercise related to resting 
immersion values since systolic blood pressure increases slightly during water-based 
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exercise. Cardiac autonomic control during aquatic exercise is directed to vagal stimulation 
at a higher level compared to land exercise. It has been reported that heart rate 
significantly decreases with increased body immersion (Barbosa et al., 2007). This 
phenomenon is believed to be related to the higher thoracic volume (Sheldahl et al., 1987), 
improved conditions for heart filling during diastole due to buoyancy, hydrostatic pressure 
(Holmer, 1974), or horizontal body position (Benelli et al., 2004), and diving bradycardia 
(Andresson et al., 2004) (as in: Barbosa et al., 2009). This makes the suggested deduction 
of 7–13 bpm debatable (Darby & Yaekl, 2000; Kruel et al., 2009) when planning water-
based training protocols aimed at adjusting training accuracy (Barbosa et al., 2009). The 
influence of hydrostatic pressure and water resistance (conditioned by the depth of 
immersion) on the similarity of water- and land-based peak cardiorespiratory responses 
was indicated by Choi et al. (2015) and Matsui et al. (2013).  
The aquatic environment has been used for various exercise modalities including 
stretching, walking, cycling, running, and swimming. The similarity of the promoted 
physiological adaptations of all the above exercises has not yet been confirmed. Exercise 
recommendations involving swimming for coronary patients are still debated. An 
important aspect of swimming in patients following a recent coronary event is the 
occurrence of signs and symptoms of exercise-induced ischemia. Studies have shown a 
delayed sensation of angina during swimming, as compared to land-based exercise 
(Magder et al., 1981). Also, a rise in blood pressure and premature ventricular contractions 
were observed in elderly patients undergoing swimming (Itoh et al., 1994). Some studies 
have reported that swimming may act as an arrhythmogenic trigger for long QT-syndrome 
(Ackerman et al., 1999). There is a relative lack of swimming research in patients following 
an acute coronary event. Further investigations are needed focused on the optimal time 
to start swimming after an acute coronary event. Swimming differs in relation to other 
types of exercises in the sense of environment, position, muscle group used, and breathing 
pattern, and requires skills and techniques in order to achieve a proper exercise intensity 
(Lazar et al., 2013). All of this dictates special requirements that cannot be met due to the 
specificity of this population of patients on the one hand, and the still insufficient 
opportunities for physiological measurements in water, on the other.  
It is believed that, due to the physical characteristics of water which lead to an 
increase in SV and CO (thus increasing cardiac efficiency), and a decrease in peripheral 
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resistance (reducing the effort required to circulate blood), aquatic exercise may be 
beneficial for patients following an acute coronary event (Hanna et al., 1993; McMurray et 
al., 1988).  
Since the physiological alterations during water immersion are primarily related to 
the hydrostatic pressure that exerts an influence on cardiovascular parameters, buoyancy 
– which acts against the force of gravity and increases the heat exchange between the body 
and the environment, they should be carefully considered for adequately prescribing 
water-based exercise training. 
 
1.2.5.3. Water-based exercise in coronary patients 
 
Aquatic exercise represents an exercise modality relatively rarely employed in 
patients after an acute coronary event since its implementation in cardiac rehabilitation 
programs is still a matter of debate (Lazar et al., 2013). Given the relatively vulnerable 
hemodynamic status of this patient population, there are concerns about the safety of this 
exercise modality. The potential risks include adverse cardiovascular hemodynamic 
responses to water immersion in the sense of possible ventricular dysfunction caused by a 
hydrostatically-driven raise in preload and CVP (Shah et al., 2017; Meyer, 2006; Pendergast 
et al., 2015), and the risk of rhythm disturbances (Schmidt et al., 2009).  
The effectiveness of water-based exercise in the healthy population has been 
widely confirmed. It was reported that different modalities of water-based exercise 
training lead to significant improvements in exercise capacity (Nishimura and Onodera, 
2001), respiratory function (McNamara et al., 2011), muscle strength and power (Alberton 
et al., 2011; Colado et al., 2009), flexibility, dynamic balance and gait (Bergamin et al., 
2013), calorie expenditure, body composition (Colado et al., 2009; Bergamin et al., 2013), 
cardiac autonomic function (Mourot et al., 2008), quality of life (Binti Krim et al., 2010; 
Penaforte et al., 2015; Sato et al., 2007), have a positive influence on CVD risk factors 
(Igarashi and Nogami, 2019; Tanaka, 2009; Nowak et al., 2008; Colado et al., 2009), and 
decrease mortality risk (Chase et al., 2008).   
Over the past two decades, the effectiveness and safety of aquatic exercise have 
also been confirmed in coronary patients, to a certain extent. There is, however, no 
consensus yet on the appropriateness of water exercises in patients after an acute 
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coronary event, or the exercise modality and training variable parameters that would be 
sufficient to achieve the desired therapeutic effect.  
A limited amount of research has been conducted on the impact of water-based 
exercise in CAD patients, as compared to the land-based modalities (Schmid et al., 2007, 
2009; Volaklis et al., 2007; Laurent et al., 2009; Teffaha et al., 2011; Choi et al., 2015). 
Furthermore, the majority of these studies had restrictions on who may participate (only 
patients with stable CAD (Volaklis et al., 2007; Teffaha et al., 2011) or patients achieving > 
7 METs at exercise testing (Tokmakidis et al., 2008)). Hence, they have included a small 
number of participants and do not reflect entirely the patient populations referred for 
cardiac rehabilitation in the immediate aftermath of a CAD event. Another important issue 
is the inferior study design (e.g., pre-post studies without comparator groups 
(Korzeniowska-Kubacka et al., 2016) or non-randomized patient separation] (Tokmakidis 
et al., 2008), but with four exceptions. In the study of Volaklis et al. (2007), 24 patients with 
stable CAD were randomized to two interventions groups prescribed 16 weeks of either 
water cycling plus water games, or land cycling plus resistance training, and a no-exercise 
control group, and it was shown that both water- and land-based protocols led to 
comparable improvements in exercise test time, muscle strength, and blood lipid profiles. 
Lee et al. (2017), on the other hand, randomly assigned 60 older (> 65 years) patients 
suffering from CAD and osteoarthritis to 24-week protocols of either aqua walking or 
treadmill walking, and demonstrated that aerobic exercise capacity was comparably 
improved after both, but that aqua walking produced significantly greater improvements 
in body composition and lipid levels. Teffaha et al. (2011) randomized 48 patients (24 with 
CAD and 24 with heart failure) to a 3-week cardiac rehabilitation program comprised of 
land cycling and calisthenics either on land or in water; in patients with CAD, both protocols 
led to a significant increase in aerobic exercise capacity. Similarly, in the study of Laurent 
et al. (2009), 24 CAD patients and 24 heart failure patients were randomized to a 3-week 
cardiac rehabilitation program comprised of land cycling plus gymnastics either on land or 
in water; in patients with CAD, both protocols produced improvements in aerobic exercise 
capacity, but only water-based training was correlated with increased NO metabolite levels 
after the intervention, indicating improved endothelial function after aquatic exercise. Due 
to the specific hemodynamic responses to training in xiphoid-level water, whereby the 
increased peripheral blood flow and enhanced shear stress yield endothelial nitric oxide 
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synthase up-regulation (Di Francescomarino et al., 2009; Ayme et al., 2015), improved 
endothelium-dependent vascular function may be hypothesized, which has indeed been 
confirmed after aquatic exercise in prehypertensive adults (Nualnim et al., 2012) and 
osteoarthritis patients (Alkatan et al., 2016), but not CAD patients. 
Studies that have investigated the health effects of water-based exercise 
performed either alone or in combination with land-based exercise in coronary patients 
(as part of cardiac rehabilitation) are summarized in Table 2.  
The literature has uniformly reported that water-based exercise improves exercise 
capacity in coronary patents and patients with stable chronic heart failure, and further that 
aquatic exercise was well-tolerated by all patients. No difference in the clinical (angina) or 
ECG (ST depression, arrhythmias) manifestations of coronary disease was found between 
water-based and land-based exercise in coronary patients (McMurray et al., 1988; Fernhall 
et al., 1990). A previous study has reported that swimming may mask ischemic symptoms; 
however, ST segment depression occurred at a similar heart rate during both cycling and 
swimming (Magder et al., 1981). 
Tefaha et al. reported improvement in LVEF only in stable CHF patients, with no 
improvement in LV EDD and end-diastolic filling pressures in both patients groups. They 
found lower diastolic atrial pressure (DAP) and diastolic blood pressure in both groups, 
decreased heart rate and increased SV only in chronic heart failure patients, and no change 
in the cardiac autonomic system (Tefahha et al., 2011). Conversely, Fiogbe et al. reported 
improvement in cardiac autonomic modulation in CAD patients after water-based exercise 
(evidenced only by the nonlinear models) (Fiogbe et al., 2017). It should be emphasized 
that there was a significant difference in duration between the two studies. The study that 
showed no effects on the cardiac autonomic system lasted 3 weeks, while the one 
conducted by Fiogbe et al. stating the opposite continued for 4 months. Two studies have 
failed to confirm the change in arterial compliance with water-based exercise (Teffaha et 
al., 2011; Maurot et al., 2010), but the latter showed that water-based exercise training 
after 3 weeks restored the main central hemodynamic responses (increased SV and CO) to 
head-out water immersion in patients with chronic heart failure (Maurot et al., 2010).  
It has been shown that water-based exercise improved muscle strength (Volaklis et 
al., 2007; Tokmakidis et al., 2008), reduced body mass, and improved the lipid profile in 
coronary patients after 4 months (Volaklis et al., 2007). Lee et al. confirmed the water-
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based exercise efficiency in reducing body mass and in decreasing the depression–anxiety 
score in older coronary patients with osteoarthritis after 6 months of exercise, but not the 
change in lipid profile. They also reported decreased (but not significantly) fasting blood 
glucose levels in both exercise groups (Lee et al., 2017). 
Korzeniowska–Kubacka et al. assessed the influence of water-based exercise 
training in moderately cold water (28–30C) on rhythm disturbance in coronary patients 
and found that, in 58% and 62% of patients, ventricular ectopic beats and supraventricular 
ectopic beats were seen more often than during normal daily activity or CPET 
(Korzeniowska–Kubacka et al., 2016). Similar results in patients with congestive heart 
failure exercising in cold water (22C) were reported by Schmidt et al. They noted a 
significant increase in premature ventricular contractions in patients with chronic heart 
failure but not in CAD patients (Schmid et al., 2009). Magder et al. documented only 
occasional ectopic beats in coronary patients on entering the water (at the temperature of 
18C and 25C), and short runs of bigeminy during swimming, and after the exercise test 
(Magder et al., 1981). 
The diversity in the concluding results of previous studies can be attributed to the 
difference in the value of the parameters of training variables. Training length varied from 
3 weeks (Teffaha et al., 2011; Mourot et al., 2009; Mourot et al., 2010), 2 months 
(Korzeniowska–Kubacka et al., 2016), 4 months (Volaklis et al., 2007; Tokmakidis et al., 
2008; Fiogbe et al., 2017), up to 6 months (Lee et al., 2017). The training frequency was 
from 2 to 5 sessions per week, with 30–80 minutes session duration. Training intensity 
differed in the sense that it was determined by the principle of individual adjustment to 
the patient, based on peak oxygen uptake obtained with ergometric testing, maximum 
heart rate, or heart rate reserve (HRR).   
The applied exercise modalities were also different. In all studies, aerobic exercise 
was used as the basic training modality, either alone (cycling, walking, swimming), or in 
combination with calisthenics (Teffaha et al., 2011; Mourot et al., 2009; Mourot et al., 
2010; Li et al., 2017) or resistance exercises (Volaklis et al., 2007). 
Activated hemostasis. Data is scarce on the exact effect of immersion in 
thermoneutral water on the hemostasis system, especially in coronary patients (Boldt et 
al., 2008). Lindahl et al. (1999) studied the impact of swimming as a regular exercise 
training program on plasma fibrinogen concentrations in patients with impaired glucose 
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tolerance, and reported decreased plasma fibrinogen levels by 0.11 g/l after 12 months of 
regular endurance training. Lins et al. (Lins et al., 200) investigated the effects of swimming 
on thrombogenic parameters (plasma fibrinogen concentration, thromboplastin time, 
partial thromboplastin time, t-PA and PAI) in coronary patients, and found plasma 
fibrinogen levels unaltered, suggesting that swimming as a form of exercise does not 
induce increased thromboembolic risk in this patient population. While swimming did not 
activate the intrinsic system, the decrease in thromboplastin time indicates extrinsic 
system activation, which is in accordance with the other trials that have explored the 
activation of the extrinsic coagulation system by exercise. Contrary, Ferguson et al. 
reported activation of the intrinsic system of coagulation during bicycle ergometer 
exercising, which would indicate the more stressing nature of this type of exercise 
(Ferguson et al., 1987).  
NT-proBNP. In contrast to the studies investigating land-based exercise, 
investigations focused on the effect of thermoneutral water immersion (Shah et al., 2018) 
or hydrotherapy (Municino et al., 2006; Svealv et al., 2009) on plasma NT-proBNP values 
have reported no significant difference in NT-proBNP levels before and after the 
intervention. 
Cardiac autonomic function. As regards the studies that have attempted to 
determine the impact of water immersion on heart rate variability (HRV), to date, most of 
them have reported a positive impact of swimming on HRV in healthy individuals, mainly 
in professional athletes (Itoh et al., 2007; Atlaoui et al., 2007; Miwa et al., 1997; Chalencon 
et al., 2012). Study results showed that, in healthy persons, thermoneutral water lowered 
the sympathetic and triggered cardiac parasympathetic activation (Mano et al., 1985; 
Mourot et al., 2008; Becker et al., 2009). If we observe these findings through HRV 
parameters, we will see that immersion in thermoneutral water increases very-low-
frequency (VLF) power spectrum values, increases the response in the high-frequency 
power spectrum, and decreases sympathovagal balance (Becker et al., 2009).  
To the best of our knowledge, only two studies so far have investigated the impact 
of thermoneutral water-based exercise on heart rate variability in coronary patients 
(Teffaha et al., 2011; Fiogbe et al., 2018). While Teffaha et al. (2011) found no change in 
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autonomic cardiac activity, Fiogbe et al. (2018) showed that 3-week long water-based 
exercise training significantly improved cardiac autonomic modulation, evaluating 
improvements primarily through significant changes in nonlinear parameters. 
Quality of life. The effects of aquatic exercise on the quality of life of coronary 
patients and stable CHF patients are well documented. In the studies examining the 
effectiveness of water-based aerobic exercise training, mostly monitored as part of cardiac 
rehabilitation programs, it was shown that it leads to psychosocial well-being, 
independently of exercise duration, intensity or modality (Cider et al., 2003; Cider et al., 
2012; Municino et al., 2006). 
Water-based exercise studies in CHF patients, prehypertensive patients, and 
patients with osteoarthritis are presented in Table 3. According to the results of the studies 
presented here, the patients tolerated thermoneutral water immersion relatively well, 
while immersion in cold or hot water caused adverse effects. Aquatic exercise improved 
exercise capacity, muscle strength and endurance, and the quality of life in a manner 
similar to the land-based training programs. Studies exploring the effects of warm water 
immersion showed increased CO, stroke volume (except in patients with severe CHF; 
Meyer, 2004), decreased SVR, increased LED, LVEF, and decreased heart rate. A single 
study with hot water immersion (41C) showed increased heart rate (33%), stroke volume, 
CO, LVEF, and a decrease in SVR (41%) (Tei et al., 1995). In the study with moderately cold 
water immersion done in patients with osteoarthritis (Alkatan et al., 2016), increased FMD, 
decreases in IL-6, SBP, HbA1c, but no change in lipid profile, serum glucose concentration, 
or other inflammatory parameters were reported. Studies that had combined training 
exercise programs (swimming plus land-based aerobic training or resistance training) 
reported greater improvements in functional capacity, lower heart rate, and systolic blood 
pressure, and increased stroke volume. No improvements in NT-proBNP were observed 
(Svealv et al., 2009; Municino et al., 2006). 
Chronic adaptations to aquatic exercise represent the accumulation of acute 
responses during each aquatic exercise session, where the exercise must be performed on 
a regular basis, and must have a certain modality and properly defined training variables 
(duration of each session, session frequency, exercise intensity) (Barbosa et al., 2009). 
Cessation of aquatic exercise for 4 months, according to the results of a study conducted 
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by Tokmakidis et al., showed a reversal of the exercise-achieved beneficial changes in body 
composition, exercise capacity and, muscle strength (Tokmakidis et al., 2008). 
To conclude, the available evidence suggests that aquatic training in both deep and 
shallow water is correlated with improved cardiorespiratory fitness. In order to optimize 
the observed improvement in cardiovascular fitness, however, further investigations are 
warranted aimed at determining at what depth, intensity, or duration water-based 


















22 M pts:  
12 CHF (isch or no-isch,  
mean age 59 yrs, NYHA 
II) 
10 CAD (PTCA, mean age 
66 yrs, EF 52%) 
24h ECG recording 7–10 days 
prior to the study 
ECG during water immersion 
Hemodynamic measurements 
twice at each stage: at rest, 
during immersion to the pelvis, 
up to the chest, after jumping-
jack for 30 sec, and after 60 sec 
of swimming 
a) 32 C 
b) 22 C 
Up to the 
pelvis, and to 
the chest 
•Increased oxygen consumption 20% in moderately cold and WW 
•PVCs increased in CW in CHF pts, not in CAD 
•Decreased HR in chest deep WW immersion in CAD and CHF pts with no 
change in CW, higher in CW during immersion to pelvis and chest, not with 
jumping-jacks or swimming 
•No change in BP in WW, increased in CW in CHF pts, not in CAD 
•Decreased peripheral vascular resistance in WW and CW during immersion 




HR, SV, BP, CI 
PVR 
10 CHF (62.9/6.3/yrs) 
10 CAD (57.2/5.6/yrs) 
10 healthy controls 
Measurements:  
Initial at rest outside the water, 
then at immersion to pelvis 
and chest, followed by 
jumping-jack exercise for 30 
sec, and 60 sec swimming. (3x 
at every stage) 
32 C 
Up to the 
chest 
During immersion: 
•decrease in HR in all groups 
•Increase in SV (30% in healthy, 41% in CAD, 17% in CHF) during imm. Further 
with exercise 
•decrease in SBP in DBP in all three groups 
• Peripheral vascular resistance decreased in all groups (21% in CHF, 30% in 
CAD, 28% in controls), further decrease with exercise 
•increased CI in immersion up to the chest, 19% in control, 21% in CAD and 
16% in CHF  
During exercise CI increased further to 87% in controls, 77% in CAD and 53% 
in CHF. 









A: moderate MI (16) 
B: severe MI (4) 
C: Moderate CHF (16) 
D: compensated 
severe CHF (NYHA III) 
(5) 
E (10) and F: healthy 
volunteers (45) 
Graded immersion in 
upright position: calf, iliac, 
crest, xiphoid and neck 
Swimming (20–25 mmin-1) 







•increase in preload in patients with moderate and severe MI (from 
xiphoid level upwards, abnormal PAm (> 60 mmHg) and PCPm 
•left ventricular overload and decrease or no change in SV in patients 
with severe CHF during neck immersion 









10 M age 55–77 with 
IHD, BMI 29.4 kg/m2 
15 minutes of interval arm 
ergometer work at 65–75% 
of attained HR as 
determined by treadmill 
testing on land and in water  








at rest and at 
workloads 40, 
60, 75% of 
V02 peak on L 
and W 
 
15 males ( 2 months 
post-MI, CABG (2 pts) 
no PTCA or 
thrombolysis),  
age  65 yrs 
 
LEx/WEx: leg 
cycloergometer 10 min rest 
period followed by 3–4 





•increased CO and SV in the resting WI, 
•during exercise increase in CO and SV  
•no diff in HR, CO and SV between groups during exercise 
•Altered  cardiac response to increased preload during exercise 
(reduced myocardial compliance) 
Schega, 
2007 
EDV, ESV, SV, 
CO 
15 male CAD pts. 
after MI 
Assigned to 3 groups 
(echo) 
1 no wall 
abnormalities  
2 asymptomatic wall 
motion abnormalities 
3 pts with LV 
hypertrophy 
2 protocols: 
i)immediate (IM) complete 
head out WI (2 stages/each 
3 min) 
ii)step-wise immersion (5 







•STEP: increased SV and CO in ankle-level immersion, then a 
decrease up to neck level. Max HR at knee level immersion, after SBP 
drop. Decrease in HR with increasing water depth. At the end of STEP 
protocol: decrease in CO, EDV, ESV, HR, DBP. 




CO, SV, TPR 
10 CAD (7 after MI)  
Age 528.6, EFLV 







•HR less in WI than on L during moderate exercise, but reversed 
relation seen at higher exertion levels. 
•SBP increase with workload, but lower in WI than on L. No change in 
DBP. 
•CO greater during WI. No diff in SV between Wi and L. 





DBP, RER  
10 CVD pts (26 male, 
11 female), age 
55.65 yrs (MI, CABG, 
angina, silent 
ischemia) 
Three exercise (walking, 
jogging, “swim“ arm 
motion) bouts of 6 min 
each in the upright position  
at an intensity of 60, 70 and 
80% of maximal HR 
obtained on CPET, with 3–4 
min rest between 
28–30 C Nipple level 
•higher VO2 max and VEmax on test 








HR, BP, SV, 








17 CHF pts. (NYHA I 
and II), mean age 67, 
88% male, mean LVEF 
33% 
10 matched control 
pts 
Gradual immersion in 
supine position 15 min, 
gentle exercise (3 min of 
kicking at a speed of 4o 
repetitions/min) 
Measurements in 1 min 
WWI, 15 min WWI, 3 min  
after exercise and 3 min 
after recovery  
33–35 C Neck level 
•Acute WWI: increased SV, CO, CI, decreased SVR, SBP; no change in 
HR or CVP; increase in LAV                                                                    
•After exercise: further increase in HR, BP, CI and CO, with no change 
in SV, SVR or CVP                                                                                                    
•In CG: the same except no change in SVR    
After WWI: increased EDV                                               
 •no change in NT-proBNP 
 
Note: AV – left atrial volume, BP – blood pressure, CAD – coronary artery disease, CHD – chronic heart disease, CHF – chronic heart failure, CI – cardiac index, CO – cardiac 
output, CW – cold water, DBP – diastolic blood pressure, DM – diabetes mellitus, HDL-C – high-density lipoprotein cholesterol, HR – heart rate, IVC – inferior vena cava, LAD 
– left atrial diameter, LDL-C – low-density lipoprotein cholesterol, LEx – land-based exercise, LV – left ventricle, LVEDV – left ventricular end-diastolic volume, LVEF – left 
ventricular ejection fraction, LVESV – left ventricular end-systolic volume, NT-proBNP – N-terminal B-type natriuretic peptide, PAm – mean pulmonary artery pressure, PCPm 
– mean pulmonary capillary pressures, PTCA – percutaneous coronary artery intervention, PVCs – premature ventricular contractions, PVR – peripheral vascular resistance, 
PVR – peripheral vascular resistance, RER – respiratory exchange ratio, SaO2 – oxygen saturation, SBP – systolic blood pressure, SV – stroke volume, SVR – systemic vascular 
resistance, TAPSE – tricuspid annular plane systolic excursion, TC – total cholesterol, TG – triglyceride, TPR – total peripheral resistance, TR – tricuspid regurgitation, VO2 max 






















VO2 peak                  
EFLV, LVEDD, 




DAP, HR, SV, 














24 M CAD after ACS 
EFLF > 50%  
Assigned to 2 groups: 
LEx age  
(53.22.9), LEx+WEx 
(age 51.63.1) 
+ 24 M CHF (isch CMP 
or idiopathic dilatat 
CMP) 
EFLV  40% 
Assigned to 2 groups: 
WEx+LEx vs LEx 
LEx + WEx group: 
5x/w, 80 min session  
(30 min cyclergo or walking+50 
min calisthenics Wex) 
LEx group: 
5x/w, 80 min session (30 min 
cyclergo+50 min calisthenics 
LEx) 
Intensity for both groups: at an 
individualized target HR 
achieved at the ventilatory 
threshold at CPET 
TOTAL SESSIONS: 15 
*No Aq HR correction 
30–32 C  1.30m 
•increase in VO2 peak in both 
(9% LEx, 10.9% Lex+WEx)         
•no change in LVEDD and end-
diastolic filling pressures   
•LVEF improved in CHF pts 
•resting DAP lower in both 
groups          
•decreased HR in CHF  
•increased SV in CHF                            
•no significant changes in 
autonomic nervous system or in 
arterial compliance  
•decreases DBP 
Maurot,   
2009 
R 







HR, SV, BP, TPR 
 
3 weeks 
24 M CAD (after ACS, 
EFLV > 40%) Assigned 
to 2 groups 
LEx (age 543) WEx 
(age 533) 
24 M CHF (isch or 
idiopathic dilatat. 
CMP) EFLV  45%)  
Assigned to 2 groups: 
LEx, age 543 LEx + 
WEx (age 533) 
LEx only group: 
30 min aerobic exercise, 5x/w, 
Intensity: 60–70% of patient  
HRR + 50 min gymnastic session 
LEx + WEx group: 
LEx aerobic+50 min gymnastic 
session in water 
TOTAL SESIONS: 15 
*No Aq HR correction 
 





•Increased exercise capacity in 
both groups (LEx 7.7%; WEx8.8%) 
•Increased plasma concentration 
of nitrates in both WEx groups 
(for CAD and CHF) no change in 
LEx 
•No changes in plasma 
catecholamines  















response to WI 
and after ET 
SAP, DAP, PP, 
SV, CO, artery 
compliance, 





12 stable CHF pts 
(isch or dilatat) (EFLV 
up to 45%) 
12 CAD pts (EF  45%) 
after acute coronary 
event 
 
No control group 
Aerobic LEx on cycle ergometer 
(30 min, 4-5x/w, at intensity 
60–70% of patient heart 
reserve) + WEx – gymnastic 
session in immersed conditions 
(40 min 3-4x/w) 
*No Aq HR correction 
30–32 C 1.3 m 
•increased VO2 peak in both pt  
groups 
•In CAD pts: WI Increased SV, CO 
and PP, and total vascular 
impedance; decrease in PR, DBP 
and SVR  
•In CHF pts: WI induced no 
change in hemodynamic 
variables, but after CRP 
significant increase seen in SV, 
CO and PP. PR lower in WI and 
after ET 
•No change in arterial 
compliance after acute water 














34 M CAD (MI, ACBG, 
PCI) pts, age 53+/-4, 
LVEF > 50% 
Assigned to 3 groups: 
LEx (12),  
AqEx (12), and  
CG (10) 
LEx: 60 min sessions, 4/w:  
2x AE (treadmill, cycling) at 60–
80% peak HR achieved at CPET, 
and 
2xRE (training at 60% of the 
maximal number of repetitions 
performed in each exercise at 
baseline) 
WEx: 60 min sessions 4/w: 2x 
AE at 50–70% of peak HR 
achieved at CPET, 2x RE (60–80 
of the maximal number of 
repetitions performed in each 
exercise at baseline) 
*No Aq HR correction 
TOTAL SESSIONS: 32 
28–30 C 1.2 m 
•Improved exercise tolerance in 
both gr (11.7% for WEx and 8.1% 
in LEx)                  
• improved muscular strength in 
both exercise groups 
•reduced body mass in both 
groups 














60 CAD (PCI) + 
osteoarthritis > 65 yrs 
Assigned to 3 gr: 
WEx (20:14 M/6F) 
LEx (21:15 M/6F)  
Non-exercise group 
(19) 
WEx (walking) : 
50 min sessions 3/w,50–60% 
HRR - 15–17 bpm at CPET 
LEx (treadmill/walking): 
50 min, 3/w, At 55–65% HRR 
TOTAL SESSIONS: 72 
Aquatic HR correction (-15-17 






•increased VO2 max 
•no change in lipid levels   
•reduced body fat and BMI 







VO2 max        






21 M CAD pts (IM, 
PCI, ACBG) age 
52.4+/-11.8 
functional capacity > 
7 METs, EF > 50%  
Assigned to  
Ex and CG 
 
WEx:  
4 sessions/week:  
2x AE 10 min warm up + 40 min 
(at 50–85% peak HR achieved 
at CPET) + 5 min stretching 
2x sessions circuit weight 
training (at 70–80% RPE) 
TOTAL SESSIONS: 16 
No aquatic HR correction  
28–30 C 1.20m  
•increased VO2 peak by 8.4% and 
exercise tolerance (by 11.8%)                          
•significant adaptations in body 
composition, muscular strength  











26 M CAD (MI+ PCI>3 
months, MI+ ACBG > 
6 months) age 50–70 
yrs 
Assigned to: 
WEx (16) and CG (14) 
60 min sessions, 3 /w 
AE (walking, jogging, adapted 
games targeting on the trunk, 
upper and lower limbs) at 
HRtarget between HRVT1 and 10% 
below the HRVT2 




•Improvement of the cardiac 
autonomic modulation in WEx 
evidenced by only the nonlinear 
models 
















and in water) 
8 weeks 
62 CAD M (post MI), 
age < 65 yrs  
Included in WEx 
No control group 
55 min session, 2/w: 
10 min WI 
40 min WEx (exercise 
improving strength, free 
swimming) 
10 min coll down 
HRterget=resting HR+60–80%of 
HRR 
TOTAL SESSIONS: 16 
28–30 C ? 
WEx: 
•increased VO2peak 15.3% 
•increased atrial and ventricular  
ectopy  
 
Note: ACS – acute coronary syndrome, AV – left atrial volume, BMI – body mass index, BP – blood pressure, CAD – coronary artery disease, CHD – chronic heart disease, CHF 
– chronic heart failure,  CI – cardiac index, CO – cardiac output, CW – cold water, DAP – diastolic atrial pressure, DBP – diastolic blood pressure, DM – diabetes mellitus, HDL-
C – high-density lipoprotein cholesterol, HR – heart rate, HRV – heart rate variability, IVC – inferior vena cava, LAD – left atrial diameter, LDL-C – low-density lipoprotein 
cholesterol, LEx – land-based exercise, LV – left ventricle, LVEDV – left ventricular end-diastolic volume, LVEF – left ventricular ejection fraction, LVESV – left ventricular end-
systolic volume, MAP – mean atrial pressure, NT-proBNP – N-terminal B-type natriuretic peptide, PAm – mean pulmonary artery pressure, PCPm – mean pulmonary capillary 
pressures, PP – pulse pressure, PTCA – percutaneous coronary artery intervention, PVCs – premature ventricular contractions, PVR – peripheral vascular resistance, PVR – 
peripheral vascular resistance, RER – respiratory exchange ratio, SaO2 – oxygen saturation, SAP – systolic atrial pressure, SBP – systolic blood pressure, SV – stroke volume, 
SVR – systemic vascular resistance, TAPSE – tricuspid annular plane systolic excursion, TC – total cholesterol, TG – triglyceride, TPR – total peripheral resistance, TR – tricuspid 
regurgitation, VEBs – ventricular ectopic beats, VO2 max – maximal oxygen uptake, WEx – water-based exercise, WI – water immersion, WW – warm water, WWI – warm 










SAMPLE SIZE, AGE, 
GENDER 














25 CHF pts (8 F)  
(NYHA II-III) 
EFLV < 45% 
Age > 70 
Assigned to  
WEx vs CG 
WEx 45 min 3x/w 
Low to moderate exercise level 
(40–70% max HRR) 
warming up (walking) 
aerobic+resistance 
relaxation 





•Improved exercise capacity and 






VO2 peak,  
6MWT 
Metabolic function: 
glucose, HbA1C, insulin,                
C-peptide, lipids 
peripheral muscle 




20 Pts > 55 yrs (4F) 
CHF (NYHA II or 
III)+DM 
EFLV < 50% 
Assigned in WEx vs 
CG (usual activity) 
WEx 45 min, 3x/w 
Low to moderate exercise level 
40–75% of max HRR 
Central circulatory exercise and 
peripheral muscle training 
program (aerobic+resistance 
training) as Cider A, 2003 





•improved exercise capacity 
(work rate and walking capacity) 
•improved muscle function 
•decreased HbA1c 
•No change in fasting glucose, 




HR, SBP, DBP,  





13 CHF (2F),  
age > 60, NYHA II–III 
EFLV  45%  
+ 13 healthy 
subjects 
Echocardiography: on land, in 
swimming pool after 12 m of 
walking through the pool, and 
5 min after peripheral muscle 
training exercise 
33–34 C Sternal notch 
•decreased HR in both groups 
•no change in BP 
•increased early diastolic filling in 
CHF 
•increase in LVEF in CHF  
•increase in LVEDV and LVESV 
only in CG 
•increased SV 




VO2 peak, VCO2, VE, 






12 CHF pts  
NYHA II–III  
age 64+/-6 yrs (3 F) 
EF < 45% 
12 healthy subjects 
LEx: all sitting on chair: 5 min 
rest – 4 min leg exercise – 4 
min recovery phase 
WEx: walk 12 m, then the same 
as on land  
Tested twice within 10 days 
33–34 °C Sternal notch 
 
 
•no differences in land versus 
water, in VCO2, VE, RF, RER, HR, 
BP in either of the groups 
•significant difference in VO2 at 








LVEF, LVEDV, LVESV 





18 CHF (5 F)  
NYHA II–III 
LVEF 319% 
 pts > 698 yrs 
Protocol: consisted of three 
observed sessions:  
(1) baseline (acute effect), (2) 
after 8 weeks without exercise 
(control period), and (3) after 8 
weeks of hydrotherapy, 2 x/w, 
45 min, at 40–70% max HRR 
 
33–34 C No data 
Acute response:              
•decreased HR, DBP, SVR 
•increased CO, SV, LVEF, E/A 
ratio, LVEDV, LVEDD, PCWP 
•no change in BNP 
8 weeks of hydrotherapy did not 











21 M CHF (isch or 
dilatative)   




CT: ET+ WEx (11) 
LEx (10) 
CT: LEx ET 30 min (aerobic 
exercise at 60–70% VO2 max)  
+ Wex 30 min (calisthenics 
exercise involving muscle 
groups of the lower and the 
upper limbs) 3x/w 
LEx: aerobic exercise 30 min 
and calisthenics exercise on 
land 30 min3x/w            




•improved exercise tolerance 
(6MWT distance) in both gr 
•decreased diastolic BP, HR in CT, 
unchanged in ET 
•increased TPR in CT, unchanged 
in ET 





VO2 peak, body mass, 
adiposity, glucose, 
HbA1c, TC, TG, SV, CO, 
carotid and femoral 









or stage 1 
hypertension > 50 






Swimming 15–20 min/d 3-4x/w 
at 60% of max HR with 
increasing intensity and 
duration up to 45 min/d, 3-
4x/w, at intensity of 70–75% of 
max heart rate 
aquatic heart rate correction 
No data No data 
•no change in VO2 peak  
•increased swimming distance 
•decreased SBP SG           
•increase in carotid artery 
compliance in SG             
•improved FMD and BRS  in SG 
•no change in body mass, 





SBP, DBP, MBP, PP, 
central arterial 
stiffness, carotid 
artery IMT, lipid 
profile, BS, HbA1c, Il-1, 
IL-2, Il-4, IL-6, IL-7, IL-
8, IL-9, IL-10, IL-12, IL-
13, UFN-, TNF- 
12 
weeks 







Initially 20–30 min a day, 3x/w 
at intensity 40–50% of HRR, 
with gradual increase to 40–
45min/d, 3x/w, at intensity of 
60–70% of HRR  
27–28 C 
 
No data  
•Increased FMD in SG  
•decreased IL-6, HbA1c, SBP, PP 
in both groups 
•No change in lipid profile, 
glucose, or other inflammatory 
parameters in both groups 
•Decreased central arterial 
stiffness in both gr. 
•Increased carotid arterial 






6MWT, VO2, body 






18 CHF pts, EF  35% 
NYHA II 
Cardio-hydrokinesitherapy 2 
WEx 30–50 min sessions per 
day, 5 days/w              (relaxing 
exercise – calisthenics – water 
walking)  
TOTAL SESSIONS: 30 
31–32 C Sternal notch 
•increased VO2 peak and  
walking distance, 
 •no change in HR, BP, NT-
proBNP, EFLV 
•improved QoL 




BP, ECG, echo-Doppler, 
expiration gas, 
intracardiac pressures 
before, during and 30 
min after bath 
 
34 CHF (7F) pts  
17–83 yrs, mean age 
58  14 yrs  
NYHA II (2), III (19), 
IV (13)  
EFLV 25  9% 
at rest for 10 minutes in a 
semirecumbent position in 
bathtub 
41 C / 
• increased oxygen consumption                 
•increased HR by 20–25 bpm, 
cardiac indexes, LVEF     
•decrease in SVR,              
•increase in PAm, PCWP, RAPm                                
•significant decrease of mitral 
regurgitation                               no 
change in BP in epinephrine 
 
Note: ACS – acute coronary syndrome, AV – left atrial volume, BMI – body mass index, BP – blood pressure, CAD – coronary artery disease, CHD – chronic heart disease, CHF 
– chronic heart failure, CI – cardiac index, CO – cardiac output, CW – cold water, DAP – diastolic atrial pressure, DBP – diastolic blood pressure, DM – diabetes mellitus, HbA1c 
– glycated hemoglobin, HDL-C – high-density lipoprotein cholesterol, HR – heart rate, HRV – heart rate variability, IVC – inferior vena cava, LAD – left atrial diameter, LDL-C – 
low-density lipoprotein cholesterol, LEx – land-based exercise, LV – left ventricle, LVEDV – left ventricular end-diastolic volume, LVEF – left ventricular ejection fraction, LVESV 
– left ventricular end-systolic volume, MAP – mean atrial pressure,  NT-proBNP – N-terminal B-type natriuretic peptide, QoL – quality of life, PAm – mean pulmonary artery 
pressure,  PCPm – mean pulmonary capillary pressures, PP – pulse pressure,  PTCA – percutaneous coronary artery intervention, PVCs – premature ventricular contractions, 
PVR – peripheral vascular resistance, PVR – peripheral vascular resistance, RER – respiratory exchange ratio, SaO2 – oxygen saturation, SAP – systolic atrial pressure, SBP – 
systolic blood pressure, SV – stroke volume, SVR – systemic vascular resistance, TAPSE – tricuspid annular plane systolic excursion, TC – total cholesterol, TG – triglyceride, 
TPR – total peripheral resistance, TR – tricuspid regurgitation, VEBs – ventricular ectopic beats, VO2 max – maximal oxygen uptake, WEx – water-based exercise, WI – water 
immersion, WW – warm water, WWI – warm water immersion, 6MWT – six minute walking test. 
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1.3. Evidence gaps 
 
In contrast to land-based exercise activity, the implementation of water-based 
exercise activity in cardiac rehabilitation programs is still under debate. Owing to concerns 
over adverse cardiovascular hemodynamic responses to water immersion – hydrostatically 
induced rise in venous return and central venous pressure leading to increased preload 
and possibly ventricular dysfunction or dysrhythmias – aquatic exercises have traditionally 
been discouraged in cardiac patients (Pendergast et al., 2015; Shah et al., 2017; Meyer, 
2006; Schmid et al., 2009). 
Over the past two decades, water-based training has gained popularity with increasing 
acknowledgement of its advantages, especially in terms of musculoskeletal health. Studies 
in patients with CAD (Teffaha et al., 2011; Volakis et al., 2007; Lee et al., 2017), left 
ventricular dysfunction, and even heart failure (Shah et al., 2017) have fairly recently 
challenged the safety concerns over aquatic exercise. The majority of studies have shown 
the comparable safety and efficacy of water-based exercise (except swimming) with land-
based exercise in the sense of improving exercise capacity (Teffaha et al., 2011; Lee et al., 
2017; Mourot et al., 2009; Tokmakidis et al., 2008; Cider et al., 2003; Korzeniowska-
Kubacka et al., 2016; Magder et al., 1981; Choi et al., 2015), improved blood pressure 
profile (Teffaha et al., 2011; Schmid et al., 2009; Schega et al., 2007), decreased peripheral 
vascular resistance (Schmid et al., 2007), adaptations in body composition and muscular 
strength (Volaklis et al., 2007). It has been shown that water-based exercises in coronary 
patients effectively increase the basal level of plasma nitrates (main NO metabolite) with 
the assumption that it may be related to an enhancement of endothelial function (Mourot 
et al., 2009). 
Previous research on the impact of water-based exercise in coronary patients is scarce 
when compared to different modalities of land-based exercise (Teffaha et al., 2011, 
Volaklis et al., 2007; Schmid et al., 2007; Choi et al., 2015). The small number of participants 
could not fully reflect the population of patients referred for cardiac rehabilitation 
immediately after an acute coronary event, since inclusion criteria were limited to achieved 
7 METs at exercise testing (Tokmakidis et al., 2008) or to stable coronary artery disease 
more than 3 months after myocardial infarction, whereas cardiac rehabilitation programs 
typically include patients soon after an acute coronary event (Teffaha et al., 2011; Volaklis 
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et al., 2007). Inferior study designs should also be mentioned, in the sense of pre-post study 
with no comparator groups (Korzenowska-Kubacka et al., 2016) or non-randomized patient 
separation (Tokmakidis et al., 2008). 
Cardiovascular safety of thermoneutral water immersion in patients with CAD has 
been relatively confirmed by several trials. Only a small number of studies assessed the 
efficacy of different water-based exercise modalities on aerobic exercise capacity, and 
none evaluated the effects of such training modalities on vascular function, or explored its 
interplay with hemostasis or low-grade inflammation. Moreover, further evidence on the 
effects of water-based exercise training on specific disease markers in patients with CAD 
would be welcome.  
Comparing the results of studies exploring cardiac rehabilitation programs published 
so far, it is obvious that there is no consensus on the training modality and the main training 
variable values (training duration, frequency, session duration, intensity) which would be 
sufficient to induce positive health-related effects in coronary patients, depending on the 
degree of coronary disease, the patient's physical condition, and possible comorbidities.   
Increased interest in the implementation of water-based exercise in cardiac 
rehabilitation has indicated the need to evaluate this type of exercise in relation to 
standard on-land types of training from the aspect of safety and efficiency in coronary 
patients after a recent acute coronary event. Therefore, we sought to determine the 
effects of water-based exercise as an integrated part of a short-term (2-week) cardiac 
rehabilitation program in coronary patients with recent an acute coronary event, and 




The doctoral thesis research explores the effects of short-term water-based and land-
based exercise training in patients with recent coronary events, in terms of the impact of 
these two types of training on exercise capacity, vascular function, cardiac autonomic 
function, disease-specific biomarkers, and health-related quality of life. The aim of the 
doctoral thesis was to explore if the two weeks of exercise training, either water-based or 
land-based, is a long enough period to cause improvements in exercise capacity and 
vascular function and to compare the effects of these two types of exercise in terms of 
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assessing if the water-based exercise training is as safe and comparably efficient in 
improving exercise capacity and vascular function as land-based exercise.  
Given the association between endothelial dysfunction and inflammation, and 
assuming that improvements in endothelium-dependent vascular function will be 
accompanied by a reduction in the markers of low-grade inflammation, endothelial 
activation, and coagulation, the aim of the study was also to determine the specific impact 
of water-based and land-based exercise training on the aforementioned biomarkers and 
health-related quality of life. As studies to date have indicated a positive impact of land-
based exercise on the modulation of cardiac autonomic balance, and only a few studies 
have explored the same topic with water-based training yielding conflicting end-results, 
one of the aims of our study was to explore the impact of water-based exercise and 
compare to the impact of land-based exercise on cardiac autonomic function in patients 
with recent coronary events. 
One of the important goals of cardiac rehabilitation is to improve the health-related 
quality of life in coronary patients. Thus, another aim of our study has become to examine 
the impact of water-based exercise training on health-related quality of life and to 
determine whether this model of exercise differs significantly from land-based exercise 




1.5.1. Primary hypotheses 
 
i) Water-based exercise training is as safe and effective as land-based training in 
improving exercise capacity, as compared to usual care (control group), in 
coronary patients. 
ii) Water-based exercise training is as effective as land-based training in increasing 
flow-mediated dilatation of the brachial artery, as compared to usual care 
(control group), in coronary patients. 
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1.5.2. Secondary hypotheses 
 
i) Water-based exercise training compared to usual care (control group) in 
coronary patients significantly improves cardiac autonomic function. 
ii) Water-based exercise training compared to usual care (control group) in 
coronary patients significantly reduces the concentration of markers of low-
grade inflammation (hsCRP, IL-6, IL-8, IL-10), endothelial activation (ICAM, 
selectin), hemostasis (D-dimer, fibrinogen), and neurohumoral activity (NT-
proBNP). 
  




2.1. Study population 
 
The study participants were recruited from the Cardiac Rehabilitation Center in 
the Šmarješke Toplice. Ninety-six patients of both gender were selected. Ninety patients 
met the inclusion criteria. Figure 1 presents the flowchart of the study. 
 
Inclusion criteria for the study were:  
- recent CAD event (2–4 weeks after myocardial infarction, coronary artery by-
pass surgery (CABG), or percutaneous coronary procedure  
- left ventricular ejection fraction above 40%. 
 
Exclusion criteria for the study were: 
- unstable coronary artery disease  
- heart valve defect that dictates specific treatment  
- condition after valve replacement 
- heart rhythm disorders 
- the presence of a permanent pacemaker  
- contraindications to exercise 
- physical or psychological disabilities precluding attendance of a training 
program  
- obstructive/restrictive lung disease, severe degree 
- recent thromboembolic events 
- hepatic dysfunction (liver parenchymal enzyme > 3 times normal)  
- age over 80 years. 
 
Patients who corresponded to the inclusion criteria were invited to participate in 
the study. A written informed consent was obtained for each participant.  
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2.2. Study design 
 
The study was designed as a prospective, randomized, open-label clinical trial with 
three parallel groups (two intervention groups and one control group). The study was 
conducted from May to October 2016 at the Cardiac Rehabilitation Center in Šmarješke 
Toplice, Slovenia. 
Participants were randomly allocated to 2 intervention and one control group, with 
a ratio of 1:1:1. Allocation to each group was determined by a randomization software-
generated numeric table (GraphPad StatMate 2.0 for Windows), additionally using urn 
randomization by drawing corresponding numbers in sealed envelopes. 
The patients allocated to intervention groups were included in a 2-week stationary 
cardiac rehabilitation program; one group underwent water-based exercise training and 
the other land-based exercise training. Patients in the control group continued their usual 
treatment but were not included in any controlled program of physical exercise for the 
duration of the study, being instead advised low-to-moderate intensity physical activity at 
home while waiting.  
Patients received standard therapy for the treatment of ischemic heart disease. 
Principles of treatment over the period of research were not changed, but medicines were 
adjusted when it was necessary to ensure that blood pressure and heart rate are optimally 
controlled.  
The study complied with the World Medical Association Declaration of Helsinki on 
ethics in medical research and was approved by the Republic of Slovenia Medical Research 
Ethics Committee (0120-655/2016-2).   










The intervention design implied the implementation of exercise protocols – one water-based 
and one land-based – involving an endurance plus calisthenics training program over the course of 
two weeks of residential cardiac rehabilitation. The exercise protocols included two daily 30-minute 
sessions, 6 days a week (24 sessions in total). Each patient’s training plan was devised on the basis 
of their results achieved during symptom-limited grade exercise testing at baseline. The peak heart 
rate (HR peak) achieved on the baseline exercise test was used to determine the level of aerobic 
intensity while training. We implemented an adapted training program such as in the studies of 
Teffaha et al. (2011) and Caminiti (2009).  
Water-based exercise training included two daily training sessions in a heated swimming 
pool (32.8 ◦C), in an upright position in hypoacratothermal (Ca-Mg-HCO3 425 mg/L) mineral water 
at the level of the xiphoid process (depth 1.3 m). The exercise protocol prescribed two training 
sessions da day – aerobic endurance and calisthenics – each lasting 30 minutes.  
Aerobic endurance exercise implied a 5-minute warm-up routine, 20 minutes of conditioning 
(water walking, side-stepping, arm cycling, adapted games targeting on the upper and lower limbs) 
at an intensity of 60–80% peak heart rate achieved on symptom-limited graded exercise test, and 5 
minutes of cool- down.  
Calisthenics included a 5-minute warm-up routine, 20 minutes of conditioning (engaging 
muscle groups of the upper and lower limb muscles, such as triceps extensions, triceps dips, 
modified leg press, leg abduction/adduction, wall push-ups) at an intensity of 60–80% of the peak 
heart rate achieved on the symptom-limited grade exercise test, and 5 minutes of cool-down.  
Land-based exercise training implied two daily 30-minute sessions, one involving bicycle 
ergometer training (5 minutes of warm-up, 20 minutes at 60–80% peak heart rate with gradually 
increased intensity, and 5 minutes of cool-down) and the other a calisthenics work-out (5-minute 
warm-up, 20 minutes of exercises engaging both upper and lower limb muscles at an intensity of 
60–80% peak heart rate, and 5 minutes of cool-down).  
Patients allocated to the control group were advised about the ways to maintain a healthy 
lifestyle, and were particularly informed of the beneficial effects of exercise and encouraged to carry 
on with their usual physical activities (i.e. regular daily activities, such as walking). They were, 
however, required not to take part in any controlled program of physical exercise for two weeks, 
during the course of the intervention. 
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A heart rate monitor was used for the continuous monitoring of heart rate during training. 
Blood pressure values were recorded at the start and after the end of each segment of training. 
Clinical parameters (fatigue, dyspnea, palpitations, chest pain) were monitored continuously during 
the intervention period. Considering the other aspects of rehabilitation (lifestyle education, a 
Mediterranean-style diet, medical supervision, psychological support), both intervention groups 
had the same protocols. Treatment principles remained the same during the course of the study, 
but the treating cardiologist was in charge of making dosing adjustments in medications to enable 
good control of risk factors. 
 
2.4. Observed parameters 
 
In all participants, at the beginning and at the end of the trial period (on Day 0, and Day 14), 
blood sample collection, 20-minute ECG recording, cardiopulmonary exercise testing, and 
ultrasound assessment of flow-mediated dilatation of the brachial artery were performed. 
The primary outcomes were changes in VO2 peak and FMD from baseline. Changes from 
baseline observed in the time- and frequency-domain parameters of heart rate variability and in 
biomarkers of low-grade inflammation (hsCRP, Il-6, IL-8, IL-10), endothelial activation (ICAM, P-
selectin), activated hemostasis (D-dimer, fibrinogen), and neurohumoral activity (NT-proBNP) were 
considered as exploratory outcomes. 
 
2.4.1. Exercise capacity 
 
Aerobic exercise capacity was determined by measuring V̇O2 peak using the method of 
cardiopulmonary bicycle exercise testing (CPET) on a cycle-ergometer Schiller CS-200 (Schiller A.G. 
Baar, Switzerland) with the Ganshorn Power Cube gas analysis unit (Ganshorn Deutschland GmbH). 
Primary flow sensors were calibrated and O2 and CO2 gas measurements were done prior to each 
test. All participants were subjected to a symptom-limited exercise test. On the day of testing, the 
participants were told to continue with their usual medical regimes and refrain from physical 
activities and heavy meals. Resting-state data and ECG were recorded 3 minutes before the 
beginning of testing. A maximal incremental protocol was employed for participant testing: after 3 
min of unloaded cycling (“0 W”), the workload on the computer-controlled cycle ergometer was 
gradually increased in a ramp-like manner to achieve predicted (on the basis on the age, gender and 
body surface) maximal workload after 10 minutes. A test was considered completed if the achieved 
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respiratory exchange ratio was ≥ 1.1. While performing the exercise, the patients wore a 
mouthpiece attached to the gas analysis unit, which allowed to measure oxygen and carbon dioxide 
flow (VO2 and VCO2, respectively). ECG, heart rate and blood pressure measurements were made 
at rest and in 2-minute intervals during testing, the cool-down period and for 6 minutes after end 
of testing. No clinically relevant adverse effects during exercise testing were recorded. 
To estimate the reproducibility of exercise testing, 10 subjects were randomly chosen and 
tested two times prior to the beginning of the intervention. The V̇O2 peak intra-class correlation 
coefficient (ICC for single measure) was 0.861, p = 0.004.  
Data obtained from the exercise testing:  
- V̇O2 peak aerobic capacity during exercise testing expressed in ml.kg-1.min-1 
- Relative change in V̇O2 peak expressed in ml min-1 
- Peak workload expresses in Watts 
- Time-to-exhaustion expressed in seconds 
 
2.4.2. Vascular function 
 
Estimation of vascular function was performed by the ultrasound assessment of flow-
mediated dilatation of the right brachial artery in standardized conditions and according to current 
recommendations (Flammer et al., 2012). A Philips ultrasound system iE 33 with a high resolution 
linear-array 10 MHz vascular probe was used.  
The brachial artery was imaged 2–10 cm above the elbow fossa. In order to evaluate 
endothelium-dependent vasodilatation, the sphygmomanometer cuff on the forearm was tightened 
so as to achieve a value of 50 mmHg above the systolic pressure. After releasing the grip 4.5 minutes 
later, the flow was measured within 15 – 20 s, and artery diameter within 60–90 s. Endothelium-
independent dilatation of the brachial artery, induced by sublingual application of 0.4 mg 
nitroglycerin by spray (Nitrolingual spray®), was estimated after a 15-minute resting period. The 
brachial artery diameter and average blood flow velocity were determined 3–4 minutes after 
dosing.  
FMD was expressed as percentage change from rest [(brachial artery diameter at peak 






2.4.3. Cardiac autonomic function 
 
Cardiac autonomic function was evaluated analyzing heart rate variability (HRV) in high-
resolution ECG recordings. 20-minute high resolution ECG recordings were collected with a 12-
channel digital recorder Schiller CS-200 (Schiller A.G. Baar, Switzerland). The measurements were 
taken between 9 AM and 11 AM in postprandial state, 10 min after supine rest in a quiet room, kept 
at 22–24 °C, with relative humidity between 40–70%. Patients were asked not to smoke or drink any 
caffeinated beverages 24 hours prior to measurements. 
First, off-line analysis of the R–R interval using R-peak detection was performed using the 
Schiller SEMA-200. Each detected beat was classified as normal, ventricular ectopic, 
supraventricular ectopic, or unknown. The location of the R-wave peak was determined with a 
resolution of 1 ms through interpolation. After automated editing, an experienced observer 
reviewed and corrected all tracings manually. Editing eliminated all abnormal beats, including the 
ones succeeding the ectopic beats in case of either ventricular or supraventricular ectopy without 
any interpolation attempted for eliminated intervals. Next, a moving–window average filter was 
applied to the edited data. For each set of five contiguous NN intervals, a local average was 
computed excluding the central interval. If the value of the central interval was 20% greater or 
smaller than the local average, it was considered to be an outlier and replaced by the local average. 
Only recordings with > 95% pure sinus beats were included in the linear and non-linear HRV analysis.  
For the HRV analysis, raw data were processed in Matlab (Math Work Inc, Natick, MA) using 
the freely available software HRV Analysis Software (HRVAS) (available at 
http://sourceforge.net/projects/hrvas/) as described in detail elsewhere (Ramshur, 2010; Solca et 
al., 2018).  
Linear HRV analysis – Several well established preselected linear HRV parameters were 
measured using time- and frequency-domain methods. 
For time-domain HRV measures, standard deviation of normal-to-normal RR intervals 
(SDNN), standard deviation of the average normal-to-normal RR intervals (SDANN), the square root 
of the mean square differences of successive normal-to-normal RR intervals (RMSSD), and the mean 
standard deviation of normal-to-normal RR intervals for every 5 min (SDNNi) were calculated. 
Frequency-domain linear HRV measures were obtained by using the Welch method for fast-
Fourier transformation. Areas of spectral peak in ranges from 0.04 to 0.15 Hz and from 0.15 to 0.40 
Hz were defined as low-frequency (LF) power indicating modulated sympathetic activity, and high-
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frequency (HF) power indicating vagal activity, respectively. The sympathovagal balance was 
calculated as the ratio of LF and HF powers (LF:HF ratio). 
Non-linear HRV analysis – The standard deviation of the short- (SD1) and long-term (SD2) 
beat-to-beat RR interval variability measure (Poincaré plot), quantifying self-similarity in an RR data 
set and distinguishing chaos from randomness by embedding a data set into a higher-dimensional 
state space, sample entropy (SE), measuring the complexity of the RR interval time series 
independently from the data length and the short-term scaling exponent obtained by detrended 
fluctuation analysis technique of the RR interval time series, which provides an estimation of fractal 
correlations in heart rate dynamics for short-term RR interval data sets (< 11 beats, α 1) were 
determined as non-linear measurements of HRV.   
 
2.4.4. Blood markers 
 
Samples of venous blood were tested for parameters indicating low-grade inflammation 
(hsCRP, IL-6, IL-8, IL-10), endothelial activation (ICAM, P-selectin), activated hemostasis (D-dimer, 
fibrinogen), and neurohumoral activity (NT-pro BNP).  
All patients had their fasting blood samples taken in the morning, after resting for 30 minutes 
in the supine position, from the cubital vein into 4.5 ml vacuum tubes containing 0.11 mol/L sodium 
citrate (Becton Dickinson, Vacutainer System Europe, Germany). Plasma was prepared within 30 
min with 20-min centrifugation at 2,000 × g. Concentrations of fibrinogen (DadeR Thrombin 
Reagent) and D-dimer (Innovance D-dimer, both Siemens Healthcare Diagnostics, Marburg, 
Germany) were determined in fresh plasma on an automated coagulation analyzer CS2100i 
(Sysmex, Kobe, Japan). The remaining plasma was aliquoted, snap frozen in liquid nitrogen and 
stored at –75◦C until analysis. NT-proBNP in thawed plasma was determined on a StratusR CS Acute 
CareTM analyzer based upon solid phase Radial Partition Immunoassay (RPIA) technology (Siemens 
Healthcare Diagnostics, Marburg, Germany). Plasma CRP, ICAM-1, IL-6, IL-8, IL-10, and P-selectin 
were measured with the xMAPR Technology utilizing magnetic beads coupled with specific 
antibodies (all R&D Systems, Minneapolis, United States) on a MagPix instrument (Luminex 






2.4.5. Health-related quality of life 
 
Assessment of the health-related quality of life was made on the basis of standardized 
Medical Outcomes Study 36 items Short-Form (SF-36) Health Survey questionnaire as one of the 
most commonly used generic measures of HRQoL that demonstrated sensitivity to significant 
treatment effects in coronary patients, suggested to be the preferred instrument when measuring 
QoL after cardiac rehabilitation (Cohen et al., 2011; Soto et al., 2005; Duenas et al., 2011; Alonso et 
al., 2004; Huber et al., 2016; Failde and Ramos, 2000; Keibzak et al., 2002; Dempster et al., 1997). 
The SF-36 questionnaire enables the estimation of any limitations in the physical, social, and 
psychological functioning of the patients (Ware and Kosinski, 2001; Ware et al., 2001).  
The SF-36 questionnaire, with a total of 36 questions, is structured as two categories: 
physical and mental, and evaluates eight dimensions of health: physical functioning (PF), role 
limitations due to physical health problems (PR), bodily pain (BP),  general health perception (GH), 
vitality – energy and fatigue (VT), social health (SH), role limitations due to emotional problems (RE), 
and mental health-psychological distress and well-being  (MH) (Ware & Sherbourne, 1992). 
Summing the item scores from the same scale gives the physical component summary (PCS) and 
mental component summary (MCS) scale scores in the range from 0 to 100, with higher scores 
indicating better health status (Ware et al., 2001; Ware et al., 1995). Calculation of the main scale 
and subcategories scale scores was done using German norms for the SF-36 questionnaire. 
 
2.5. Statistical methods 
 
2.5.1. Sample size calculation 
 
Sample size calculation suggested the inclusion of 90 patients (30 per group) to achieve 80% 
power at a significance level of 0.05 for detecting a between-group difference (and assumed 
between-subject standard deviation) of 1 MET (3.5 ml kg
-1 min-1).  
 
2.5.2. Statistical analysis 
 
Data are presented as mean (standard deviation) for normally distributed continuous 
variables and as median (interquartile range) if they lacked normal distribution. Between-group 
differences in the patients’ baseline characteristics were tested by ANOVA or the Kruskal-Wallis test, 
as appropriate.  
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Differences in end-of-study V̇O2 peak, which was our primary objective, between the study 
groups were tested using ANCOVA, controlling for baseline VO2 peak and patient’s age. ANCOVA 
including age and baseline measurements as covariates was used for all the other normally 
distributed variables. Post hoc differences were tested by the Sidak test.  
Variables, measured in percentages (FMD and NMD), were logarithmized before the 
analysis. For the logarithmized FMD, the assumption of homogeneity of regression slopes was 
violated, so the between-group differences were tested using between- and within-group ANOVA 
with age as a covariate. 
As for the other variables measured as ratios (pNNx, pVLF, pLF, pHF, nLF, nHF, LFHF), the 
distribution of the logarithmized values differed from normal, the statistical procedure was equal to 
the one for other non-normally distributed variables. For these variables, the change from baseline 
for each patient was calculated and Kruskal-Wallis test was used to test the differences in change 
from baseline between the study groups. When statistically significant differences between groups 
were found, Mann-Whitney U was used to test pairwise differences.   
As part of the exploratory analysis, differences from baseline within each group were also 







The results are based on 89 participants (30 in land-based group, 29 in water-based group, 
and 30 in control group) who completed all the testing and training requirements of the study (mean 
age 59.9 ± 8.2 years, 77.5% males, mean VO2 peak at baseline 14.8 ± 3.5 ml kg-1 min-1). One 
participant in the water-based exercise group was excluded from the study due to upper respiratory 
tract infection. Both exercise modalities were safe. No adverse events were observed in either of 
the intervention groups during the course of the study. Table 4 presents the characteristics of the 
study groups. 
 
Fig. 2. Characteristics of the patient groups by underlying disease 
 
There was a significant difference between participants in the water-based and land based 
exercise groups in terms of age (p = .026) (Fig 3.). Therefore, all the obtained end-of-study parameter 
values were subsequently controlled for baseline values and age of the patients. There was no 
significant difference in gender distribution between the groups. No significant association of 






































Table 4. Baseline characteristics of the patients who completed the study and between-group differences (data are 
shown as frequencies and percentages if not indicated otherwise) 
 
ABBREVIATIONS: SD = standard deviation, IQR = interquartile range, CI = confidence interval, FMD – flow-mediated dilatation, NMD 
– nitroglycerin-mediated dilatation, CAD = coronary artery disease, MI = myocardial infarction, PCI = percutaneous coronary 
intervention, CABG = coronary artery by-pass graft, HBP = high blood pressure, DM = diabetes mellitus, ACE – angiotensin-converting-
enzyme inhibitor, ARB – angiotensin II receptor blockers.  
* Annotation for groups that differ as found by post hoc tests are provided in the brackets.  
 
Variables 
Patients who completed 












Age, mean (SD), years 59.9 (8.2) 62.4 (7.6) 56.7 (8.4) 60.6 (8.3) .026 I-II 
Gender, m/f, n (%) 69	(77.5)/ 20	(2.5) 21	(70)/9	(30) 24	(82.8)/5	(17.2) 24	(80)/6	(20) .464	
BMI kg/m2, median (IQR) 29.4	(26.8–31.9)	 29	(26.5–31.6)	 30	(27.1–32.6)	 29.3	(26.8–30.9)	 .799	
VO2 peak (ml/kg/ min) 14.8	(3.5)	 13.1	(2.8)	 14.6	(3.3)	 16.6	(3.6)	 .001	I-III	
FMD (%) 6.9	(3.5–8.6)	 5.5	(3.1–8.6)	 7.2	(4.0–8.7)	 7.0	(3.7–8.6)	 .623	
NMD (%) 10.6	(7.4–13.4)	 10.6	(7.0–13.3)	 10.5	(8.5–14.0)	 10.9	(6.0–13.4)	 .918	
Dg     .523	
MI+PCI, n (%) 60	(67.4)	 19	(63.3)	 17	(58.6)	 24	(80)	  
PCI, n (%) 3	(3.4)	 1	(3.3)	 2	(6.9)	 0	(0)	  
CABG, n (%) 9	(10.1)	 3	(10)	 3	(10.3)	 3	(10)	  
MI+CABG, n (%) 17	(19.1)	 7	(23.3)	 7	(24.1)	 3	(19)	  
HBP, n (%) 52	(58.4)	 18	(60)	 14	(48.3)	 20	(66.7)	 .350	
Dyslipidemia, n (%) 65	(73)	 19	(63.3)	 22	(75.9)	 24	(80)	 .318	
Family history, n (%) 53 (59.6)	 19 (63.3)	 18 (62.1)	 16 (53.3)	 .692	
Obesity, n (%) 20	(22.5)	 6	(20)	 7	(24.1)	 7	(23.3)	 .921	
DM, n (%) 15	(16.9)	 3	(10)	 5	(17.2)	 7	(23.3)	 .385	
Low PA level n (%) 44	(49.4)	 17	(56.7)	 15	(51.7)	 12	(40)	 .415	
Smoking status, n (%) 48	(53.9)	 15 (59)	 16	(55.2)	 17	(53.9)	 .863	
Aspirin, n (%) 86	(96.6)	 29	(96.7)	 29	(100)	 28	(93.3)	 .366	
β blockers, n (%) 76	(85.4)	 26	(86.7)	 24	(82.8)	 26	(86.7)	 .887	
Statins, n (%) 79	(88.8)	 26	(86.7)	 26	(89.7)	 27 (90)	 .906	
ACE/ARB, n (%) 72	(80.9)	 24	(80)	 22	(75.9)	 26 (86.7)	 .566	
Fibrinogen (g.L-1) 3.0	(2.8-3.5)	 3.0	(3.0-3.4)	 3.3	(3.0-3.9)	 3.0 (2.7-3.4) .101	
D-dimer (μg.L-1)	 470	(250-730)	 625	(280-1222)	 400	(270-810)	 310 (200-510) .002	I-III.	II-III	
Hs CRP (mgL-1)) .65	(.40-1.68)	 .66	(.37-1.72)	 .92	(.56-1.80)	 .49 (.33-1.26) .371	
IL-6 (ngL-1) 9.6	(7.2-11)	 10.1	(7.5-11.7)	 9.6	(7.5-11.3)	 7.5 (6.9-9.6) .032	I-III,	II-III	
IL-8 (ngL-1) 18.4	(16.6-21.7)	 19.6	(16.4-21.3)	 17.8	(16.6-20.7)	 19.5 (16.6-23) .440	
IL-10 (ngL-1) 15.8	(12.7-20.7)	 17.6	(12.7-21.7)	 16.8	(12.7-25.7)	 14.7 (12.7-15.8) .180	
ICAM (ngmL-1) 507	(354-710)	 372	(270-506)	 523	(362-873)	 662 (507-806) .001	I-II,	I-III	
P-selectin (ngL-1) 26.8	(5.9)	 27	(6.8)	 25.4	(4.9)	 27.8 (5.6) .278	





3.1. Exercise capacity 
 
Exercise capacity, determined as V̇O2 peak, improved significantly in both interventional 
groups as compared to controls.  
Table 5 shows exercise capacity measure values before and after exercise for each group, 
comparison of the same with a paired t-test within groups, and comparison between groups (last 
column). An increase of all four parameters compared to baseline values, is observed in both 
intervention groups, but not in control group. Comparison across all four variables between groups 
using covariance analysis shows that the groups differ statistically significantly in their progress. Post 
hoc comparisons show that differences are present between all pairs of groups, with all four 
variables making the most progress in the water-exercise group, followed by the land-exercise 
group, and no progress in the control group.  
At the end of the study period, when controlling for baseline V̇O2 peak and age of the 
patients the mean estimate end-of-study V̇O2 peak improved in land-based exercise group up to 
15.3% (16.7 [95%CI 16–17.4] ml kg-1 min-1; p<.001 for change from baseline) and up to 27.4% (18.6 
[ (95%CI 17.9–19.3] ml kg-1 min-1; p<.001 for change from baseline) in water-based training group, 
while an increase was not observed in control group (– 0.6%, 14.9 [95%CI 14.2–15.6] ml kg-1 min-1, p 
= .775 for change from baseline) (Fig 4., Fig 6).  
The land exercise group has on average 1.8 (95% CI: 0.8 – 2.8) ml kg-1 min-1 and the aquatic 
exercise group 3.7 (95% CI: 2.7 – 4.7) ml kg-1 min-1 higher end-of-study V̇O2 peak in comparison to 
baseline V̇O2 peak values. 
As mentioned, age differed statistically significantly between the intervention groups, with 
younger age in water-based training. Therefore, we looked at the correlation between the progress 
in V̇O2 peak and age. We found that the correlation (although statistically significant) is very weak (r 
= - 0.24), and that the impact of age on the progress of V̇O2 peak is minimal. Due to age relatedness, 
we also did a covariance analysis for V̇O2 peak. Namely, we were interested in the difference 
between the groups at the end, with age and the initial V̇O2 peak values control. We have found that 
all groups differ from each other in the described way, i.e. that patients in the water-based exercise 











Data are shown as mean and standard deviation (SD) or median and 25th percentile – 75th percentile. Note: VO2 – 







































Fig. 6. Changes in aerobic exercise capacity (peak oxygen consumption) expressed on a logarithmic scale 
(from: Vasić D et al. Front Physiol. 2019; Frontiers in Physiology 10 (2019): 903) 
 
 
In both intervention groups, a significant increase in peak workload was observed. In land-
based exercise, an increase by 25.7% (p < .001), in water-based exercise by 28.4% (p < 0.001), with 
no significant changes in the control group 0.9% (p = 0.755) (Fig 7.). Mean estimate peak workload 
values in patients in the land-based exercise group rose from 70 (15) W to 88 (21) W, while patients 
in the water-based exercise group improved their mean peak workload values from 88 (21) W to 





















Fig. 7. Comparison of mean relative (%) changes in peak workload for each study group 
 
Time-to-exhaustion significantly improved in both land-based and water-based exercise 




Fig. 8. Comparison of mean relative (%) changes in time-to-exhaustion for each group 
 
It was found that the increase in peak oxygen consumption at the end of the study was not 
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3.2. Vascular function 
 
Water-based training, as well as land-based training led to improvement in endothelial 
function, estimated by FMD (Table 6). In both exercise groups, in comparison to controls, significant 
differences were noticed in end-of study change from baseline in FMD. Greater improvements were 
seen in water-based exercise group: from baseline values of 7.2% (IQR: 4.0–8.7) to end-of-study 
values of 9.2 % (IQR: 7.4–12.9), p< .001, compared to land-based exercise group: from baseline 
values of 5.5% (IQR: 3.1–8.6) to end-of-study values of 8.8% (IQR: 5.3–11.4), p< .001 (Fig 9, Fig 11). 
In the control group, no significant changes were recorded, p = 0.629.  
Endothelium-independent vasodilatation (NMD) improved significantly in both intervention 
groups, i.e. in land-based exercise from baseline values of 10.6% (IQR: 7.0 – 13.3) to end-of study 
values of 11.1% (IQR: 9.0 – 14.3), P <  .001, and in water-based exercise from baseline 10.5% (IQR: 
8.5 – 14.0) to end-of study 11.4 (IQR: 7.6 – 13.4), p =  .042 (Fig 10, Fig 11).  
When we considered the differences in progress between groups while controlling for 
endothelium-independent values at baseline and the age of the patients and acknowledging the 
correction for multiple comparisons, we found that statistically significant differences existed only 
between the land-based exercise group and control group. 
Ten subjects were randomly selected to estimate the reproducibility of FMD and the intra-









Data are shown as mean and standard deviation (SD) or median and 25th percentile – 75th percentile. Note:  FMD – 


































Fig. 11. Changes in flow-mediated dilatation and non-flow-mediated dilatation expressed on a logarithmic scale 
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3.3. Cardiac autonomic function 
 
When analyzing HRV parameters before and after rehabilitation in our patient cohort, we 
observed no significant change in the selected time-domain HRV parameters in patients undergoing 
water- or land-based exercise, or in the control group. Time-domain HRV data are summarized in 
Table 7.  
However, in regard to frequency-domain HRV parameters, we observed a statistically 
significant change in LF/HF index in the group of patients who underwent water-based exercise (p 
= 0.036). Frequency-domain data is shown in Table 8.  
Furthermore, a significant change of the nonlinear HRV parameter 1 (p = .043), a strong 
indicator of vagal modulation, and a marginally statistically significant change of another nonlinear 
HRV parameter SE (p = .096), were observed in the same group of patients. Nonlinear HRV 




Table 7. Measurements of HRV parameters (IBI and time-domain) for the three study groups at baseline and after 




Data are shown as mean (standard deviation) or median (Q1–Q3). IBI – inter-beat interval; SDNN – standard deviation of all normal 
R–R (NN) intervals; SDANN – standard deviation of the average NN interval calculated over a short period; NNx – number of valid 
adjacent NN values not separated by data breaks; pNNx – proportion of valid adjacent RR values not separated by data breaks; rMSSD 
– root mean square of successive NN interval differences; SDNNi – mean of the standard deviations of all the NN intervals for each 5 
min segment; SDHR –  standard deviation of heart rate; HRVti – heart rate variability triangular index; TINN – triangular interpolation 
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Table 8. Measurements of HRV parameters (frequency domain: Welch) for the three study groups at baseline and 




Data are shown as mean (standard deviation) or median (Q1–Q3). aVLF – absolute value in very low frequency; aLF – 
absolute value in low frequency; aHF – absolute value in high frequency; pVLF – power of the very low frequency band; 
pLF – power of the low frequency band; pHF – power of the high frequency band; aTotal – total power, variance of all 
NN intervals;  nLF – power in the low-frequency range, normalized; nHF – power in the high-frequency range, 
normalized; LF/HF -ratio of normalized low-and high-frequency power; peakVLF – peak frequency of the very low-
frequency band; peakLF – peak frequency of the low-frequency band; peakHF – peak frequency of the high-frequency 
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Fig. 13. Change in frequency domain: Welch – HRV parameters for the three study groups at baseline and after 









Table 9. Measurements of HRV parameters (Poincaré and nonlinear) for the three study groups at baseline and after 
training, and between-group differences 
 
 
Data are shown as mean (standard deviation) or median (Q1–Q3). SD1 – Poincaré plot standard deviation perpendicular 
to the line of identity; SD2 – Poincaré plot standard deviation along the line of identity; SampEn – sample entropy; 1 – 
detrended fluctuation analysis which describes short-time fluctuation; 2 – detrended fluctuation analysis which 
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Fig. 14. Change in Poincaré and nonlinear HRV parameters for the three study groups at baseline and after training, 











3.4.1. Markers of inflammation and endothelial activation  
 
When analyzing the end-of study values of inflammatory markers (hsCRP, IL-6, IL-8, IL-10) or 
parameters of endothelial activation (ICAM, P -selectin), no significant changes were noticed in both 
exercise groups. Data are summarized in Table 10. 
 
Table 10. Measurement of markers of inflammation and endothelial activation for the three study groups at baseline 
and after training, and between-group differences 
 
 
Data are shown as mean and standard deviation (SD) or median and 25th percentile – 75th percentile. Note:  hsCRP – 





3.4.2. Markers of activated hemostasis and neurohumoral activity 
 
When investigating the parameters of activated hemostasis, fibrinogen end-of-study values 
lower than baseline were observed in patients in the water-based exercise group, with a drop from 
3.3 g l-1 (IQR: 3.0 – 3.9) to 3.0 g l-1 (IQR: 2.7 – 3.8),  but the decrease was statistically insignificant (p 
= .248). In the land-based exercise group, we recorded a mild, insignificant rise in fibrinogen levels, 
from the mean estimate peak values of 3.0 g l-1 (IQR: 3.0 – 3.4) to 3.2 g l-1 (IQR: 3.0 – 3.5), p =  .875. 
No significant changes were noted in the control group. 
D-dimer levels were lower in all three groups, but only in the water-based exercise group did 
the decrease show statistical significance, p = .001; -7.5%; from median 400 μg. L-1   (IQR: 270 – 810) 
to median 370 μg.L-1 (IQR: 260 – 590). Borderline significance was noted in land-based exercise, 
from median 625 μg. L-1 (IQR: 280 – 1220) to median 465 μg. L-1 (IQR: 270 – 1070), p =  .66 (Fig 15). 
NT-proBNP plasma concentrations at baseline were significantly higher in the land-based 
exercise group (707 ng.L-1; IQR: 401–1604), compared to levels in the water-based exercise group 
participants (396 ng.L-1; IQR: 296–541; p<0.001) or controls (111 ng.L-1; IQR: 66–221; p< .001). 
After the intervention period, NT-proBNP levels were significantly reduced only in the water-
based exercise group (-22.2% from baseline, from median 396 ng. L-1 (IQR: 296 – 541) to median 
308 ng.L-1 (IQR: 187 – 394) (Fig 16). No significant changes were recorded in patients from the land-




Table 11. Measurements of markers of activated hemostasis and neurohumoral activity for the three study groups at 
baseline and after training, and between-group differences 
 
 
Data are shown as mean and standard deviation (SD) or median and 25th percentile – 75th percentile. 
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3.5. Health-related quality of life 
 
For both intervention groups, assessment at the end of the study revealed statistically 
significant improvements in all eight domains of QoL, when controlling for baseline values (p<0.001). 
Water-based exercise training, same as land-based exercise training, led to improvement in the 
physical component score, from 62.1 (IQR: 50.9 – 80.3) to 83.5 (IQR 78.6 – 97.1), p< .001, in water-
based training, and from 61.8 (IQR: 42.9 – 79) to 82.4 (IQR: 75.2 – 97), p< .001, in the land-based 
training group; and the mental component score, from 62.6 (IQR: 54.8 – 86.8) to 92.3 (IQR: 85.4 – 
97), p< .001, in the water-based training group and  from 61.5 (IQR: 44.6 – 76.2) to 89 (IQR: 82.6 – 
94.9), p< .001, in the land-based training group (Fig. 17 and Fig. 18). Patients in both exercise training 
groups showed improvements in all physical and mental subcategories in comparison to control 
group. Data are summarized in Table 12. 
The greatest improvements were seen in the mental component summary in both exercise 
groups. The percentage change from baseline in the MCS for the land exercise group equaled 44.7% 
and for the water exercise group 47.4% (Fig. 18). The largest improvement in subcategories was 
seen in RP. Patients in the control group experienced significant improvements in mental health, 








Data are presented as mean (standard deviation) or median (interquartile range). PCS – physical component summary; 
MCS – mental component summary; PF – physical functioning; RP – role functioning limitations due to physical 
problems; RE – role limitations due to emotional problems; VT – vitality – energy and fatigue; MH – mental health; SF – 
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In our study, we demonstrated that supervised short-term exercise training – carried out 
either in thermoneutral water or on land – is safe and improves aerobic exercise capacity and 
vascular function in coronary patients.  
Patients after a recent CAD event have generally been cautioned against aquatic exercise 
due to its uncertain efficiency and concerns about an increased risk of adverse events. In our study, 
we demonstrated that a water-based exercise program comprised of two daily training sessions 
improved aerobic exercise capacity (measured by VO2 peak) and endothelial function (measured by 
FMD) in patients attending a 2-week residential cardiac rehabilitation, yielding larger improvements 
of the mentioned parameters than an exercise program performed on land, with no adverse 
cardiovascular events during the study.  
To our knowledge, this is the largest study of water- vs. land-based exercise training in 
patients after a recent CAD event, and the first to address vascular function in this context. Our 
findings support a growing body of evidence confirming the safety and effectiveness of water-based 
exercise in coronary patients. This suggests that aquatic exercise modalities could be a suitable 
option for a cardiac rehabilitation exercise program for selected patients after a recent CAD event, 
such as patients with concomitant musculoskeletal conditions, frailty, or at risk of falls, or for those 
who may personally prefer water-based exercise training 
 
4.1. Exercise capacity 
 
Our study revealed that both types of exercise, land-based and water-based, significantly 
improved exercise capacity (measured by peak oxygen consumption, VO2) in comparison to 
controls, with larger improvements in the water-based exercise group. The magnitude of baseline-
adjusted V̇O2 peak increase — roughly 1 MET (3.7 ml kg-1min-1; 95% CI: 2.7- 4.7) — in the water-
based group represents a clinically significant achievement (Conraads et al., 2015). The 
improvement in exercise capacity measured by the VO2 peak in the water-based exercise and land-
based exercise groups is comparable to the increments reported in previous studies that assessed 
water-based exercise training (Teffaha et al., 2011; Caminiti et al., 2011; Cider et al., 2012; Mourot 
et al., 2009).  
In our study, the V̇O2 peak improvements were greater than those previously described in 
randomized trials of short-term (3 weeks) water-based rehabilitation (in the range of 2.0 – 2.4 ml 
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kg−1 min−1) (Laurent et al., 2009; Teffaha et al., 2011). However, the more stable and younger 
populations of coronary patients (mean age 52 and 54 years, respectively) enrolled by both authors 
may have been responsible for the higher baseline VO2 peak (20 and 22 ml kg−1 min−1, 
respectively), and thus apparently smaller improvements in aerobic exercise capacity. 
Conversely, the end-of-study V̇O2 peak in our patients (16.7 and 18.4 ml kg−1 min−1, 
respectively) was lower than previously reported in other researches done in coronary patients 
(Casillas et al., 2007; Winzer et al., 2018), but still higher in comparison with the studies of water-
based exercise in patients with chronic heart failure. A likely cause could be the specific 
characteristics of our patients, in the sense that they represented a population of coronary patients 
referred for cardiac rehabilitation after recent myocardial infarction and/or revascularization 
procedure and had a risk spectrum that ranged from stable forms of coronary disease to clinically 
manifest forms of cardiac dysfunction.  
End-of-study V̇O2 peak in our study increased significantly in the water-based exercise group 
(p < 0.001 after covariance analysis controlling for age and baseline capacity). Greater 
improvements with water- vs. land-based exercise training in coronary patients have been 
previously observed (Teffaha et al., 2011; Lee et al., 2017), however, in comparison to previous 
reports (Maurot et al., 2010; Teffaha et al., 2011) where the magnitude of difference was 1 ml kg− 
1 min− 1, this value was larger in our study (2 ml kg− 1 min− 1). Still, due to the large confidence 
intervals for our estimations, our study was underpowered to provide a final conclusion on the true 
relevance of differences in the end-of-study V̇O2 peak between aquatic and land-based training. In 
terms of methodology, the difference giving more value to water-based as opposed to land-based 
exercise could be attributed to a randomization failure (namely, the older age of the patients in the 
land-based exercise group with a lower baseline V̇O2 peak). 
Another possible explanation could be that the larger improvements could be attributed to 
either the specific physiology of thermoneutral water immersion or the higher aquatic exercise 
intensity. As regards the specific physiology, thermal water immersion has been associated with 
hemodynamic and peripheral responses, such as increased stroke volume and ejection fraction, 
reduced heart rate, pronounced systemic, pulmonary, coronary vasodilatation, and accentuated 
neurohormonal adaptations (reduction of renin, angiotensin II, and aldosterone activity, decreased 
sympathetic tone, increase in the release of atrial natriuretic peptide), correlated with 
improvements in myocardial efficiency and endurance (DiCarlo et al., 1991; Tei et al., 1995; Mourot 
et al., 2010; Gabrielsen et al., 2000). 
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Previous studies (Teffaha et al., 2011; Lee et al., 2017) have compared water- vs. land-based 
calisthenics in combination with land-based endurance training (cycling). By contrast, our water-
based exercise protocol (both endurance and calisthenics) required patients to be immersed in 
water to the xiphoid level. 
As far as intensity is concerned, aquatic exercise was prescribed based on the peak heart 
rate achieved during a symptom-limited graded exercise test performed on a land bicycle 
ergometer. On the one hand, it is not possible to directly interchange the assumed intensity 
between water-based aerobic exercise and land-based cycling. On the other hand, the intensity 
derived from the peak heart rate may not be as precise a measure of metabolic stress as, for 
example, ventilatory thresholds, especially in patients with cardiovascular disease (Carvalho and 
Mezzani, 2011). Because threshold determination is often challenging in clinical practice, most 
studies – ours included – continue using the peak heart rate in exercise prescription (Mann et al., 
2013). Our intervention protocol sought to equalize total energy expenditure in both groups but 
was not adjusted for the aquatic heart rate (maximum rate 13% or 10 bpm lower than in land-based 
exercise) (Di Carlo et al., 1991). In this respect, results obtained from previous investigations have 
proved inconclusive: some confirm the higher intensity (and therefore also the rationale for heart 
rate adjustment) of water-based exercise (Lee et al., 2017), while others do not, including studies 
with coronary patients exercising up to 75% VO2 peak (Tokmakindis et al., 2008; Maurot et al., 2009; 
Teffaha et al., 2011). A possible way to reconcile these inconclusive results could be to further assess 
the specific protocols of water-based training, where level could be of crucial importance. The 
deeper water in our trial (xiphoid process level) – which has been found to improve buoyancy and 
reduce resistance (Cider et al., 2003) – may be responsible for the comparable intensity of water- 
based exercise, but also by the hydrostatic-forces-induced response to immersion. 
 
4.2. Vascular function 
 
Endothelial dysfunction is the initial step of atherosclerosis and, thus, is implicated in the 
pathogenesis and clinical course of coronary artery disease (Schächinger et al., 2000). Measurement 
of flow-mediated vasodilatation (FMD) of the brachial artery is a confirmed method for assessing 
endothelial function in humans (Flammer et al., 2012).  
In patients with CAD, endothelium-dependent vascular dysfunction may be associated with 
impaired systemic (skeletal muscle) and coronary (myocardial) perfusion, resulting in exercise 
intolerance and myocardial ischemia during exertion, respectively (Bruning and Sturek, 2015). 
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Furthermore, in CAD, endothelial dysfunction correlates with low-grade inflammation and increased 
monocyte adhesion, the promoters of atherosclerotic plaque formation and rupture, and with the 
increased hemostatic activity promoting coronary thrombosis (Kokkinos and Myers, 2010; Winzer 
et al., 2018). Land-based exercise training, on the other hand, has been shown to provoke a reversal 
or reduction of these abnormalities. The seminal study of Hambrecht et al. (2000) demonstrated 
that, after 4 weeks of in-hospital bicycle ergometer training, the endothelium-dependent arterial 
vasomotion in CAD patients improved, probably due to the restored balance between the synthesis 
and depletion of vasoactive and vasoprotective nitric oxide (NO) (Hambrecht et al., 2003).  
In terms of mechanistic causes, this is mostly a consequence of the response to exercise-
induced shear stress (Kokkinos and Myers, 2010; Bruning and Sturek, 2015). Also, regular land-based 
aerobic exercise training is connected with reduced low-grade inflammation (as determined by the 
levels of high-sensitivity C-reactive protein (hsCRP), cell adhesion (as determined by cell adhesion 
molecules, such as ICAM and P-selectin), and hemostatic activity (as determined by the markers of 
coagulation and fibrinolysis, such as fibrinogen and D-dimer) (Womack et al., 2003; Pedersen, 2017). 
This suggests a complex interplay of the effects of aerobic exercise on the endothelium, low-grade 
inflammation, cell adhesion, and hemostasis in patients suffering from CAD (Kokkinos and Myers, 
2010; Winzer et al., 2018). 
Previous studies have confirmed that exercise training increases flow-dependent 
vasodilatation augmenting blood flow and laminar shear stress, acting as a stimulus for endothelial 
up-regulation (Di Francescomarino et al., 2009). 
In our study, both types of exercise training, water- and land-based, led to improvements in 
vascular function (between 2 and 3 absolute percentage change improvements). Flow-mediated 
dilatation – a marker of endothelial function (Flammer et al., 2012) – increased significantly in both 
intervention groups after 2 weeks of exercise training, with larger improvements again observed 
after aquatic exercise. Similar improvement have been reported in land-based aerobic exercise (Di 
Francescomarino et al., 2009), however, there are still no published studies investigating the effect 
of water-based aerobic exercise in coronary patients. In view of the mostly longer duration of 
exercise programs in previous studies, our trial was comparably short-term, indicating that 
improved endothelial function can be observed after just two weeks of exercise training. This is in 
agreement with the results reported in human trials (Tinken et al., 2008) and animal models 
(Graham and Rush, 2004). 
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The larger improvements in endothelial function with water-based training documented in 
our study may imply an additional effect of the thermal vasodilatation, increased peripheral blood 
flow, and enhanced shear stress, yielding endothelial nitric oxide synthase up-regulation. Improved 
endothelial function after water-based exercise training, reflected by increased plasma nitric oxide 
levels, has been previously described in coronary patients (Conraads et al., 2015). Also, increased 
FMD has been reported in adults with prehypertension (Nualnim et al., 2012) and osteoarthritis 
patients engaged in water-based exercise training (Alkatan et al., 2016). In the only study that 
compared water-based exercise (swimming) with land-based exercise (cycling), Alkatan et al. (2016) 
reported greater improvement in endothelial function after aquatic training (4 vs. 1% absolute 
percentage change improvement), which contradicts our results. These differences could partly be 
explained by the type (swimming) and duration (8 weeks) of exercise. In addition, the study of 
Alkatan et al. (2016) included osteoarthritis patients without cardiovascular disease. 
 
4.2.1. Endothelial cell activation 
 
In response to endothelial cell activation, cell adhesion molecules (CAMs) ICAM-1 and VCAM 
-1 are expressed on the surface of endothelial cells and leukocytes mediating the atherosclerotic 
inflammatory process (Verma and Anderson, 2003; Petridou et al., 2007). Activated endothelial cells 
cleave adhesion molecules and release them into the circulation as soluble adhesion molecules 
(sICAM and sVCAM), where they can be measured (Adamopoulos et al., 2001).  
Our findings are consistent with the results of two studies with the same study populations 
as ours. Oliveira et al. noticed no change in inflammatory (hsCRP, IL-6, IL-10, TNF-) and endothelial 
activation (sICAM-1, sVCAM-1) biomarkers in coronary patients following MI after an 8-week 
aerobic exercise training program (Oliveira et al., 2015). Similar results were reported by Munk et 
al. after 6 months of aerobic exercise training in coronary patients after PCI (Munk et al., 2009). 
Two studies with study populations similar to ours (coronary patients after myocardial 
infarction, PCI, or CABG) reported significant decreases in sICAM and sVCAM after 8-week  (Ribiero 
et al., 2012) and 6-week (Schumacher A et al., 2005) aerobic exercise training programs. In the last 






4.2.2. Low-grade inflammation 
 
Vascular wall inflammation has an important role in the pathogenesis of coronary artery 
disease. Proinflammatory cytokines IL-6, IL-8, TNF-, the antiinflammatory cytokine IL-10, and the 
acute phase protein CRP directly mediate all the stages of angiogenesis. Their increased plasma 
concentrations indicate the presence of low-grade inflammation associated with atherosclerosis 
(Plaisance and Grandjean, 2006). 
Regular low-to-moderate intensity exercise training is associated with an antiinflammatory 
effect, observed from the aspect of reduction in the serum concentrations of CRP and 
proinflammatory cytokines and increased concentrations of the antiinflammatory cytokine IL-10 
(Munk et al., 2009; Goldhammer et al., 2005; Balen et al., 2008; Kim et al., 2008; Dorneles et al., 
2016). However, several studies failed to show a decrease in inflammatory parameters (Niessner et 
al., 2006; Luk et al., 2001; Hansen et al., 2008; Sixt et al., 2008). 
Regular long-term exercise training has been found to reduce low-grade inflammation 
(Nimmo et al., 2013), which is one of the characteristics of atherosclerosis in general and coronary 
artery disease in particular. Considering the link between inflammation and endothelial dysfunction 
and the key role of endothelial integrity in the promotion of cell adhesion and coagulation, we 
hypothesized that improved endothelium-dependent vascular function would be associated with 
decreased levels of markers of low-grade inflammation, endothelial adhesion, and coagulation.  
However, contrary to the (FMD-assessed) improved vascular function, the markers of 
inflammation and endothelial activation showed no improvements at the end of the study period. 
Our results are not correlated with the results of most previous studies. In our study, no significant 
changes in IL-6, IL-8, IL-10 or hsCRP were noted.  
Possibly, our training period of two weeks was too short to produce such changes. It seems 
that the duration of intervention is crucial for improvement in the markers of inflammation since 
most of the studies showing improvements included either land-based (Munk et al., 2009; 
Schumacher et al., 2006; Goldhammer et al., 2005) or water-based (Alkatan et al., 2016) exercise 
interventions lasting at least 12 weeks.  
Additionally, our findings suggest that improved FMD unaccompanied by a decrease in 
inflammation markers (interleukins and hsCRP) and inflammation-induced endothelial activation 
markers (P-selectin and ICAM) is probably the result of immediate exercise-induced hemodynamic 
alterations and does not imply a reversal of the vascular dysfunction caused by inflammation. 
However, such a consideration is also debatable considering the results of the study in which 
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Simmons et al. investigated the effects of thermoneutral water immersion on peripheral endothelial 
function in healthy individuals during 4 consecutive days and found that on the 2nd and 3rd day of 
immersion there was a significant improvement in endothelial function (12.3% and 16.1%, 
respectively) compared to the basal values, but the 4th-day values did not differ from the basal 
(Simmons et al., 2017). 
Another possibility is that long-term changes in body mass, composition, and metabolism 
brought about by exercise training could, in the long run, be responsible for reversing low-grade 
chronic inflammation in coronary artery disease. Information on this subject is still scarce and our 
two-week training regimen, just like longer 12-week exercise programs (Mohammadi et al., 2018), 
failed to provoke any significant changes in the body mass index. Also, potential changes in body 
composition that could be induced by water-based exercise were not investigated.  
 
4.2.3. Activated hemostasis 
 
An activated hemostatic system has an important role in both atherogenesis and 
atherothrombosis (Kannel, 2005). Hemostatic indices of thrombogenesis, specifically, elevated 
plasma levels of fibrinogen and D-dimer are known predictors of subsequent cardiovascular events 
in patients with coronary artery disease (Koenig et al., 2000; Meade et al., 1986). Impaired 
hemostatic balance in patients with coronary artery disease is a basic pathophysiological mechanism 
of potential complications of ischemic heart disease. It has been confirmed that exercise training 
improves hemostasis by reducing procoagulatory activity and increasing fibrinolytic capacity (Lee 
and Lip, 2003). 
With respect to plasma fibrinogen levels before and after training in water-based and land-
based training groups, the results of our study are inconsistent with the literature published so far. 
Namely, in none of the intervention groups did we notice dynamics of fibrinogen values similar to 
those in previous studies exploring the effects of regular land-based physical activity  (Lee & Lip, 
2003; Eliason et al., 1996; Suzuki et al., 1992; Wosornu et al., 1992; Lee et al., 2006; Dudaev et al., 
1986; Stratton et al., 1991; Vanninen et al., 1994; Lindahl et al., 1999; Folsom et al., 1991) or the 
effects of swimming on fibrinogen levels (Lins et al., 2003). But, our findings are consistent with the 
studies that explored the effects of land-based exercise (Ponjee et al., 1993; Stratton et al., 1991; 
Shanjani et al., 2014) or water-based exercise (Lins et al., 2001) and found that plasma fibrinogen 
levels remained nearly unaltered by swimming in coronary patients. 
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The presence of fibrinogen and fibrin-degradation products during the progression of 
atherosclerotic lesions has been widely confirmed (Eitzman et al., 2005; Seehaus et al., 2009). 
Coronary patients thus usually have elevated plasma fibrinogen levels. Respecting the given upper 
limit of 3.0 g/l (Chou et al., 2004), baseline values were elevated in both intervention groups. A 
discrete decrease in fibrinogen plasma values was seen in the water-based exercise group, and a 
slight increase in the land-based exercise group after the intervention, but with no statistical 
significance. 
Baseline plasma D-dimer values were slightly increased in patients randomized into the land-
based exercise group, which is expected given that these are commonly seen in patients with 
coronary heart disease. A significant decrease in plasma D-dimer values was recorded after the 
intervention only in the water-based exercise group, by 7.5%. Shanjani et al. (2014) and Lee et al. 
(2006) also reported a significant decrease in plasma D-dimer values, but after a land-based exercise 
program. Erickson–Berg (2002) reported unaffected plasma D-dimer values after land-based 
exercise; however, it should be emphasized that the exercise protocol in their study was very low-
intensity. Since immersion in thermoneutral water did not lead to changes in plasma D-dimer levels 
(Boldt et al., 2008), the results of our study recorded in the water-based exercise group can be 
considered solely as a consequence of exercise training. 
 
4.2.4. Neurohumoral activation 
 
NT-proBNP is an established biomarker for the diagnosis, prognosis, and management of 
heart failure of different etiology (Kragelund et al., 2005; Maisel et al., 2002; Zhu et al., 2016). 
Associated with the severity of coronary artery lesions in patients with acute coronary syndromes 
(Sadanandan et al., 2004) and stable coronary artery disease (Ndrepepa et al., 2007; Ndrepepa et 
al., 2005), it provides long-term prognosis in the sense of subsequent cardiovascular events and 
death both following hospital admission for acute coronary syndrome and in patients with stable 
CAD (Wei et al., 2013; De Lemos et al., 2001; Mega et al., 2004; Morrow et al., 2003; Richards et al., 
1998; James et al., 2003; Bibins-Domingo et al., 2007). Linear association between plasma levels of 
NT-proBNP and future events was reported among patients with the greatest risk (NT-proBNP level 
above 500 pg/mL), while a very low risk of future adverse events was indicated by NT-proBNP 
plasma levels lower than 100 pg/mL (Bibins-Domingo et al., 2007).   
NT-proBNP was a strong and independent prognostic factor for all-cause death and major 
cardiovascular events (MACEs) in individuals older than 65 years and MACEs in individuals younger 
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than 65 years in a community-based population (Zhu et al., 2016). Elevated plasma NT-proBNP levels 
also identify at-risk individuals even without echocardiographic evidence of systolic dysfunction 
(Bibins-Domingo et al., 2007; Kistorp et al., 2005), which would indicate that elevated NT-proBNP 
levels may just reflect subclinical levels of ventricular dysfunction (elevated filling pressures due to 
diastolic dysfunction) or inducible ischemia (Bibins-Domingo et al., 2003). 
Previous studies examining the effects of land-based exercise training on plasma NT-proBNP 
levels had uniform results, meaning that all reported decreased NT-proBNP values in both CHF 
(Passino et al., 2006; Conraads et al., 2004) and coronary patients (Berent et al., 2009; Giallauria et 
al., 2006; Giallauria et al., 2005; Saghiv et al., 2017; Irzmański et al., 2006). The studies were 
performed during cardiac rehabilitation including a land-based exercise program. Participants were 
coronary patients after an acute coronary event, PCI, or CABG. Except for the studies of Irzmanski 
et al. (2006) that lasted 12 days and Berent et al. (2009) that lasted 25 days, the other continued for 
12 weeks (Saghiv et al., 2017; Giallauria et al., 2005; Giallauria et al., 2005). The training program 
consisted of aerobic exercises performed at 60–70% of VO2 peak achieved at the symptom-limited 
exercise test. The decrease in circulating NT-proBNP values ranged from 27% (Saghiv et al., 2017) to 
65% (Giallauria et al., 2006). 
Shah et al. (2018) examined the effect of immersion in thermoneutral water on NT-proBNP 
levels in patients with CHF mainly of ischemic etiology. They reported no significant difference in 
NT-proBNP levels before and after thermoneutral water immersion (xiphoid process level) in nine 
male patients.    
The absence of changes in the level of NT-proBNP in plasma was noted by the authors of two 
studies examining the effects of hydrotherapy in patients with ischemic and non-ischemic heart 
failure (Municino et al., 2006; Svealv et al., 2009). Svealv et al. reported improvement in left 
ventricular systolic function and increase in early diastolic filling velocity, but no change in BNP 
values in 18 patients with stable CHF after 8 weeks of hydrotherapy. Left ventricular filling 
alterations were found to correlate with NT-proBNP levels so that the improvement of the diastolic 
filling rate leads to a decrease in NT-proBNP (Palazzuoli, 2010). Municino et al. (2006) also found no 
difference in NT-proBNP levels before and after 3 weeks of cardio-hydrokinesitherapy in CHF 
patients. Nonetheless, they reported improved functional capacity (measured by VO2 peak) in these 
patients. The fact that, in both studies, an improvement was observed in the parameters that 
happened to be associated with the decrease in NT-proBNP in the investigations monitoring the 
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effects of land-based exercise requires an explanation of the reasons for the absence of the same 
effect in water. 
 Our results are not consistent with the results of the aforementioned water-based exercise 
studies, since we noted a significant decrease in the plasma NT-proBNP levels in the water-based 
exercise group measured after cardiac rehabilitation. Reduction by 22.2% documented in our study 
is, to a certain extent, close to the results reported by Berent et al. (2009) and Saghiv et al. (2017), 
namely, 34% and 27% decrease in plasma NT-proBNP values, respectively, in coronary patients after 
land-based exercise cardiac rehabilitation. Similar results (34%) for NT-proBNP reduction in CHF 
patients after a nine-month land-based training program were reported by Passino et al. (2006) 
Decreased NT-proBNP plasma values in patients from our water-based exercise group may be 
explained by the fact that, in the same patients, a significant improvement in functional capacity 
and endothelial function was recorded after cardiac rehabilitation. Contrary to the results in the 
water-based exercise group, in our land-based exercise group, no statistically significant changes in 
NT-proBNP values were seen. These results cannot be explained by the short duration of 
rehabilitation, since Irzmanski R et al. (2006) reported a decrease in NT-proBNP values > 40% in 
coronary patients after just 12 days of land-based exercise training. Therefore, we sought further 
clarification and attributed this to the fact that the patients in the land-based exercise group were 
older, consequently of lower functional capacity, and having higher NT-proBNP values at baseline. 
 
4.3. Cardiac autonomic function 
 
In the HRV analysis performed in our patients who underwent water- or land-based exercise 
and the control group, the most important finding was that only water-based exercise significantly 
increased the vagal tone and thereby established the fractal complexity of heart rhythm. This 
suggests that water-based exercise carries a more protective effect on cardiac health in coronary 
patients, and could therefore be an integral part of the regular rehabilitation program of patients 
after myocardial infarction or surgical myocardial revascularization. 
In recent years, a growing body of evidence has indicated that sympathovagal balance and 
the associated variability in cardiac rhythm alter not only with aging and various cardiovascular 
pathologies, but also with the individual level of physical fitness and training. (Routledge FS et al, 
2010) Vagal tone has been shown to increase with increasing physical fitness (and thereby also the 
vagal-modulated HRV parameters), protecting well-trained individuals from the most serious 
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complications of cardiovascular diseases – sudden cardiac death, myocardial infarction and/or 
malignant heart rhythm disturbance (Makivic et al., 2013; Javorka et al., 2002; Sartor et al., 2013). 
While the impact of different forms of physical exercise on linear HRV indices in healthy 
individuals, recreational and professional athletes, or in populations with mild cardiovascular 
diseases has been extensively studied (Fu and Levine, 2013; Furlan, 1993; Arai et al., 1989; Besnier 
et al., Aubert et al., Javorka et al., 2002), the effects of different types of physical exercise in the 
rehabilitation process on linear and especially non-linear HRV parameters in patients after 
myocardial infarction or surgical myocardial revascularization are less well defined. With the 
constantly improving treatment modalities, alleviating symptoms and prolonging long-term survival 
even in populations with the most advanced forms of cardiovascular pathologies, clinical decisions 
about the most beneficial rehabilitation strategies are becoming increasingly relevant, since only an 
optimal rehabilitation program will provide the best possible treatment outcomes. 
So far, studies have shown that land-based exercise protocols can increase selected time-
domain linear HRV parameters, suggesting that this exercise modality has the ability to enhance 
vagal tone and thus has beneficial effects on cardiovascular health in patients after myocardial 
infarction or surgical myocardial revascularization (Abolahrari–Shirazi et al., 2019; Hautala et al., 
2001; Yamamoto, 2001; Leich et al., 2007). However, upon observing our patients who had 
undergone water-based exercise, land-based exercise, or no exercise at all, we could not 
demonstrate any statistically significant differences in the selected vagal-mediated linear HRV 
parameters (all time-domain indices and the HF frequency-domain HRV index) before and after the 
pre-selected rehabilitation program in either group of patients. Since the exact pathophysiological 
mechanisms contributing to the different extent of vagal enhancements after diverse forms of 
physical fitness have not been completely elucidated, the distinct findings of our study are not 
completely clear and can be at least partly attributed to the different beginning of rehabilitation 
intervention after a primary event (myocardial infarction or open-heart surgery), different exercise 
duration, different exercise regimens for the same types of exercise, or different medical therapy 
applied to patients in comparable studies.  
In our study, the patients were included in 3 different types of rehabilitation regimes less 
than 2 months after a primary event. The rehabilitation intervention lasted only 2 weeks. The water-
based program included moderate physical fitness training in water with an average temperature 
of 32.8 degrees Celsius. All patients were on optimal medical therapy according to the latest 
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guidelines, with all individuals receiving blockers of beta-adrenergic receptors which are known to 
significantly influence both time- and frequency-domain linear HRV parameters. 
Interestingly, when performing the linear HRV analysis in our study, we did detect a 
statistically significant change in the HF/LF parameter after the rehabilitation intervention in our 
water-based exercise group. However, since the exact role of HF/LF index is still debatable and since 
the majority of researchers use the parameter to quantify the degree of sympathovagal balance, 
this observation indicates that water-based rehabilitation programs have the ability to enhance 
both branches of the autonomic nervous system to a greater degree and faster than land-based 
protocols or rehabilitation programs not including water-based exercise modalities. Nevertheless, 
no further conclusions regarding autonomic regulation after diverse rehabilitation interventions can 
be made by observing solely the conventional, linear HRV parameters.  
A vast body of evidence collected in the last decade indicates that nonlinear HRV analysis, 
based on mathematics of complex dynamics and fractal geometry, provides more accurate insights 
into autonomic regulation of the heart and possesses the ability to illuminate abnormalities of heart 
rate behavior in various physiological and pathological conditions, not evident with conventional 
linear HRV techniques (Huikuri et al., 2003; Stein & Reddy, 2005). In our study, nonlinear HRV 
analysis revealed a significant increase in α1 parameter in the water-based exercise group after the 
rehabilitation intervention, whereas no significant change was observed in any nonlinear HRV 
parameters in the land-based exercise group or the no-exercise group after our rehabilitation 
program.  
A significant increase in α1, a strong indicator of vagal modulation, indicates that 
rehabilitation programs including water-based training – as compared to solely land-based training 
– may provide more pronounced vagal tone enhancement and restoration of the fractal complexity 
of heart beat, thereby acting more protectively on the cardiovascular health of coronary patients. 
These findings suggest that water-based training should be considered an essential part of any 
regular rehabilitation intervention in patients after myocardial infarction or following surgical 
myocardial revascularization. 
Nonetheless, the exact pathophysiological mechanisms underlying the diverse impact of 
water- and land-based exercise on the autonomic modulation of the heart remain unveiled. One 
possible explanation could lie in the uneven physical workload of our patients in the intervention 
groups. Although the estimated workload in both water- and land-based group was the same, it 
could well be that the water-based exercise group was indeed exposed to a greater workload, 
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meaning that the patients in the water-based exercise group underwent a physically more intensive 
rehabilitation intervention. This could have helped those individuals to increase their physical fitness 
to a greater degree and, consequently, to achieve a greater increase in vagal tone.  
Another reason for the post-rehabilitation difference in autonomic heart regulation between 
the intervention groups could be the influence of hydrostatic pressure provided by water. Because 
of altered hydrostatic pressures, water-based physical activity increases heart rate and respiratory 
rate in a different manner compared to land-based exercise and thus enables specific adaptations 
of the body to physical exertion. Despite the so-called aquatic correction, which takes into account 
the differences in hydrostatic pressures in the assessment of physical exertion in water-based 
exercise programs, the real impact of hydrostatic pressure on a specific patient is extremely 
individually conditioned and depends on many pathophysiological factors and mechanisms. To 
unveil the exact pathophysiological mechanisms leading to differences in autonomic regulation of 
the heart after diverse regimens of physical training, further prospective, randomized, and big 
population-based studies are warranted in the future.  
 
4.4. Health-related quality of life 
 
Physical, psychological, and social factors are the most important determinants of the 
health-related quality of life (HRQoL). Exercise training plays a significant role in improving the 
quality of health, primarily because it leads to improvements in the functional capacity of the patient 
and, indirectly, to a reduction in depression and anxiety and improved social functioning. 
By analyzing the impact of the type of exercise on HRQL in our cohort of coronary patients, 
we demonstrated that both exercise types – water-based and land-based exercise training led to 
significant improvements in all domains of health-related QoL over the course of two weeks, as 
assessed by the SF-36 questionnaire. Physical and mental component summary scores significantly 
increased between the two interview periods in both exercise training groups. Intervention groups 
experienced significant changes in all domains of HRQL, with no significant differences in these 
changes between the intervention groups.  
Significant changes in health-related QoL were also reported in previous studies, but it 
should be noted that none of them evaluated changes in quality of life in such a short period as the 
two weeks of exercise-based cardiac rehabilitation in our study. The majority of recent studies 
related to changes in the quality of life in coronary patients after exercise-based rehabilitation lasted 
from 8 weeks (Oldridge et al., 1991; Hirano et al., 2005, Marchionni et al., 2003) or 3, 6 and 12 
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months (FaildeI and Soto, 2006; Anchah et al., 2017; Staniute et al., 2010; Muller- Nordhorn et al., 
2004), up to 3 years (Tofighi et al., 2012).  
Considering the correlation between our findings with the results of previous studies, an 
approximate similarity exists with the results of Hirano et al., who investigated changes in health-
related quality-of-life after 8 weeks of exercise-based cardiac rehabilitation in patients after cardiac 
surgery. They reported significant changes in seven out of eight SF-36 subscale scores in all domains, 
except mental status (Hirano et al., 2005). 
When evaluating changes in the health-related quality-of-life over a similar period of 2 
months, Oldrige et al. (1988) reported significantly greater improvements in mental health and 
exercise tolerance. In the same patients, after 12 months, all measures of health-related quality-of-
life were improved. Faildel and Soto (2006) revealed a decrease in the physical component summary 
of health-related quality-of-life 3 months after cardiac rehabilitation in patients after an acute 
coronary event. Similar results have been documented by Brown et al.  Staniute et al. (2010) 
assessed the health-related quality-of-life in coronary patients at the beginning of cardiac 
rehabilitation, and after a 6-, 12-, 18-, and 24-month follow-up. The greatest improvement of health-
related quality-of-life was seen at 6 months, with poorer results during follow-up. Increase in the 
physical component after 6 months but worse mental component summary was reported by Anchah 
et al. (2017) in patients after an acute coronary event. 
The diversity of results in existing studies can be explained by the diversity of the studied 
patients, in the sense of many factors influencing the health-related quality-of-life, such as severity 
of the acute coronary event, treatment method, cardiovascular risk profile (Woo and White, 1994; 
Staniute et al.), age (Barakat et al., 1999; Sotto et al., 2005), gender (Duenas et al., 2011; Hanratty 
et al., 2010), family and social support (Leifheit–Limson et al., 2012), educational level, income level 






Our study has several limitations. First, it was designed as a single-center study and thus 
included only a limited number of patients who had suffered a recent acute coronary event. 
Therefore, our results cannot be extrapolated to other patients with cardiovascular disease.  
Second, our surrogate endpoints, although relevant, are alone insufficient to confirm the 
clinical relevance of our findings, which will require larger clinical trials. As well, our study assessed 
exercise capacity, vascular function, and low-grade inflammation; although we offer some 
information about the impact of water-based exercise in patients with cardiovascular disease, our 
results provide only limited data about the potential (patho)physiological response to aquatic 
exercise in comparison to land-based training in CAD patients. Further studies are needed to explore 
the specific effects of aquatic exercise e.g. on body composition and metabolism in patients with 
coronary artery disease. 
Third, the between-group differences at baseline indicate randomization failure. As this had 
led to certain statistical adjustments, our study should be labeled pilot and hypothesis-generating. 
The effects of both interventions in comparison to control may have been overestimated 
because both intervention groups participated in the residential cardiac rehabilitation (adjusting for 
some confounders, such as diet) and the control group did not. 
The specific type (xiphoid-level endurance plus calisthenics exercise training) and duration 
of our program (two weeks) allowed us to only explore immediate physiological responses, without 
focusing on any sustainable effects of regular training. Considering immersion and intensity, ours 
was a study of deep-water (xiphoid level) training without heart rate aquatic adjustment. For this 
reason, we advise caution when attempting to extrapolate our results to other forms of aquatic 






To our knowledge, this is the largest study of water- vs. land-based exercise training in 
patients after a recent CAD event, and the first to address vascular function in this context.  
The results of our study confirms our primary hypotheses that water-based exercise training 
is as effective as land-based exercise training in improving exercise capacity and flow-mediated 
dilatation of the brachial artery, as compared to usual care (control group) in coronary patients.  
Our study validates the assumptions that, in patients with a recent coronary event: 
- Water-based exercise training is more effective than land-based exercise training in 
improving exercise capacity, 
- Water-based exercise training is more effective than land-based exercise training in 
improving flow-mediated dilatation of the brachial artery, 
- Water-based exercise training significantly improves cardiac autonomic function, which was 
not recorded after land-based exercise training,  
- Water-based exercise training significantly reduces serum concentrations of NT proBNP and 
D-dimer, as opposed to land-based exercise training, 
- Neither water-based nor land-based exercise training reduce serum levels of fibrinogen, 
hsCRP, IL-6, IL-8, IL-10, ICAM and selectin, 
- Both types of exercise, water-based and land-based, improve health-related quality of life. 
Our findings suggest that aquatic exercise modalities performed in thermoneutral water could 
be a suitable option in the short-term residential cardiac rehabilitation of selected patients after a 
recent CAD event, such as those with concomitant musculoskeletal conditions, frailty, or at risk of 
falls, or for those who may personally prefer water-based exercise training.  
Observations in our study apply exclusively to clinically stable low-risk patients with stable sinus 
rhythm, with preserved left ventricular ejection fraction, with no heart valve defect that dictating 
specific treatment and severe degree of obstructive/restrictive lung disease or recent 
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Walther, Claudia, Sven Möbius-Winkler, Axel Linke, Mathias Bruegel, Joachim Thiery, Gerhard 
Schuler, and Rainer Halbrecht. “Regular Exercise Training Compared with Percutaneous Intervention 
Leads to a Reduction of Inflammatory Markers and Cardiovascular Events in Patients with Coronary 
Artery Disease.” European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal 
of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac 
Rehabilitation and Exercise Physiology 15, no. 1 (February 2008): 107–12.  
https://doi.org/10.1097/HJR.0b013e3282f29aa6. 
 
Wan, Siu-Hin, Paul M. McKie, John A. Schirger, Joshua P. Slusser, David O. Hodge, Margaret M. 
Redfield, John C. Burnett, and Horng H. Chen. “Chronic Peptide Therapy With B-Type Natriuretic 
Peptide in Patients With Pre-Clinical Diastolic Dysfunction (Stage B Heart Failure).” JACC: Heart 
Failure 4, no. 7 (July 2016): 539–47. https://doi.org/10.1016/j.jchf.2015.12.014. 
 
Wang, J., M. S. Wolin, and T. H. Hintze. “Chronic Exercise Enhances Endothelium-Mediated Dilation 
of Epicardial Coronary Artery in Conscious Dogs.” Circulation Research 73, no. 5 (November 1993): 
829–38. https://doi.org/10.1161/01.res.73.5.829. 
 
Wang, Jong-Shyan, Yu-Wen Chen, Shu-Er Chow, Hsiu-Chung Ou, and Wayne Huey-Herng Sheu. 
“Exercise Paradoxically Modulates Oxidized Low Density Lipoprotein-Induced Adhesion Molecules 
Expression and Trans-Endothelial Migration of Monocyte in Men.” Thrombosis and Haemostasis 94, 
no. 4 (October 2005): 846–52. https://doi.org/10.1160/TH05-02-0139. 
 
Wannamethee, S. Goya, Peter H. Whincup, Lucy Lennon, Olia Papacosta, and Gordon D. Lowe. 
“Associations Between Fibrin D-Dimer, Markers of Inflammation, Incident Self-Reported Mobility 
Limitation, and All-Cause Mortality in Older Men.” Journal of the American Geriatrics Society 62, no. 
12 (December 2014): 2357–62. https://doi.org/10.1111/jgs.13133. 
 
Ware, J. E., and M. Kosinski. “Interpreting SF-36 Summary Health Measures: A Response.” Quality 
of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and 
Rehabilitation 10, no. 5 (2001): 405–13; discussion 415-420.  
https://doi.org/10.1023/a:1012588218728. 
 
Ware, J. E., M. Kosinski, M. S. Bayliss, C. A. McHorney, W. H. Rogers, and A. Raczek. “Comparison of 
Methods for the Scoring and Statistical Analysis of SF-36 Health Profile and Summary Measures: 
 
166 
Summary of Results from the Medical Outcomes Study.” Medical Care 33, no. 4 Suppl (April 1995): 
AS264-279. 
 
Ware, John E., and Cathy Donald Sherbourne. “The MOS 36-Ltem Short-Form Health Survey (SF-36): 
I. Conceptual Framework and Item Selection.” Medical Care 30, no. 6 (June 1992): 473–83. 
https://doi.org/10.1097/00005650-199206000-00002. 
 
Ware, John E., Mark Kosinski, and James E. Dewey. How to Score Version 2 of the SF-36 Health 
Survey: (Standard & Acute Forms) ; [SF-36v2]. 3. ed. Lincoln, RI: QualityMetric, 2001. 
Wegge, Julia K., Christian K. Roberts, Tung H. Ngo, and R. James Barnard. “Effect of Diet and Exercise 
Intervention on Inflammatory and Adhesion Molecules in Postmenopausal Women on Hormone 
Replacement Therapy and at Risk for Coronary Artery Disease.” Metabolism: Clinical and 
Experimental 53, no. 3 (March 2004): 377–81. https://doi.org/10.1016/j.metabol.2003.10.016. 
 
Wei, Gao, Ren Yaqi, Wang Ningfu, and Hou Xuwei. “N-Terminal Prohormone B-Type Natriuretic 
Peptide and Cardiovascular Risk in Stable Coronary Artery Disease: A Meta-Analysis of Nine 
Prospective Studies.” Reviews in Cardiovascular Medicine 14, no. 2–4 (2013): e92-98. 
 
Weiss, C., T. Velich, J. Niebauer, K. Hauer, B. Kälberer, W. Kübler, and P. Bärtsch. “Activation of 
Coagulation and Fibrinolysis after Rehabilitative Exercise in Patients with Coronary Artery Disease.” 
The American Journal of Cardiology 81, no. 6 (March 15, 1998): 672–77. 
https://doi.org/10.1016/s0002-9149(97)01026-6. 
 
Wennerblom, Bertil, Leon Lurje, Jens Solem, Hans Tygesen, Marita Udén, Rein Vahisalo, and Åke 
Hjalmarson. “Reduced Heart Rate Variability in Ischemic Heart Disease Is Only Partially Caused by 
Ischemia.” Cardiology 94, no. 3 (2000): 146–51.https://doi.org/10.1159/000047309. 
 
Wentzel, J. J., Y. S. Chatzizisis, F. J. H. Gijsen, G. D. Giannoglou, C. L. Feldman, and P. H. Stone. 
“Endothelial Shear Stress in the Evolution of Coronary Atherosclerotic Plaque and Vascular 
Remodelling: Current Understanding and Remaining Questions.” Cardiovascular Research 96, no. 2 
(November 1, 2012): 234–43. https://doi.org/10.1093/cvr/cvs217. 
 
Werner, Christian, Tobias Fürster, Thomas Widmann, Janine Pöss, Cristiana Roggia, Milad Hanhoun, 
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8.1. LIST OF ABBREVIATIONS 
 
ACS   - acute coronary syndrome 
AE   - aerobic exercise 
aHF   - absolute value in high frequency 
aLF   - absolute value in low frequency  
aTotal   - total power, variance of all NN intervals  
aVLF  - absolute value in very low frequency 
BAFMD - brachial artery flow-mediated dilation 
BMO   - body-mass index 
BP  - bodily pain 
CABG   - coronary-artery bypass surgery 
CAD    - coronary artery disease 
CAMs  - cell adhesion molecules 
CBF   - coronary blood flow 
CG    - control group 
CHF   - chronic heart failure 
CI  - cardiac index 
CO   - cardiac output 
CPET   - cardiopulmonary exercise test 
CR  - cardiac rehabilitation 
CVD   - cardiovascular disease 
CVP  - central venous pressure 
CW  - cold water immersion 
DAP   - diastolic atrial pressure 
DBP   - diastolic blood pressure 
DM   - diabetes mellitus  
ESS   - endothelial shear stress 
FMD   - flow-mediated dilatation 
GH   - general health  
HbA1c   - glycated hemoglobin 
HDL-C  - high-density lipoprotein cholesterol  
HR  - heart rate   
HRQoL  - health-related quality of life 
HRV   - heart rate variability 
HRVti   - heart rate variability triangular index  
hsCRP    - high-sensitivity C-reactive protein 
IBI   - interbeat interval  
ICAM-1 - intercellular adhesion molecule-1 
IHD   - ischemic heart disease 
IL   - interleukin  
INF-   - interferon-gamma 
LAD   - left atrial diameter 
LAV    - left atrial volume 
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LDL-C   - low-density lipoprotein cholesterol 
LEx   - land-based exercise 
LF/HF   - ratio of normalized low- and high-frequency power  
LVEDD  - left ventricular end-diastolic diameter 
LVEDV  - left ventricular end-diastolic volume 
LVEF   - left ventricular ejection fraction 
LVESV    - left ventricular end-systolic volume  
MAP   - mean atrial pressure 
MCS   - mental component summary 
METs   - metabolic equivalents 
MH   - mental health 
MI  - myocardial infarction 
nHF  - power in the high-frequency range, normalized 
nLF  - power in the low-frequency range, normalized 
NMD  - nitroglycerin-mediated dilatation 
NNx   - number of valid adjacent NN values not separated by data breaks 
NO   - nitric oxide 
NT-proB-NP  - N-terminal probrain-type natriuretic peptide 
oxLDL   - oxygenated LDL 
PAI–1   - plasminogen activator inhibitor 
Pam   - mean pulmonary artery pressure 
PCI   - percutaneous coronary intervention 
PCPm   - mean pulmonary capillary pressure 
PCS   - physical component summary 
Peak HF  - peak frequency of the high-frequency band 
Peak LF  - peak frequency of the low-frequency band 
Peak VLF  - peak frequency of the very low-frequency band  
PF   - physical functioning 
pLF   - power of the low-frequency band 
pHF   - power of the high-frequency band 
pNNx   - proportion of valid adjacent RR values not separated by data breaks 
PP  - pulse pressure 
PR   - pulse rate 
PVCs   - premature ventricular contractions 
pVLF   - power of the very low-frequency band 
PVR   - peripheral vascular resistance 
PWP   - pulmonary wedge pressure 
RAAS   - renin–angiotensin–aldosteron system 
RE   - resistance exercise 
RER   - respiratory exchange ratio  
 rMSSD - root mean square of successive NN interval differences 
ROS   - reactive oxygen species 
eNOS   - nitric oxide synthase 
RP   - role functioning limitations due to physical problems 
RPE   - rate of perceived exertion 
SampEn - sample entropy 
SaO2   - oxygen saturation 
SAP   - systolic atrial pressure 
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SD1   - Poincaré plot standard deviation perpendicular to the line of identity  
SD2   - Poincaré plot standard deviation along the line of identity 
SDANN - standard deviation of the average NN interval calculated over short periods 
SDHR   - standard deviation of heart rate 
SDNN   - standard deviation of all normal R–R (NN) intervals 
SDNNi  - mean of the standard deviations of all NN intervals for each 5 min segment  
SF   - social functioning 
SPB   - systolic blood pressure 
SV   - stroke volume 
SVR   - systemic vascular resistance 
t-PA   - tissue plasminogen activator 
T2D   - type 2 diabetes mellitus 
TAPSE   - tricuspid annular plane systolic excursion 
TC   - total cholesterol 
TG   - triglycerides 
TH   - T-helper cells 
TINN   - triangular interpolation interval histogram  
TNF-   - tumor necrosis factor-alpha  
Treg   - regulatory T-cells 
Vc  - vital capacity 
VCAM-1  - vascular adhesion molecule-1 
VEmax  - maximum minute ventilation 
V̇O2 peak - peak oxygen uptake 
WEx   - water-based exercise 
WI   - water immersion 
WWI   - warm water immersion 
1   - detrended fluctuation analysis describing short-term fluctuations 
2   - detrended fluctuation analysis describing long-term fluctuations 




8.2. LIST OF FIGURES 
 
Fig. 1.   Patient selection and study design flowchart - p. 74 
Fig. 2.   Characteristics of the patient groups by underlying disease - p. 82 
Fig. 3.   Mean age of the patients by group - p. 82 
Fig. 4.   Comparison of mean relative (%) changes in peak oxygen consumption for each      
study group - p. 85 
Fig. 5.  Comparison of mean relative (%) changes in VO2 for each group - p. 86 
 
Fig. 6.  Changes in aerobic exercise capacity (peak oxygen consumption) expressed on a 
logarithmic scale - p. 86 
Fig. 7.  Comparison of mean relative (%) changes in peak workload for each study group - p. 
87 
Fig. 8.  Comparison of mean relative (%) changes in time-to-exhaustion for each group - p. 87 
Fig. 9.   Comparison of mean relative (%) changes in FMD for each study group - p. 89 
Fig. 10. Comparison of mean relative (%) changes in NMD for each study  group - p. 90 
Fig. 11. Changes in flow-mediated dilatation and non-flow-mediated dilatation expressed on 
a logarithmic scale - p. 90 
Fig. 12. Change in IBI and time-domain HRV parameters for each study group at baseline and  
after training, and between-group differences - p. 93 
Fig. 13. Change in frequency domain: Welch – HRV parameters for the three study groups at 
baseline and after training, and between group differences - p. 95 
Fig. 14. Change in Poincaré and nonlinear HRV parameters for the three study groups at 
baseline and after training, and between-group differences - p. 97 
Fig. 15.Comparison of mean relative (%) changes in D-dimer values for each study group - p. 
100 
Fig. 16. Comparison of mean relative (%) changes in NT-proBNP values for each study group - 
p. 100 
Fig. 17. Comparison of mean relative (%) changes in physical component summary for each 
study group - p. 103 
Fig. 18. Comparison of mean relative (%) changes in mental component summary for each 
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Table 1. Studies examining the effect of water immersion in coronary and CHF patients - p. 
59 
Table 2. Water-based exercise studies in patients with coronary artery disease - p. 62 
 
Table 3. Water-based exercise studies in CHF patients, prehypertensive patients, and 
patients with osteoarthritis - p. 65 
 
Table 4. Baseline characteristics of the patients who completed the study and between-
group differences (data are shown as frequencies and percentages if not indicated 
otherwise) - p. 83 
 
Table 5. Exercise capacity measurements for the three study groups at baseline and after 
training, and between group differences - p. 85 
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NAVODILA: Vprašalnik sprašuje o tem, kako gledate na svoje zdravje. Iz odgovorov bomo zvedeli, kako se 
počutite in kako dobro lahko opravljate svoja običajna opravila. 
 
Odgovorite na vsa vprašanja tako, da izberete in označite odgovor. Če niste prepričani, kako odgovoriti na 
katero od vprašanj, izberite odgovor, ki je po vašem mnenju najboljši. 
 
 


















2.   Kako bi sedaj na splošno ocenili svoje zdravje, če ga primerjate s svojim zdravjem pred enim letom? 
(obkrožite eno številko) 
Veliko boljše kot pred enim letom..............................................................................1 
 
Nekoliko boljše kot pred enim letom..........................................................................2 
 
Približno enako kot pred enim letom .........................................................................3 
 
Nekoliko slabše kot pred enim letom.........................................................................4 
 





3.   Naslednja  vprašanja  zadevajo  stvari,  ki  jih  najbrž  počnete  ob  običajnih  dnevih.  Vas  zdaj  vaše 
zdravstveno stanje pri teh dejavnostih ovira? Če vas ovira, ocenite v kakšni meri: 
 













a. Težka   opravila,   recimo   tek,   vzdigovanje   težkih 







b. Zmerno  težka  opravila,  recimo  premikanje  mize, 












































































4.   Ste imeli v preteklih 4 tednih zaradi telesnega zdravja pri delu ali pri drugih rednih dnevnih opravilih 
katerega od naštetih problemov? 
 
(v vsaki vrsti obkrožite eno številko) 
 
 DA NE 












c. Ste bili omejeni tako, da niste mogli opravljati določene 





d. Ste s težavo opravljali delo ali druge dejavnosti (tako, da 










5.   Ste imeli v preteklih  4 tednih zaradi čustvenih  težav (recimo da ste bili potrti ali zelo zaskrbljeni)  pri 
svojem delu ali pri drugih rednih dnevnih opravilih katerega od naštetih problemov? 
 
(v vsaki vrsti obkrožite eno številko) 
 
 DA NE 
a.         Ste morali skrajšati čas namenjen delu ali drugim dejavnostim? 1 2 
b.         Ste postorili manj kot bi želeli? 1 2 






6. Koliko so v preteklih 4 tednih vaše telesno zdravstveno stanje ali čustvene težave ovirale vaše običajno 
družabno življenje v krogu družine, prijateljev, sosedov, ali drugih ljudi? 
 













7.   Ste v preteklih 4 tednih v telesu čutili kakšne bolečine? 
 
(obkrožite eno številko) 
Nobenih .....................................................................................................................1 













8.   Koliko so vas v preteklih 4 tednih bolečine ovirale pri vašem običajnem delu (tako izven doma kot pri 
hišnih opravilih)? 











9.   Ta vprašanja sprašujejo o tem, kako ste se počutili in kako vam je šlo v preteklih 4 tednih. Za vsako 
vprašanje poiščite odgovor, ki najbolje opisuje, kako ste se počutili. Koliko časa v zadnjih 4 tednih ste bili: 















































c. Tako na tleh, da vas nič ni 












































































































10. Koliko časa so vas v preteklih 4 tednih vaše telesno zdravstveno stanje ali čustvene težave 
ovirale pri družabnem življenju (na primer pri srečanjih s prijatelji, sorodniki, itd.)? 
 
(obkrožite 
























11. Koliko vsaka od naslednjih trditev za vas DRŽI ali NE DRŽI? 
 


















a. Zdi se mi, da malo hitreje 












b. Tako zdrav sem kot vsi 
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